How To Treat A Mental Illness

Transcription

1 Ira David Glick, MD Pacific Research Partners, LLC 1611 Telegraph Avenue, Suite 100 & Suite 1550 Oakland, CA CONTACT INFORMATION: Site Selection and Information: Bobbie Theodore, Site Liaison Tel. (866) Fax (208) AFFILIATIONS: Collaborative Neuroscience Network, LLC Valley View Street, Suite 3 Garden Grove, CA Collaborative Neuroscience Network, LLC Redondo Avenue, Suite 500 Long Beach, CA Collaborative Neuroscience Network, LLC S. Vermont Avenue, Suite F-100 Torrance, CA Stanford University Medical Hospital EDUCATION: 1957 B.S., Dickinson College, Carlisle, Pennsylvania 1961 M.D., New York Medical College INTERNSHIPS AND RESIDENCIES: Candidate, New York Psychoanalytic Institute, New York, NY Rotating Internship, Beth Israel Hospital, New York, NY Psychiatry Residency: First Year Resident, Hillside Hospital, Glen Oaks, New York Second Year Resident, Mt. Zion Hospital, San Francisco, CA Chief Resident, Hillside Hospital 12/31/

2 LICENSURE: New York State Medical License 1963 Diplomate of the National Board of Medical Examiners 1963 California State Medical License - (G 9084) 1968 Diplomate of the American Board of Psychiatry and Neurology 1980 Mental Health Administrator, Commission on Certification in Administrative Psychiatry of the American Psychiatric Association Maryland Medical License (License number available on request) PROFESSIONAL EXPERIENCE: Principal Investigator, Present Pacific Research Partners, Oakland, CA Professor Emeritus, Psychiatry, June 2010 Present Director, Schizophrenia Research Clinic, 1993 June 2010 Director of Inpatient & Partial Hospitalization Services, Stanford University School of Medicine & Stanford University Hospital Acting Deputy Chief of Staff and Chief of Psychiatry, Veterans Administration Hospital, Palo Alto, CA Associate Medical Director, Payne Whitney Clinic, Department of Psychiatry, The New York Hospital Senior Science Advisor to the Director, National Institute of Mental Health, Rockville, MD Director, Inpatient Services, Director, of the Family Therapy Program, Director, Outpatient Department, Cornell Medical Center Chief, Clinical Research Ward, (Renamed the Inpatient Treatment & Research Service, 5/1/75) Director, Medical Student Education, Langley Porter Neuropsychiatric Institute and Dept. of Psychiatry, School of Medicine University of California, San Francisco Service Record: Captain, Army of the United States, Chief, Psychiatry Service, U.S. Army Hospital Specialized Treatment Center, Fort Gordon, Georgia 12/31/

3 PROFESSIONAL EXPERIENCE (continued): Staff Psychiatrist and Research Associate, Hillside Hospital, Glen Oaks, New York INVESTIGATOR EXPERIENCE: INTEREST: Adolescent Psychiatry Anxiety Bipolar Disorder Depression Insomnia Mania Schizophrenia ADHD Alzheimer s Disease Anxiety Dementia Multiple Sclerosis Post Traumatic Stress Disorder (PTSD) Sleep Disorders CLINICAL TRIAL EXPERIENCE: Addiction A Phase III, multi center, double blind, placebo controlled, randomized withdrawal study to evaluate the maintenance and efficacy of XXX in adults aged with moderate to severe binge eating A Twelve-week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Doseranging Study with Follow-up Evaluating the Safety and Efficacy of XXX for Smoking Cessation in Healthy Adolescent Smokers A Phase III, Multicenter, Open-label, 12-month Extension Safety and Tolerability Study of XXX in the Treatment of Adults with Binge Eating Disorder A Phase III, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Dose-optimization Study to Evaluate the Efficacy, Safety, and Tolerability of XXX in Adults Aged Years with Moderate to Severe Binge Eating Disorder Bipolar Disorders A Phase III, 52-week, Multicenter, Open-label Study to Evaluate the Effectiveness of an Intramuscular Depot Formulation of XXX as Maintenance Treatment in Patients with Bipolar I Disorder A Randomized, Double-Blind, Placebo-Controlled, Phase III Study to Evaluate the Efficacy and Safety of Once a Day, XXX as an Adjunctive Therapy to Treatment-as- Usual in the Maintenance Treatment of Bipolar 1 Disorder in Adult Subjects 12/31/

4 CLINICAL TRIAL EXPERIENCE (continued): A Randomized, Double-Blind, Placebo-Controlled, Phase III Study to Evaluate the Efficacy and Safety of Once a Day, XXX Tablet for Sublingual Administration XXX in the Treatment of Acute Depressive Episodes Associated With Bipolar 1 Disorder in Adult Subjects Who Are on Lithium or Valproate A Phase IIIb, Double-Blind, Placebo-Controlled Trial of XXX in the Prevention of Recurrence of a Mood Episode After Stabilization of an Acute Manic/Mixed Episode in Subjects With Bipolar 1 Disorder Depression A Double-Blind, Placebo-Controlled, Randomized Add-On Study of XXX for Patients With Major Depressive Disorder (MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy A Phase III, Open-Label Extension Study to Assess the Safety and Tolerability of Treatment With XXX in Patients Who Have Completed Study XXX A Phase II, Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of XXX in the Adjunctive Treatment of Subjects with Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment A Phase III Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of XXX vs. Placebo in the Treatment of Psychotic Symptoms in Patients with Major Depressive Disorder with Psychotic Features A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of XXX in Major Depressive Disorder A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Active-Referenced, Flexible Dose Study on the Efficacy of XXX on Cognitive Dysfunction in Adult Subjects with Major Depressive Disorder A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Active Controlled, Parallel Group, Multicenter Study to Assess the Safety and Efficacy of 2 Fixed Dose Groups of XXX as Monotherapy Treatment in Patients with Major Depressive Disorder with an Inadequate Response to Antidepressant Therapy A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of XXX Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment 12/31/

5 CLINICAL TRIAL EXPERIENCE (continued): A Phase III,Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Flexible Dose Titration, Efficacy and Safety Study of XXX in Combination with an Antidepressant in the Treatment of Adults with Major Depressive Disorder with Inadequate Response to Prospective Treatment with an Antidepressant A Multicenter, Randomized, Double-Masked, Placebo-Controlled, Parallel Study to Investigate the Safety and Efficacy of 20 mg XXX versus Placebo in Adult Subjects with Major Depressive Disorder Followed by a 52-week Open-label Extension A Phase III, Open-label, Multicenter, 12-month Extension Safety and Tolerability Study of XXX in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder With Residual Symptoms or Inadequate Response Following Treatment With an Antidepressant A Phase IV, Multicenter, Randomized, 8-week, Double-blind, Placebo-controlled, Parallel-group, Study to Evaluate the Efficacy of Two Fixed Doses (50 and 100 MG/Day) of XXX in Adult Outpatients with Major Depressive Disorder (MDD) A Phase III,, Multicenter, Randomized, Double-Blind, Parallel Group, Placebo- Controlled, Efficacy and Safety Study of 3 Fixed Dose Groups of XXX as an Adjunct to an Antidepressant in Patients with Major Depressive Disorder Who Exhibit an Inadequate Response to Antidepressant Therapy. A Phase III, Long-Term, Open-Label, Flexible-Dose, Extension Study Evaluating the Safety and Tolerability of XXX in Subjects With Major Depressive Disorder A Phase III, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed-Dose Study Comparing the Efficacy and Safety of 2 Doses (10 and 15 mg) of XXX in Acute Treatment of Adults With Major Depressive Disorder A Phase III, Randomized Placebo-Controlled, Double-Blind Study of XXX Flexible- Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients with Major Depressive Disorder Who Are Partial Responders to XXX Treatment. A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Phase III, Efficacy and Safety Study of XXX in Flexible Doses as an Adjunct to an Antidepressant in Patients with Major Depressive Disorder Who Exhibit an Inadequate Response to Antidepressant Therapy. A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III, Long-Term Safety and Tolerability Study of XXX as an Adjunct to an Antidepressant in Patients with Major Depressive Disorder Who Exhibit an Inadequate response to Antidepressant Therapy 12/31/

6 CLINICAL TRIAL EXPERIENCE (continued): Schizophrenia An Exploratory, Multicenter, Open-label, Flexible-dose XXX Trial in the Treatment of Adults with Early-Episode Schizophrenia A 12-Week, Randomized, Phase II, Double-blind, Parallel-group, Study of Two Dose Levels of XXX Compared to Placebo in the Adjunctive Treatment of Outpatients with Sub-Optimally Controlled Symptoms of Schizophrenia A Phase II, Randomized, Multicenter Study to Evaluate the Efficacy and Safety of XXX for the Treatment of Schizophrenia to Mitigate or Prevent XXX -Induced Weight Gain A Phase III, Multicenter, Extension of Study XXX to Assess the Long-term Safety and Durability of Effect of XXX in Subjects with Stable Schizophrenia A Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of XXX in Subjects with Acute Exacerbation of Schizophrenia A Phase II, partial-blind, multi-center extension study to evaluate the long-term safety and health outcomes of XXX in subjects who completed Study XXX (Long-Term Safety and Efficacy of XXX in Subjects with Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study XXX) A 12-week, Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of XXX in the Acute Treatment of Adults With Schizophrenia A 12-week, Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of XXX in the Acute Treatment of Adults With Schizophrenia A Randomized, Double-blind, Placebo-controlled, Parallel, 12 Week, Phase III Study of 2 Doses of XXX or Placebo as an Adjunctive Pro-cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy A Phase III Multicenter 40-Week Extension Study to Evaluate the Safety and Clinical Effects of Prolonged Exposure to 1 and 2 mg Doses of XXX as an Adjunctive Pro cognitive Treatment in Subjects with Schizophrenia on Chronic Stable Atypical Antipsychotic Therapy A Phase IIb, 12 week randomized, double-blind, placebo-controlled, parallel group, multiple dose, proof-of-concept study to evaluate the effects of XXX on cognition in stable schizophrenia patients 12/31/

7 CLINICAL TRIAL EXPERIENCE (continued): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, Parallel-group, Phase II Study of the Safety and Efficacy of XXX in the Treatment of Cognitive Deficits in Schizophrenia (CDS) in Non-smokers A Phase III, Randomized, Multicenter, Double-Blind, Non-inferiority Study of XXX 3 Month and 1 Month Formulations for the Treatment of Subjects with Schizophrenia A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of XXX on Schizophrenia Negative Symptoms A Multicenter, Open-label, Single-arm Flexible Dose (20-80 mg Twice Daily, Phase III Study of XXX in Outpatients who complete (rollover) a previous XXX Study and a Study duration of up to 2 years after US XXX Monotherapy Launch A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on XXX on Schizophrenia Negative Symptoms A Phase III, Short-term, Muticenter, Placebo-controlled, Randomized Withdrawal Study of XXX Monohydrate with DSM-IV-TR Schizophrenia A Phase III, Multicenter, Open-label Study to Assess Hospitalization Rates in Adult Subjects with Schizophrenia Treated Prospectively for 6 Months with XXX Compared with 6-month Retrospective Treatment with Oral Antipsychotics in a Naturalistic Community Setting in the United States A Fifteen-Month, Prospective, Randomized, Active-Controlled, Open-Label, Flexible- Dose Study of XXX Compared with Oral Antipsychotic Treatment in Delaying Time to Treatment Failure in Adults with Schizophrenia Who Have Been Incarcerated A Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Three Fixed Doses of XXX in the Treatment of Adults With Acute Schizophrenia A Multicenter, Double-Blind Comparison of XXX and Aripiprazole in Patients with DSM-IV-TR Schizophrenia Followed by Open-Label Treatment with XXX A Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Three Fixed Doses of XXX in the Treatment of Adults With Acute Schizophrenia A Phase III, Multicenter, Double-Blind, Placebo-Controlled Study of 3 Doses of XXX versus Placebo in Patients with DSM-IV-TR Schizophrenia A Long-Term, Open-Label, Multicenter Study of XXX Compared to Atypical Antipsychotic Standard of Care in Patients with DSM-IV-TR Schizophrenia 12/31/

8 CLINICAL TRIAL EXPERIENCE (continued): A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of XXX Evaluating Time to Relapse in Subjects With Schizoaffective Disorder A Randomized, 6-week, Open-Label Study Evaluating the Safety, Tolerability, and Efficacy of XXX for the Treatment of Schizophrenia or Schizoaffective Disorder in Subjects SWITCHED From Other Antipsychotic Agents and A 24-Week, Flexible- Dose, Open-label Extension Study of Subjects Switched to XXX for the Treatment of Schizophrenia or Schizoaffective Disorder A 12-week, Randomized, Multicenter, Open-label, XXX Flexible Dose Study Assessing Efficacy, Safety and Tolerability of Two Switch Approaches in Schizophrenia Patients Currently Receiving XXX or XXX 12/31/

9 FUNDED RESEARCH ACTIVITIES: G.D. Searle Research Grant for the study Pseudopregnancy Treatment of Periodic Psychiatric Illness National Institute of Mental Health Grant for the project MH Short vs. Long Psychiatric Hospitalization: A Controlled Study $133,000, Supplement $ 25, Lederle Research Grant for the study XXX Treatment in Schizophrenia Endo Research Grant for the study XXX vs. XXX: Double Blind Investigation of the Treatment of Acute Schizophrenia National Institute of Mental Health Grant for Medical Student Psychiatric Education, $395, Vice Chancellor's Advisory Committee on Instructional Improvements Grant, UCSF, for project Effectiveness and Efficiency in Small Group Teaching with Mary Malloy, MD $ 1, National Institute of Mental Health - Biomedical Research Support Grant for the study Inpatient Family Intervention: A Controlled Study $ 15, National Institute of Mental Health Contract -to develop a Model Psychopharmacology Curriculum for Psychiatric Residency Training (with David Janowsky MD) under the auspices of the American College of Neuropsychopharmacology $ 4, National Institute of Mental Health Grant for project Inpatient Family Intervention: Evaluation of Practice, $180, National Institute of Mental Health, Cooperative Clinical Agreement Award for the project, Treatment Strategies in Schizophrenia, $863, Supplement $104, Competitive Renewal $688, Supplement $30,000 12/31/

10 FUNDED RESEARCH ACTIVITIES (continued): 1987 XXX Research Award for the project, Delivery and Compliance to Good Medical Treatment $ 20, XXX Grant for the study, XXX in the Treatment of the Negative Symptoms of Schizophrenia National Institute of Mental Health Grant, Marital Treatment for Bipolar Disorder Patients, Co-Principal Investigator with John Clarkin, PhD, P.I. $520, (Cornell) XXX Research Grant for the study: XXX in the & Prevention of Mania 1993 (Stanford) 1992 XXX Research Grant for the study: XXX for the Treatment of Schizophrenia and Schizoaffective Disorder 1992 (Cornell) XXX Research Grant for the study: The Safety and Efficacy of XXX in Schizophrenic Patients 1993 (Stanford) A Double-Blind, Haldol-Referenced, Placebo-Controlled Study 1993 Pharmacologic Medication Discovery & Development Project (PMDDP) Supported by XXX $10, XXX for the Study, Treatment of Adolescent Depression with XXX 1993 XXX Grant for the study, Safety and Efficacy of XXX in the Prevention of Mania in Patients With Bipolar Disorder 1995 XXX Unrestricted grant to develop a Model Psychopharmacology Curriculum for Residents (Committee Chair) under the auspices of the American Society of Clinical Psychopharmacology 1995 XXX Research Grant for the study, XXX versus XXX in the Treatment of Schizophrenia and other Psychotic Disorders 1995 XXX Grant for the study, Dose-Response Study in the Treatment of Negative Symptoms of Schizophrenia with XXX $50,000 12/31/

11 FUNDED RESEARCH ACTIVITIES (continued): 1995 XXX Research Grant for the study, A Comparative Cost Effectiveness Study of XXX and Usual Care versus XXX and Usual Care in the Treatment of Bipolar Disorder 1996 XXX Research Grant for the study, A Multi-center, Open, Randomized Comparison of and Usual Care on Health Outcomes in Subjects with Schizophrenia and Schizoaffective Disorder 1997 XXX Research Grant for the study, A Multi-center, Randomized, Double-Blind, Placebo and Active Controlled Study of XXX in Schizophrenic and Schizoaffective Patients 1997 XXX Research Grant for the study, A Phase III Double-Blind Placebo-Controlled Study of XXX in the Treatment of Psychosis, with XXX as Active Control 1998 XXX Corporation, A Prospective, Randomized, International, Parallel-group Comparison of XXX vs. XXX in the Reduction of Suicidality in Patients with Schizophrenia or Schizoaffective Disorder Who Are at Risk for Suicide 1998 Research Grant for the investigator initiated study, XXX vs XXX for the Long-Term Treatment of Schizophrenia and Schizoaffective Disorder with Marder S. $100, XXX, The Acute and Long-Term Efficacy of XXX in First-Episode Psychotic Disorders: A Randomized Double-Blind Comparison with XXX 1998 XXX Pharmaceuticals, A Multi-Center, Placebo Controlled Double Blind Study Comparing the Safety and Efficacy of XXX with Schizophrenia or Schizoaffective Disorder Needing Inpatient Care XXX, XXX vs. Placebo in the Treatment of Subjects with Schizophrenia or Schizoaffective Disorder 2009 Educational Outreach Initiative Grant $5, XXX, A Multi-center, Double-Blind, Randomized, Active-Controlled, Study to Evaluate the Long-term Efficacy, Safety and Tolerability of an Intramuscular Depot Formulation of XXX in Patients with Schizophrenia 12/31/

12 FUNDED RESEARCH ACTIVITIES (continued): 2008 Schizophrenia Trials Network associated with NIMH Contract XXX Comparison of Optimal Antipsychotic Treatment for Schizophrenia (COATS: A Pilot Study) XXX in the Treatment of Antipsychotic-Induced Weight Gain in Schizophrenia (METS: A Pilot Study) 2008 Keeping Up With Advances in Psychopharmacology in the New Millenium, four lectures at medical schools in Israel, supported by the Sarlo Fund and the Ingrid D. Tauber Philanthropic Fund from the Jewish Community Endowment Fund, San Francisco, June, $4, XXX, Validation of the Reasons for Antipsychotic Discontinuation/Continuation Questionnaire (RAD-Q) and Interview (RAD-I) 2007 A Six Week, Double-Blind, Placebo-Controlled Phase III Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of Flexible Doses of Oral XXX in Adolescents with Schizophrenia XXX, A Randomized, Double-Blind, Parallel-Group, Flexible-Dose Study Exploring the Neurocognitive Effect Of XXX Versus XXX In Patients With Schizophrenia Using the XXX 2007 American College of Neuropsychopharmacology, ACNP Public Outreach Initiative Schizophrenia Education Day. (also supported by XXX) $5, XXX, An Open-Label Study of Equetro in Outpatients with Aggressive Symptoms & Behavior (investigator initiated study) $125, XXX, A Multi-center, Randomized, Double-Blind, Placebo-Controlled, 16-week Study of XXX Used as Dual Therapy in the Treatment of Patients with Chronic Stable Schizophrenia or Schizoaffective Disorder Demonstrating an Inadequate Response to XXX Monotherapy XXX, A Multi-center, Double-Blind, Flexible-Dose, 6-month Trial Comparing the Efficacy and Safety of XXX in Stable Subjects with Predominant, Persistent Negative Symptoms of Schizophrenia CAMP (Foundation for NIH), Clinical Management of Metabolic Problems in Patients with Schizophrenia: Switching to XXX vs. XXX $116,900 12/31/

13 FUNDED RESEARCH ACTIVITIES (continued): 2005 American College of Neuropsychopharmacology, ACNP Public Outreach Program $ 5, XXX vs. XXX Double Blind. (investigator initiated Study) $120, XXX, Parallel-Group Efficacy and Safety Study of Two Fixed Doses of XXX in the Treatment of Schizophrenia Co-Investigator of a XXX Grant for a project Fostering Collaboration Through Clinical Education: A Clinical Neurosciences Seminar, Clinic and Curriculum Series in Child Psychiatry and Pediatric Neurology (with Joshi SV, Chang KD and Hahn J) XXX Education Fund 2004 XXX, Comparison of Atypicals for First Episode (CAFE) $30, XXX, The Treatment of Schizophrenia and OCD Symptomatology with XXX (investigator initiated study). $80, XXX, Efficacy and Weight Reduction Effects of XXX in Stabilized Patients with Schizophrenia and Weight Associated with Atypical Antipsychotics (investigator initiated study with Reaven). $105, XXX, An Open-Label Follow-Up Study of the Long-Term Safety of XXX in Patients with Psychosis Pfizer, Zodiac International Schizophrenia Study to Compare the Cardiovascular Safety of XXX and XXX XXX, A 12 Week Multicenter, Randomized, Double-Blind, Placebo Controlled Evaluation of XXX as Adjunctive Therapy in the Treatment of Cognitive Impairment in Patient with Schizophrenia or Schizoaffective Disorder 2001 XXX, A Multicenter, Randomized, Double-Blind, Placebo Controlled Study of Flexible Doses of XXX Versus XXX In the Treatment of Patients with Treatment-Resistant Schizophrenia 12/31/

14 FUNDED RESEARCH ACTIVITIES (continued): 2000 National Institute of Mental Health, sub-contract, Comparative Effectiveness of Antipsychotic Medications in Patients with Schizophrenia CATIE. Human Genetics Initiative $550, Development of a Model Psychopharmacology Curriculum for Psychiatric Residents. (through the American Society of Clinical Psychopharmacology) Supported in part by XXX $15,000 EDITORIAL AND ADVISORY BOARDS: Family Process 1981 Journal of Clinical Psychopharmacology 1981 Contemporary Family Therapy - An International Journal The Journal of Family Therapy (England) Board of Advisors, Dickinson College The Journal of Family Psychotherapy National Council of Advisors on Development and External Affairs, UCSF 1989 Progress in Neuropsychology and Biological Psychiatry Advisory Board, MultiMedia Reviews in Psychiatry, Massachusetts General Hospital Board Member, The National Mental Health Project 1993 Sertindole Advisory Board,, Neuroscience Venture, Abbott Laboratories Gralnick Foundation Awards Committee 1996 CNS Science Advisory Board, Wyeth Ayerst Pharmaceutical Advisory Board, Janssen Pharmaceutica and Research Foundation Advisory Board, Institute for Healthcare Quality, Minneapolis 1997 Advisory Board, Zeneca Pharmaceuticals 12/31/

15 EDITORIAL AND ADVISORY BOARDS (continued): 1998 Advisory Board, Otsuka Pharmaceuticals 1999 Advisory Board, Hoechst Marion Roussel (Aventis) 1999 Advisory Board, NPSP Pharmaceuticals Bipolar Clinical Advisory Board, Boca Raton 2001, 2005 Advisory Board, Pfizer (Geodon) Pharmaceuticals 2001 Board of Directors, National Foundation for Depressive Illness, Inc. 2002, 04,05 Advisory Board, Shire Pharmaceuticals 2002, 03,04,05 Advisory Board, Bristol-Myers Squibb California Neuroscience Advisory Board Editorial Board, The Journal of Clinical Psychiatry Editorial Board, The Physician and Sports Medicine 2009 Advisory Board, Pfizer. Anxiety Disorders AWARDS: Skull & Key Award: Dickinson College. Given yearly to College's most outstanding freshman 1959 National Foundation Medical Student Fellowship, Dept. of Physical Medicine & Rehabilitation, New York Medical College (Summer) 1960 National Institute of Mental Health Research Training Grant, Dept. of Psychiatry, New York Medical College (Summer) 1961 Stephen P. Jewett Award : Dept. of Psychiatry, New York Medical College. One award given each year for proficiency in psychiatry to a fourth year medical student 1968 Army Commendation Medal: U.S. Army Hospital, Ft. Gordon, Georgia Career Teacher in Psychiatry: National Institute of Mental Health, MH Dept. of Psychiatry Nominee for the Kaiser Award for Excellence in Teaching, and the UCSF Budget Committee Award for Special Recognition of Distinction in Teaching 12/31/

16 AWARDS (continued): 1979 American Journal of Nursing, 1979, Books of the Year Award, presented for "Psychiatric Hospital Treatment for the 1980's" Consultant, Psychiatric Education Branch of the National Institute of Mental Health Ad Hoc Reviewer for the Psychosocial & Biobehavioral Treatments Subcommittee of the Treatment Development and Assessment Research Review Committee, NIMH 1982 Member, Special Review Committee on Depression, ADAMHA, NIMH (July) 1987 Fulbright Research Scholar, Japan, (January through July) Research Fellowship, the Japanese National Institute of Mental Health, Itchikawa, Japan, (January through July) 1987 The American Psychiatric Association and Psychiatric Institute of America (PIA) Award for Hospital Psychiatric Research, awarded annually for research in the field of hospital psychiatric treatment The Best Doctors in America 1990 The Seymour D. Vestermark Award, awarded annually "to recognize leadership & creativity in psychiatric education, "by the American Psychiatric Association, (given to the ACNP for a Model Curriculum in Psychopharmacology developed by a subcommittee which I co-chaired with David Janowsky, MD) 1990 Director's Award, National Institute of Mental Health 1991 The Association for Academic Psychiatry Psychiatric Education Award, Honorable Mention, awarded biannually for Innovative Educational Materials and Techniques, for the Model Curriculum in Psychopharmacology 1991 One of three recipients of Alumni Achievement Awards from New York Medical College 1991 Runner-up for The American Academy of Clinical Psychiatrists Clinical Research Award MacArthur Foundation Research Network on Depression 12/31/

17 AWARDS (continued): 1993 The Van Ameringen Award in Psychiatric Rehabilitation, awarded annually by American Psychiatric Association, in recognition of outstanding and sustained contributions to field of psychiatric rehabilitation in areas of research, service and education (in 1992, I was given Honorable Mention for this same award) 1994 The Gralnick Award, given annually by the American Psychological Foundation to a researcher whose work covers the psychosocial aspects of schizophrenia with an emphasis on the early stages of the disorder 1996 Association for Academic Psychiatry Annual 1997 Education Award for outstanding contributions as an educator, both in curriculum development and in presentation 2000 Annual Outstanding Achievement Award of the Northern California Psychiatric Society (NCPS) of the APA, recognizes a member of NCPS who has made significant and exceptional contributions to the field of psychiatry Distinguished Contribution to Family Systems Research Award. This annual AFTA award recognizes an individual for outstanding research on subjects central to the field of family therapy Rockefeller Foundation Award for Residence at Bellagio, Italy, Summer Metzger-Conway Fellow, Clarke Center, Dickinson College, Carlisle, PA 2003 Fulbright Lecturing Award, India 2004 Excellence in Teaching Award, Stanford University School of Medicine, Stanford, CA. In recognition of contributions to the educational mission of the school Nominee for Franklin G. Ebaugh, Jr. Award for excellence in teaching, SUSM 2005 First Annual Irma Bland Award for Excellence in Teaching Residents, given annually by the American Psychiatric Association to Departments of Psychiatry for outstanding and sustaining contributions made as a faculty Paul Hoch Distinguished Service Award for Contributions to the College, presented by the American College of Neuropsychopharmacology 12/31/

18 AWARDS (continued): 2006 Dickinson College Distinguished Alumni Award for Professional Achievement. This yearly award names alumni who have demonstrated outstanding accomplishment, as well as strength of character, in their professional and civic lives CINP 2006 Lundbeck Neuroscience Foundation Prize for Education in Psychiatry and Neurology, one award given every 2 years for education in psychiatry and neuroscience to an individual (or group) who has attained particularly valuable achievements in the field of postgraduate education in psychiatry and neuroscience The American College of Psychiatrists (ACP) Distinguished Service in Psychiatry Award, one award given each year to recognize distinguished achievements and leadership in the field of psychiatry The Association for Academic Psychiatry, Distinguished Life Fellow, given each year for mastery in a career dedicated to educational endeavors, demonstrated generativity by unselfishly guiding the next generation of academic psychiatrists, and engaged in passing on the traditions of the past to the next generation of academic psychiatrists National Alliance on Mental Illness (NAMI) exemplatory Psychiatrist Awards ACADEMIC APPOINTMENTS: Professor of Psychiatry & Behavioral Sciences, Stanford University School of Medicine 2010 Emeritus Professor Professor of Psychiatry, Cornell University Medical College, New York, NY School of Medicine, University of California, San Francisco (UCSF): Assistant Clinical Professor of Psychiatry and of Obstetrics & Gynecology Career Teacher in Psychiatry of the National Institute of Mental Health at Langley Porter Neuropsychiatric Institute Associate Clinical Professor Professor of Psychiatry in Residence, School of Medicine Assistant Clinical Professor of Psychiatry, Medical College of Georgia Instructor & Assistant Attending Psychiatrist, New York State Psychiatric Institute, College of Physicians and Surgeons, Columbia University 12/31/

19 OTHER TRAINING: Dept. of Research, Hillside Hospital: Seminar on Research Methods in Psychiatry, D. Klein, MD J. Starkweather, PhD, Dept. of Information Systems, UCSF: An Introduction to Computer Programming PL Dept. of Psychiatry, UCSF: Seminar on Supervision, R. Wallerstein, MD Dept. of Psychiatry, UCSF: Seminars on Models in Psychiatry, J. Ruesch, MD Dept. of Psychology, Langley Porter Neuropsychiatric Institute: Course on Advanced Statistics, W. Hargreaves, PhD Dept. of Psychology, Langley Porter Neuropsychiatric Institute: Advanced Statistics, 226- A & B, R. Elashoff, PhD and W. Hargreaves, PhD UCSF: Health Sciences Education Seminar, E. Rosinski, PhD 1972 Dept. of Anatomy, UCSF: Course on Cell Structure & Function, R. Long, PhD 1972 Dept. of Physiology, UCSF: Course, Endocrinology 101, C. Kragt, PhD 1972 Dept. of Business Administration, Philosophy of Management University of California, Berkeley Science, C. Churchman, PhD 1973 Cardiovascular Research Institute, UCSF: Group Practice in the Art of Teaching, N. Staub, MD Dept. of Psychiatry, Albert Einstein College of Medicine: Administrative Psychiatry & Mental Health Planning, S. R. Kaplan, M.D. COMMITTEES: University Of California, San Francisco, School of Medicine: Department of Psychiatry Committees: Administrative Planning Team, Langley Porter Institute Interdisciplinary Education Committee, Dept. of Psychiatry, School of Medicine Medical Student Education Committee, Dept. of Psychiatry, School of Medicine 1976 Ad Hoc Committee for Alexander Simon Award, Dept. of Psychiatry 1976 Subcommittee for Basic Curriculum, Residency Training, Dept. of Psychiatry Departmental Task Force on Revision of Medical Student Curriculum, Dept. of Psychiatry 12/31/

20 COMMITTEES (continued): Committee on Academic Affairs, Dept. of Psychiatry, School of Medicine, UCSF Staff Affiliate Review Committee, Langley Porter Institute Departmental Committee on Medical Student Education, Dept. of Psychiatry Review Committee for Appointments and Promotions of Regular Faculty, Dept. of Psychiatry Departmental Committee on Medical Student Education, Dept. of Psychiatry 1973 Building Committee, Langley Porter Institute 1972 Noon Conference Committee, Langley Porter Institute Residency Training Committee, Langley Porter Institute Residency Selection Committee, Langley Porter Institute 1970 Ad Hoc Committee on Outpatient Psychiatric Care, Dept. of Psychiatry Course Committee, Sophomore Psychiatry Course, Dept. of Psychiatry Ad Hoc Committee on Residency Training, Langley Porter Institute 1969 Annual Graduation and Departmental Meeting, Langley Porter Institute 1969 Course Committee, Freshman Psychiatry Course, Dept. of Psychiatry Chairman, Public Health and Safety Committees, Langley Porter Institute Research Committee, Clinical Research Ward, Langley Porter Institute School of Medicine Committees: Curriculum Committee Subcommittee on Evaluation Basic Clinical Course Operations Subcommittee1974; Acting Chairman, Screening and Promotions Committee Search Committee, Director of Psychiatric Nursing, Cornell University Medical College: Department of Psychiatry Committees Steering Committee Residency Training Committee Appointments and Promotions Committee Formulary Committee 1990 Task Force on Vertical Services Executive Committee Executive Committee Space Committee Fellowship Selection Committee Residency Training Committee Computer Committee Media Committee PGY IV Education Committee Inpatient Steering Committee 12/31/

21 COMMITTEES (continued): Family Therapy Planning Group, PGY II Education Committee Departmental Research Committee- Chairman, ; Residency Training Committee Fellowship Selection Committee Stanford University School Of Medicine: Departmental Committees Appointment & Promotions Chair, Credentials Committee, Chairman Residency Training Committee Executive Committee Hospital Committees UCSF/Stanford Merger - Brown & Toland Medical Group Mental Health Executive Committee Inpatient Management Committee Operations Improvement Committee Psychiatry Business Plan Committee Clinic Executive Committee Mentoring Jacob S. Ballon, M.D., American Psychiatric Institute for Research & Education REGIONAL AND NATIONAL PROFESSIONAL SOCIETIES: American Medical Association American Psychiatric Association 1971 Fellow Foundations' Fund Board for Research in Psychiatry (Chair, ) 1999 Life Fellow 1999 Member, Committee on Research on Psychiatric Treatments 2003 Sub-committee on Antipsychotic Drugs & Diabetes Mellitus Northern California Psychiatric Society (NCPS) Committee on Awards Counselor-at-Large 12/31/

22 REGIONAL AND NATIONAL PROFESSIONAL SOCIETIES (continued): American College of Psychiatrists Fellow 1996 Committee on Honorary Fellowships Society of Biological Psychiatry Resource Development Committee 1997 Task Force on the Future of SBP 2001 George N. Thompson Award Committee, Society of Biological Psychiatry American College of Neuropsychopharmacology 1973 & 1978 Scientific Associate Member Education and Training Committee, (Chair, ) 1984 Fellow Co-Chair, Committee to Develop a Model Curriculum in Psychopharmacology Committee on Problems of Public Concern Task Force on Coordinating Academic Industry & Government Efforts in Psychopharmacology 1989 & '96-98 Task Force on Psychotropic Drug Prescribing Privileges for Non-physicians Task Force on Scientific Misconduct Mentor, NIMH/Mead Johnson Minority Award Program Finance Committee (Chair, ) Constitution and Rules Committee (Chair, ) Education and Training Committee (Co-Chair, ) History Committee Public Information Committee 1973 Association for Academic Psychiatry, Charter Member Secretary 1983 Co-Chairman and Founder, Section on Residency Training Fellowship Committee 2008 Distinguished Life Fellow 1978 The Hastings Center-Institute of Society, Ethics and the Life Sciences 1978 American Family Therapy Academy Board of Trustees 1985 Committee on History of AFTA 1980 American Association of Psychiatric Administrators 12/31/

23 REGIONAL AND NATIONAL PROFESSIONAL SOCIETIES (continued): 1982 Association for Clinical Psychosocial Research, Founding Member Steering Committee 1988 Fellow Group for the Advancement of Psychiatry, Committee on the Family 1991 Program Committee 1992 Ad hoc Committee to Develop Practice Guidelines 1989 Psychiatric Research Society 1990 Collegium Internationale Neuro-Psychopharmacologicum (C.I.N.P.) 2002 CINP Regional Committee for North America Academia, Medicine & Psychiatric Foundation 1992 Fellow American Society of Clinical Psychopharmacology, Founding Member Model Curriculum Committee, Chair 1995 Work Group, Interface with Government & Industry, Clinical Trials Committee Scientific Advisory Board Treasurer 2005 Co-chair, Joint ASCP-AADPRT Curriculum Project (with David Goldberg, MD) International Society for Sports Psychiatry, Founding Member 1993 Chair, Scientific Program 1993 Executive Board Chair, Nomination Committee 1997 West Coast College of Biological Psychiatry, Fellow 1998 Program Chair 1998 Pacific Rim College of Psychiatrists, Fellow VISITING PROFESSORSHIP & LECTURES: 1972 VP: Dept. of Psychiatry, School of Medicine, University of San Marcos, Lima, Peru, (August) 1) Teaching of Psychiatry to Medical Students 2) Family Therapy Today Distinguished Lecturer, Lederle Pharmaceutical Co 12/31/

24 VISITING PROFESSORSHIP & LECTURES (continued): 1979 VP: Dept. of Psychiatry, College of Medicine, University of Arizona, Health Science Center, Tucson, Arizona 1980 Gary N. Spero Community Mental Health Memorial Lecture Series, "The Family Model in Inpatient and Day Hospital Settings," Maimonides Medical Center, Brooklyn 1980 VP: Dept. of Psychiatry, University of Connecticut Health Center, Farmington, Connecticut 1981 VP: Maudsley Hospital, Tavistock Clinic and Hospital for Sick Children, London 1) "The Family Model in an Inpatient Setting", Seminar on Hospital Psychiatry,Mental Health Workers, Great Britain 2) "Family Therapy and Hospitalization", Tavistock Clinic 3) "Family Research", Marlborough Hospital 4) "Family Research", Grand Rounds, Hospital for Sick Children 5) "Indications and Contraindications for Family Therapy", The Family Institute of London 1982 Keynote Address, "Guidelines for Family Therapy," as part of a continuing education course entitled "Clinical Techniques for the Practice of Family Therapy," sponsored by the Dept. of Psychiatry, Long Island Jewish- Hillside Medical Center Visiting Faculty Program, Mead Johnson Pharmaceutical Co VP: Dept. of Psychiatry, University of California, San Diego 1983 VP: Dept. of Psychiatry, College of Medicine, University of Arizona Health Sciences Center, Tucson, Arizona 1984 Schweppes Visiting Professor, The Menninger Clinic, Topeka 1985 VP: Dept. of Psychiatry, University of Wisconsin Medical School, Madison, "The Shrinking of Hospital Psychiatry" 1985 VP, Dept. of Psychiatry, Medical University of South Carolina, Charleston 1) Grand Rounds, "Inpatient Family Intervention - A Controlled Study" 2) Inge Taylor Memorial Lecture, "Why Don't Patients Receive Appropriate Psychiatric Treatment?" 3) All Day Seminar with Psychiatry Residents, "Theory & Practice of Integrative Psychiatry" 12/31/

25 VISITING PROFESSORSHIP & LECTURES (continued): 1985 VP: Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Dept. of Psychiatry, "The Family Model: Does It Have Anything to Offer for the Treatment of Affective Disorders?" 1985 VP: Fairfield Hills Hospital, Newtown, Connecticut, "Treating the Hospitalized Patient and Their Family" 1986 VP: Dept. of Psychiatry, School of Medicine, University of Verona, Italy, Jan- Jun 1990 Visiting Lecturer Series, "Effectiveness in Psychiatric Care," New Jersey College of Medicine and Dentistry, Newark 1990 Invited Speaker, "What a Psychiatric Hospital Can and Cannot Do: A Review of Efficacy Studies." At a conference, "The Role of the Mental Hospital in the 21st Century," sponsored by the London Psychiatric Hospital, Ontario, Canada 1990 Invited Lecture, "New Wine in New Bottles: The Changing Role of Psychiatric Hospitals for Patients and Their Families," at The Sheppard Pratt National Symposium on Schizophrenia, Baltimore 1991 Academic Lecture: "New Models for the Treatment of the Chronically Mentally Ill,"Annual Meeting of the Ontario Psychiatric Association, Toronto (February) 1991 Invited Lecture: "A Survival Guide for the Family of the Borderline Patient (and Vice Versa)," New Approaches to the "Borderline Syndrome," Sixth Tokyo Institute of Psychiatry International Symposium, Tokyo, Japan (November) 1993 VP & Invited Lecture: University Institutions of Psychiatry, Geneva, School of Medicine, University of Geneva, Switzerland and Invited Lecture, "Effectiveness in Psychiatric Care: A Follow-up Study of the Treatment of Hospitalized Patients with Major Affective Disorder seen in Europe, Asia and the U.S. United States" (April) 1993 VP: Institute of Clinical Psychiatry, School of Medicine, University of Pisa, Pisa, Italy, with Invited Lecture, "Effectiveness in Psychiatric Care: A Follow-up Study of the Treatment of Hospitalized Patients with Major Affective Disorder in Europe, Asia and the United States" 1993 Invited Lecture, "Effectiveness in Psychiatric Care: A Follow-up Study of the Treatment of Hospitalized Patients with Major Affective Disorder in Europe, Asia and the United States," Dept. of Psychiatry, Second School of Medicine, Naples, Italy (April) 12/31/

26 VISITING PROFESSORSHIP & LECTURES (continued): 1993 Invited Lecture, "Effectiveness in Psychiatric Care: A Follow-up Study of the Treatment of Hospitalized Patients with Major Affective Disorder in Europe, Asia and the United States," Institute of Clinical Psychiatry and the Dept. of Psychiatry, School of Medicine, Verona, Italy Academic Lecture: "Combining Medications with Psychosocial and Rehabilitation Strategies for the 1990's," 2nd Annual Psychopharmacology Clinical Day, Department of Psychiatry, University of Toronto, Toronto (October) Distinguished Lecturer, Professors of Psychiatry Series: New Strategies of Treatment for Axis I Disorders, VP, Department of Psychiatry, School of Medicine and Surgery, University of Bari, Italy, June. Keynote Speaker, Strategies of Intervention in Family Psychotherapy, First National Congress, Italian Society for Research and Interventions on the Family, Subsection of the Italian Psychiatric Society Keynote Address, Combination Therapy for the Treatment of Psychosis, Third Annual STEP Symposium, Improving the Prognosis of Psychotic Disorders (Schizophrenia Treatment & Evaluation Program), University of North Carolina at Chapel Hill, June, Keynote Address, Combination Therapy for the Treatment of Axis I Disorders, 1996 Taipai Mental Health Conference, Taipai, Taiwan, December VP, Department of Psychiatry, University of Iowa Hospital and Clinics, Iowa City, March Award Lecture, Through the Golden Chalkboard: Reflections on the Teaching- Learning Process in Psychiatry, 1997 Annual Meeting of the Association of Academic Psychiatry, March, VP, Department of Psychiatry & Internal Medicine, St. Francis Medical Center, Pittsburgh, PA 1998 Principal Speaker, Lone Star : Society, The Family and Individual Identity, as part of the film series of the New Orleans Museum of Art and Department of Psychiatry LSU, entitled: Lights, Camera - Analysis, New Orleans, October, /31/

27 VISITING PROFESSORSHIP & LECTURES (continued): 1998 Keynote Speaker, New Treatments for Schizophrenia and Other Psychoses, at the National Satellite Symposium for the Argentine Psychiatric Society, Time for Change in the Treatment of Psychosis, Buenos Aires, Argentina, November, Principal Speaker, at the National Conference organized by the Uruguayan Ministry of Health,Uruguayan Society of Psychiatry and the Psychiatric Department of the School of Medicine in the National University, Montevideo, Uruguay, November 1998: New Atypical Antipsychotics and Their Indications Combining Medication and Psychotherapy for Axis I Disorders 1999 Visiting Professor, University Hospital Utrecht, The Netherlands, Summer Plenary lectures at the Schizophrenia Symposium, Eastern Idaho Regional Medical Center, Idaho Falls, ID, June, 1999: New Strategies for the Treatment of Axis I Disorders New Treatments for Schizophrenia 1999 Plenary Lecture, New Diagnositic Methods and Treatments for Schizophrenia: Turning the Treatment Corner at the Annual Meeting of the Canadian Psychopharmacologic Association, Halifax, June, Guest Lecture, The New Atypical Antipsychotics for New Indications, Annual Meeting, Korean Psychopharmacology Association, Korea, April, Visiting Professor, EPPIC Program, University of Melbourne, Melbourne, Australia, August, Invited Lecture, Novel Antipsychotics: What We ve Learned; What We Need to Know. CME course on Novel Antipsychotics, Case Western Reserve University School of Medicine, Cleveland, September, Visiting Professor, Family Studies Unit, National Institute Mental Health and Health Series (NIMHANS), Bangalore, India Combining Medication and Psychotherapy The New Model of Inpatient Psychiatry 2004 Inaugural Lecture, Gary N. Spero Memorial Lectureship, Schizophrenia and Psychosis: New Data, New (Combined) Treatments & New Controversies. Department of Psychiatry, Weill Medical College of Cornell University, New York, March, /31/

28 VISITING PROFESSORSHIP & LECTURES (continued): 2004 Visiting Professor, School of Medicine, University of Iowa Combining Medication and Psychotherapy for Axis I Disorders Schizophrenia: New Data and New Controversies 2005 At the Indonesian Society for Biological Psychiatry, Psychopharmacology and Sleep Medicine, Jakarta, Indonesia, February, Educational Symposia, The Teaching of Psychopharmacology: Circa 2005 Opening Plenary Lecture: Developing a Curriculum in Psychopharmacology 2005 Lecture: Developing a Curriculum in Psychopharmacology. Teaching Psychopharmacology: Substance, Methods, Science. Pre-Meeting: American Association of Directors of Psychiatric Residency Training, Tucson, AZ, March, Invited Lecture, Collaboration With Big Pharma, as part of the Stanford Summer Research Institute, entitled Careers in Geriatric Psychopharmacology. Stanford, CA, July, Invited Lecture. Using a Psychopharmacology Curriculum to Improve Training. Dept of Psychiatry, Cape Town Medical School, Cape Town, South Africa, April, Invited Lecture: CATIE Trial Results. At the Annual ECNP (European College of Neuropsychopharmacology) Meeting, Paris, September Invited Lecture: Clinical Antipsychotic Trials in Intervention Effectiveness. Oregon Psychiatric Association, Lake Oswego-Portland, OR, March Panel Discussion on CATIE trial, with W Hoffman, M Reaves, D Ruthven 2007 Invited Lecture: Teaching of Psychopharmacology Worldwide, consultant for the Lundbeck Institute, Copenhagen, Denmark, March Invited Participant: Joint Committee on Long-Term Management of Schizophrenia, Houston, April and October, 2007, Chaired by William Carpenter and John Newcomer Visiting Professor and Invited Lectures: The Teaching of Psychopharmacology: 2008, Department of Psychiatry, Sackler School of Medicine, Tel Aviv University and Sheba Medical Center, Tel Aviv, Israel Department of Psychiatry, Rappoport Faculty of Medicine Institute of Technology, Technion, Haifa, Israel 12/31/

29 VISITING PROFESSORSHIP & LECTURES (continued): Visiting Professor and Invited Lectures at the Institute of Clinical Psychiatry and Polyclinica Hospital, University of Milan, Italy. 1) Update on Treatment of Schizophrenia 2) Combining Medication with Psychotherapy for Axis I Disorders Invited Lecturer: How We Should Teach Psychopharmacology, ECNP School of Neuropsychopharmacology, St Catherine s College, Oxford, England, July, Invited Lecture: Current Status and Overview of Marital and Family Psychotherapy, at the Psychotherapy Institute, Dept of Psychiatry, School of Medicine, University of Verona, Italy, October, Visiting Professor and Invited Lecture at the Department of Psychiatry, Penn State College of Medicine, Hershey, PA, January 2010 Long-term Treatment of Schizophrenia with Antipsychotics: Recent Research Combining Drugs and Psychotherapy for Axis I Disorders 2010 Visiting Professor, sponsored by the Clark Center at Dickinson College, Carlisle, PA, Jan 2010 The New Neuroscience, Psychology and Psychiatry: History and Challenges for the Future The Athlete as Role Model: Life after Sports PUBLICATIONS: Books, Monographs, Bibliographies: 1. Glick ID, Balon R (eds.): The American Society of Clinical Psychopharmacology Model Psychopharmacology Curriculum for Medical Students, ASCP, POB 40395, Glen Oaks, NY 11004, Keitner G, Heru A, Glick I: Clinical Manual of Couples & Family Therapy. American Psychiatric Publishing, Inc., Arlington, VA, 322 pgs, Tandon R, Glick ID, Goldman M, Jibson MD, Marder SR, Mellman TA: Managing Schizophrenia, A Comprehensive Primer McMahon Publishing Group, New York, /31/

30 PUBLICATIONS (continued): 4. Ritvo EC, Glick ID: The Concise Guide to Marriage and Family Therapy. American Psychiatric Press, Inc. Washington, DC, 2002, pp Spanish Edition translated by Jose Luis Nunez Herrejon, Madrid, Manual Moderno pubs. 5. The ASCP Model Psychopharmacology Curriculum, for Psychiatric Residency Programs, Training Directors, and Teachers of Psychopharmacology. The American Society of Clinical Psychopharmacology, Inc., P.O. Box 40395, Glen Oaks, NY Glick ID (Editor of all four editions with a large committee for each edition) : 1999 First Edition Second Edition Third Edition Fourth Edition 2008 Fifth Edition Invited Lectures: 1) Schizophrenia (with M. Jibson), 2) Combining Pharmacotherapy & Psychotherapy, 3) The Art of Psychopharmacology (with R. Balon) 6. DeBattista C, Glick ID (ed.). The Medical Management of Depression. Essential Medical Information Systems, Inc. Durant, OK: Second Edition 2002 Third Edition 7. Glick ID (ed): Treating Depression, San Francisco, Jossey-Bass, Translated into Turkish by Yayin Dagitrin, Global Publishers. 8. Clarkin JF, Haas GL, Glick ID (eds): Affective Disorders and the Family: Assessment and Treatment, New York, Guilford Press, Grunebaum H, Beavers WR, Berman E, Combrinck-Graham L, Glick ID, et al: (Formulated by the Committee on the Family, Group for the Advancement of Psychiatry), The Family, the Patient, and the Psychiatric Hospital: Toward a New Model. New York, Brunner/Mazel, l Glick ID, Janowsky DS, Salzman C, Shader RI: A Model Psychopharmacology Curriculum for Psychiatric Residents. Nashville, TN, The American College of Neuropsychopharmacology, 1984 a) Translated into Japanese, Japanese Journal of Psychopharmacology, 6: , 1986 b) Reprinted in Psychopharmacology: The Third Generation of Progress, edited by Herbert Y. Meltzer. Raven Press, New York, , 1987 c) Translated into Japanese for the Lectures on Clinical Psychiatric Issues, Part II, edited by Yamaguchi T, Tajima S. Chugoku-shikoku Psychotherapy Workshops, Hiroshima and Nichidai Seishin-shinkeika Workshops, Tokyo /31/

31 PUBLICATIONS (continued): 11. Glick ID, Hargreaves WA: Psychiatric Hospital Treatment for the 1980s: A Controlled Study of Short Versus Long Hospitalization. Lexington, Mass., Lexington Press, Glick ID, Kessler DR: Marital and Family Therapy. New York, Grune and Stratton, Summarized in Foote C, Levy RJ, Sander FEA, Cases and materials on family law, second edition, Boston, Little, Brown, 1976, pp Second Edition Translated into Japanese by Koji Suzuki, MD; 2nd printing, Translated into Chinese by Xiang De-Zhao, MD Third Edition, with Clarkin JF & Kessler DR. Published by American Psychiatric Press, Inc., Washington, D.C Fourth Edition, with Berman E, Clarkin JF & Rait D. American Psychiatric Press, Inc., Washington, D.C Spanish Edition, translated by Raquel Martin Lanas, Madrid, Grupo Medica, 13. Glick ID, Haley J: Family Therapy and Research: An Annotated Bibliography of Articles and Books Published New York, Grune and Stratton, Glick ID, Weber D, Rubinstein D, Patten J: Family Therapy and Research: An Annotated Bibliography of Articles, Books, Videotapes and Films Published , 2nd Edition, New York, Grune and Stratton, Haley J, Glick ID: Psychiatry and the Family, An Annotated Bibliography of Articles Published, Palo Alto, California, Family Process, Journal Articles: 1. Glick ID, Singer B: Follow-up of patients discharged from the rehabilitation service of a hospital for treatment of chronic disease. Arch Phys Med Rehab 44:29-36, Greenberg IM, Glick ID, Match S, Riback SS: Family therapy: Indications and rationale. Arch Gen Psychiat 10:7-24, Glick ID, Grauber DN: Kartagener s syndrome and schizophrenia: Report of a case with chromosomal studies, Am J Psychiatry 121: , Glick ID, Salerno LF, Royce JR: Psychophysiologic factors in etiology of preeclampsia. Arch Gen Psychiat 12: , Glick ID: Mood and behavioral changes associated with the use of the oral contraceptive agents: A review of the literature. Psychopharmacol 10: , Glick ID, Setleis H, Woerner MH, Pollack M: Schizophrenia in siblings reared apart: A case report. Am J Psychiatry 124: , /31/

32 7. Glick ID: The "sick" family and schizophrenia - cause and effect? Supplement, Dis Nerv Syst 29: , May Hauptman B, Glick ID: Auditory hallucinations with imipramine. J Hillside Hosp 17:32-34, Mardikian B, Glick ID: Patient-staff meetings: A study of some aspects of content, tone and speakers. Ment Hygiene 53: , Glick ID, Sternberg D: Performance IQ as a predictor of hospital treatment Comprehen Psychiat 10: , Goldfield MD, Glick ID: Self-mutilation of the female genitalia. J Nerv Ment Dis 31: , Glick ID, Hauptman B, Klein DF: Pseudopregnancy treatment of periodic psychiatric illness: A pilot study. Psychiat Quart 44: , Chastko HE, Glick ID, Gould E, Hargreaves WA: Patients' posthospital evaluation of psychiatric nursing treatment. Nurs Res 20: , Glick ID, Winstead D: Childhood a sociality in the differential diagnosis of schizophrenia with drug abuse vs. psychosis with drug intoxication. Psychiat Quart 47: , O'Hanrahan T, Glick ID: Drug abuse and function in graduate students. Comprehen Psychiat 14: , Langee H, Glick ID, Hoffman B, Silver LB, Morrison AP: The requirements of a residency training program, circa Am J Psychiatry 130: , Glick ID, Goldfield MD, Kovnat P: Recognition and management of psychosis associated with hemodialysis. Calif Med 119:56-59, Glick ID, Hargreaves WA, Goldfield MD: Short versus long hospitalization: A prospective controlled study. 1. Preliminary results of a one year follow up of schizophrenics. Arch GenPsychiat 30: , Glick ID, Hargreaves WA, Raskin M, Kutner SJ: Short versus long hospitalization: A prospective controlled study. II. Inpatient results for schizophrenics. Am J Psychiat 132: , Glick ID, Hargreaves WA, Drues J, Showstack JA: Short versus long hospitalization: A prospective controlled study. III. Inpatient results for non-schizophrenics. Arch Gen Psychiatr 33:78-83, /31/

33 21. Gould E, Glick ID: Patient-staff judgments of treatment program helpfulness on a psychiatric ward. Br J Med Psychol 49:23-33, Glick ID, Hargreaves WA, Drues J, Showstack JA: Short or long hospitalization for psychiatric disorders? Psychopharm Bull 11(4):35-37, 1975 (abstract). 23. Glick ID, Hargreaves WA, Drues J, Showstack JA: Short versus long hospitalization: A prospective controlled study. IV. One-year followup results for schizophrenics. Am J Psychiatry 133: , Glick ID, Hargreaves WA, Drues J, Showstack JA: Short versus long hospitalization: A prospective controlled study. V. One year followup results for nonschizophrenics. Am J Psychiatry 133: , Leib AC, Underwood PR, Glick ID: The staff nurse as primary therapist: A pilot study. J Psychiatric Nurs Ment Health Services 14:11-17, Hargreaves WA, Glick ID, Drues J, Showstack JA, Feigenbaum E: Short versus long hospitalization: A prospective controlled study. VI. Two year followup results for schizophrenics. Arch Gen Psychiatry 34: , Glick ID, Hargreaves WA, Drues J, Showstack JA: Short versus long hospitalization: A prospective controlled study, VII. Two year followup results for nonschizophrenics. Arch Gen Psychiatry 34: , Gould E, Glick ID: The effects of family presence and family therapy on outcome of hospitalized schizophrenic patients. Family Process 16: , Glick ID, Epstein LJ: Increasing learning during the psychiatric residency. Comprehen Psychiatry 18: , Dinaburg D, Glick ID, Feigenbaum E: Use of marital therapy in the treatment of female alcoholism. J Studies Alcohol 38: , l. Showstack JA, Hargreaves WA, Glick ID, O'Brien RS: Psychiatric followup studies: Practical procedures and ethical concerns. J Nerv & Ment Dis 166:34-43, Glick ID, Bennett SE: Psychiatric complications of progesterone and oral contraceptives. J Clin Psychopharmacology 1: , Glick ID: Short-term intensive psychiatric hospital treatment: Which treatment and for whom? J Nat'l Assoc Private Psychiatr Hosp 9:8-11, /31/

34 34. Young RD, Glick ID, Hargreaves WA, Braff D, Drues J: Therapists A-B score and treatment outcome with psychiatric inpatients: A table of random numbers. Br J Med Psychol 52: , Braff D, Stone C, Callaway E, Geyer M, Glick ID, Bali L: Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 15: , Drues J, Hargreaves WA, Glick ID, Klein DF: Premorbid asocial adjustment and outcome in schizophrenia. J Nerv & Ment Dis 166: , Braff DL, Bachman J, Glick ID, Jones R: The therapeutic community as a research ward: Myths and facts. Arch Gen Psychiat 36: , Kessler DR, Glick ID: Brief family therapy. Psychiatric Clinics of North America, 2:75-84, (Reprinted in Advances in Family Psychiatry, Vol. III, Howells J (Ed), NY Int. Press). 39. Glick ID, Hargreaves WA: Hospitals in the 1980s: Service, training and research. Hosp & CommPsychiatr 30: , Davis C, Glick ID, Rosow I: The architectural design of a psychotherapeutic milieu. Hosp & Comm Psychiatr 30: , Glick ID, Kessler DR: Family Therapy, in the American Psychiatric Association's Syllabus for Self-Assessment Program (PKSAP=IV), 1979, pp Glick ID, Stewart D: A new drug treatment for premenstrual exacerbation of schizophrenia. Comprehensive Psychiatry 21: , Glick ID, Marcotte DB: Psychiatric aspects of basketball. Psychiatric Annals 10:3, Clarkin JF, Glick ID: Duration of hospitalization as a variable in outcome. The Psychiatric Hospital 13:50-54, Young RC, Gould E, Glick ID, Hargreaves WA: Personality inventory correlates of outcome in a follow up study of psychiatric hospitalization. Psychological Reports 46: , Binder R, Glick ID, Rice M: A comparative study of parenteral molindone and haloperidol in the acutely psychotic patient. J Clin Psychol 42: , Johnson GR, Glick ID, Young R: Length of stay of patients in sheltered care and physical space: A comparative study. Psychological Reports 47: , /31/

35 48. Glick ID, Braff DL, Johnson J, Showstack JA: Outcome of irregularly discharged psychiatric patients. Am J Psychiatry 138: , 1981, (French translation, Medecine et Hygiene, 44: , 1986). 49. Glick ID: A family therapist in the People's Republic of China. Int'l J Family Therapy, 4: , Pynoos RS, Glick ID: The use of joint consultations in inpatient psychiatry. Am J Psychiatry, 140: , Clarkin JF, Glick ID: Recent developments in family therapy: A review. Hosp Comm Psychiatry, 33: , Reprinted in Psychotherapies (French). 52. Glick ID, Showstack JA, Klar HM: Toward the definition and delivery of appropriate care. Am J Psychiatry 139: , Braff DL, Glick ID, Griffin P: Thought disorder and depression in psychiatric patients. Comp Psychiatry, 24:57-64, Frosch WA, Glick ID, Talbott JA: The teacher as impediment to learning: The problem of focal conviction. Arch Gen Psychiatry, 40:1257, Glick ID, Borus JF: Marital and family therapy for troubled physicians and their families. JAMA, 251: , Translated into Japanese, JAMA, pp 27-32, Brown R, Kocsis J, Glick ID: Efficacy and feasibility of high dose tricyclic antidepressant treatment in elderly delusional depressives. J Clin Psychopharm, 4: , Glick ID, Klar HM, Braff DL: Guidelines for hospitalization of chronic psychiatric patients. Hosp & Comm Psychiatry, 35: , Chen C, Glick ID: Core tasks in the resident's mastery of psychiatric administration. Admin in Mental Health, 12: , Glick ID, Clarkin JF, Spencer JH, et al: Inpatient family intervention. A controlled evaluation of practice: I. Preliminary results of the six-months follow-up. Arch Gen Psychiatry, 42: , Reprinted in the Sixth Edition of the Psychiatric Knowledge and Skills Self-Assessment Program VI of the American Psychiatric Association 60. Roy-Byrne P, Pynoos RS, Glick ID: The inpatient psychiatric unit as consultation service. Can J Psychiatry, 31:54-58, /31/

36 61. Glick ID, Spencer J: Inpatient family therapy: On the boundary between past and present. Fam Proc, 24: , Janowsky DS, Glick ID, Lash L, et al: Psychobiology and psychopharmacology: Issues in clinical research training. J Clin Psychopharmacol, 6:1-7, Gruenke LD, Craig JC, Klein FK, Glick ID, et al: Determination of chlorpromazine and its major metabolites by gas chromatography/mass spectrometry: Application to biological fluids. Biomedical Mass Spectrometry, 12: , Glick ID, Fleming L, DeChillo N, et al: A controlled study of transitional day care for non-chronically-ill patients. Am J Psychiatry, 143: , Glick ID: Treating the new American couple. J of Sex & Marital Therapy, 12: , Translated into Japanese for the Journal of the Japanese Association of Group Psychotherapy, Haas GL, Glick ID, Spencer JH: The patient, the family, and compliance with posthospital treatment for affective disorders. Psychopharmacology Bulletin, 22: , Talbott JA, Glick ID: The inpatient care of the chronically mentally ill. Schizophrenia Bulletin, 12: , Haas GL, Glick ID, Clarkin JF, et al: Inpatient family intervention: A randomized clinical trial II. Results at hospital discharge. Arch Gen Psychiatry, 45: , Braff DL, Glick ID, Johnson MH, Zisook S: The clinical significance of thought disorder across time in psychiatric patients. J Nerv Ment Dis, 176: , Glick ID, Marcotte DB: Psychiatric aspects of basketball. JSports Medicine & Physical Fitness, 29: , Greenberg L, Fine SB, Cohen C, Larson K, Michaelson A, Rubinton P, Glick, ID: An interdisciplinary psychoeducation program for schizophrenic patients and their families in an acute care setting. Hospital & Community Psychiatry, 39: , Andreason NC, Glick ID: Bipolar affective disorder and creativity: Implications and clinical management. Comprehensive Psychiatry, 29: , Spencer JH, Glick ID, Haas GL: A randomized clinical trial of inpatient family intervention, III. Overall effects at followup for the entire sample. Am J Psychiatry, 145: , /31/

37 74. Burti L, Glick ID, Tansella M: Measuring the Treatment Environment of a Psychiatric Ward and a Community Mental Health Center After the Italian Reform. Community Mental Health Journal, 26: , l Glick ID, Showstack JA, Cohen C, Klar HM: Between Patient and Doctor: Improving the Quality of Care for Serious Mental Illness. Bulletin of the Menninger Clinic, 53: , Glick ID, Spencer JH, Clarkin JF, et al: A Randomized Clinical Trial of Inpatient Family Intervention IV. Followup Results for Subjects with Schizophrenia. Schizophrenia Research, 3: , Glick ID, Jacobs M, Lieberman J, et al: Prediction of Short Term Outcome in Schizophrenia: Depressive Symptoms, Negative Symptoms, and Extrapyramidal Signs. Psychopharmacology Bulletin, 25: , Clarkin JF, Glick ID, Haas GL, et al: A randomized clinical trial of inpatient family intervention, V. Results for affective disorders. J Affective Disorders, 18:17-28, Glick ID, Burti L, Suzuki K, Sacks M: Effectiveness in psychiatric care: I. A crossnational study of the process of treatment and outcomes of major depressive disorder. J Nerv Ment Disease, 179:55-63, Glick ID, Clarkin JF, Haas G, et al: A randomized clinical trial of inpatient family intervention: VI. Mediating variables and outcome. Family Process, 30:85-99, Haas GL, Glick ID, Clarkin JF, et al: Gender and schizophrenia outcome: A clinical trial of an inpatient family intervention. Schizophr Bull, 16: , Glick ID: Improving treatment for the severely mentally ill: Implications of the decadelong Italian psychiatric reform. Psychiatry, 53: , Glick ID, Burti L, Minakawa K, Maehara K, Sacks M: Effectiveness in psychiatric care: II. Outcome for the family after hospital treatment for major affective disorder. Annals of Clinical Psychiatry, 3: , Glick ID, Janowsky DS, Salzman C, Shader RI: A proposal for a model psychopharmacology curriculum for psychiatric residents. Neuropsychopharmacology, 8:1-5, Glick ID, Burti L, Suzuki K, Sacks M: Effectiveness in psychiatric care: IV. Achieving effective medication management for major affective disorder. Psychopharmacology Bulletin 28: , /31/

38 86. Glick ID: Medication and family therapy for schizophrenia and mood disorder. Psychopharmacology Bulletin, 28: , Olfson M, Glick ID and Mechanic D: Inpatient treatment of schizophrenia in general hospitals. Hospital & Community Psychiatry, 44:40-44, Glick ID, Burti L, Okonogi K, Sacks M: Effectiveness in psychiatric care: III. Psychoeducation and outcome for patients with major affective disorder and their families. British Journal of Psychiatry, 164: , Glick ID, Clarkin JF, Haas GL, Spencer JH: Clinical significance of inpatient family intervention: VII. Conclusions from the clinical trial. Hospital and Community Psychiatry, 44: , Glick ID, Dulit RA, Wachter E, Clarkin JF: The family, family therapy & borderline personality disorder. J Psychotherapy Practice and Research, 4: , Carpenter D, Clarkin JF, Wilner PJ, Glick ID: Personality pathology among married adults with bipolar disorder. Journal of Affective Disorders, 34: , Guttman HA, Beavers WR, Berman E, Combrinck-Graham L, Glick ID, et al: A model for the classification and diagnosis of relational disorders. J Psychiatric Services, 46: , Hanrahan M, Glick ID: Improving outpatient treatment for severely mentally ill persons: doing the right thing. Administration Policy in Mental Health, 23: , Schooler NR, Severe JB, Glick ID, Hargreaves WA, Keith SJ: Transition From Acute To Maintenance Treatment: Prediction of Stabilization. Internat l Clin Psychopharm, 11 (suppl2):85-91, Glick ID, Lecrubier Y, Montgomery S, Vinar O, Klein DF: Efficacious and safe psychotropics not available in the United States. Psych Annals, 26: , Schooler NR, Keith SJ, Severe JB, Matthews SM, Bellack AS, Glick ID: Relapse and rehospitalization during maintenance treatment of schizophrenia: The effects of dose reduction and family treatment. Archives of Gen Psych, 54: , Guttman HA, Beavers WR, Berman E, Combrinck-Graham L, Glick ID, et al: (Group for the Advancement of Psychiatry Committee on the Family): Global assessment of relational functioning scale (GARF): I. Background and Rationale. Family Proc, 35: , /31/

39 98. Clarkin JF, Carpenter D, Hull J, Wilner P, Glick ID: Effects of psychoeducational intervention for married bipolar patients and their spouses. Psychiatric Services, 49: , Glick ID: The inpatient family intervention (IFI) experience. Italian J Psych Behav Sci, 1:1-9, Pearsall R, Glick ID, Pickar D, Suppes T, Tauscher J, Jobson KO: A new algorithm for treating schizophrenia. Psychopharmacology Bulletin, 34: , Schultz SC, Thompson P, Jacobs M, Ninnan PT, Robinson D, Weiden P, Yadalam K, Glick ID: Lithium augmentation fails to reduce symptoms in poorly responsive schizophrenic outpatients. J Clin Psychiatry, 60: , Mordacai D, Glick ID: Divalproex for the treatment of geriatric bipolar disorder. In J Geriatric Psychiatry, 14: , Ambrosini PJ, Wagner KD, Biederman J, Glick I: Multicenter open-label sertraline study in adolescent oupatients with major depression. J Am Child Adolesc Psychiatry, 38: , Jeste DV, Glick ID: Editors Introduction: Intervention research in psychosis: past, present, and future. Schizophrenia Bulletin, 26: , Mueser KT, Sengupta A, Schooler NR, Bellack AS, Xie H, Glick ID, Keith SJ: Family treatment and medication dosage reduction in schizophrenia: effects on patient social functioning, family attitudes, and burden. J Consulting & Clinical Psychology; 69:3-12, Glick ID, Suppes T, DeBattista C, Hu R, Marder S: Clinical update: psychopharmacological treatment strategies for depression, bipolar disorder and schizophrenia. Annals Internal Medicine 134:47-60, Glick ID, Janowsky DS, Zisook S, Lydiard RB, Oesterheld J, Ward NG, Ellison J, Shear MK, Doraiswamy PM, Preven DW, Ross P, Klein DF: Teaching psychopharmacology in the 1990s: the first year experience with The American Society of Clinical Psychopharmacology model psychopharmacology curriculum. Academic Psychiatry, 25:1-8, Glick ID, Horsfall JL: Psychiatric conditions in sports: diagnosis, treatment, and quality of life. The Physician and Sportsmedicine, 29: 45-55, Reprinted in The Physician and Sportsmedicine, 3:29-34, /31/

40 109. Glick ID, Lemmens P, Vester-Blokland E: Treatment of the symptoms of schizophrenia: a combined analysis of double-blind studies comparing risperidone with haloperidol and other antipsychotic agents. International Clinical Psychopharmacology, 16: , Klein DF, Glick ID et al: Improving clinical trials: American Society of Clinical Psychopharmacology recommendations. Archives of General Psychiatry, 59:72-278, Glick ID, Murray SF, Vasudevan P Marder SR, Hu RJ: Treatment with atypical antipsychotics: new indications and new populations. J Psychiatric Research 35: , Glick ID, Berg PH: Time to study discontinuation, relapse and compliance with atypical or conventional antipsychotics in schizophrenia and related disorders. International Clin Psychopharm 17:65-68, Glick ID, Dixon L: Patient and family support organization services should be included as part of treatment for chronic psychiatric illness. J Psychiatric Practice, 8:63-69, Davis JM, Chen N, Glick ID: A meta-analysis of the efficacy of second-generation antipsychotics. Archives of General Psychiatry 60: , Davis JM, Chen N, Glick I. Letter: Subjecting meta-analyses to closer scrutiny:little support for differential efficacy among second-generation antipsychotics at equivalent doses. Arch Gen Psychiatry 2006; 63: Stroup TS, McEvoy JP, Swartz MS, Byerly M, Glick ID, et al: The NIMH antipsychotic trials of intervention effectiveness (CATIE) project: Schizophrenia trial design and protocol development. Schizophrenia Bulletin 29:15-32, Jibson MD, Glick ID, Tandon RT: Schizophrenia and other psychotic disorders. Focus 2:17-30, Glick ID, Carter WG, Tandon R: A paradigm for treatment of inpatient psychiatric disorders: from asylum to intensive care. J Psychiatric Practice 9:1-5, Glick ID, Zaninelli R, Hsu C, et al: Patterns of concomitant psychotropic medication use during a two year study comparing clozapine and olanzapine for the prevention of suicidal behavior. J Clinical Psychiatry 65: , Glick ID: Adding psychotherapy to pharmacotherapy: data, benefits, and guidelines for integration. Am J Psychotherapy 58: , Zisook S, Benjamin S, Balon R, Glick ID, et al: Alternate methods of teaching psychopharmacology. Academic Psychiatry 29: , /31/

41 121. Glick ID: Undiagnosed bipolar disorder: new syndromes and new treatments. The Primary Care Companion to the J Clin Psychiatry 6:27-33, Glick ID, Zisook S: The challenge of teaching psychopharmacology in the new millennium: the role of curricula. Academic Psychiatry 29: , Green AI, Tohen MF, Hamer RM, et al: First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol. Schizophrenia Research 66: , Glick ID: Psychosis: new perspectives and strategies: l Encephale 37:49-50, Glick ID: Atypical antipsychotics: new data and new controversies. Japanese J Clin Psychopharmacology 6: , Simpson GM, Glick ID, Weiden PJ, Romano SJ, Siu CO: Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder. Am J Psychiatry 161: , Glick ID, Marder SR: Long-term maintenance therapy with quetiapine versus haloperidol decanoate in patients with schizophrenia or schizoaffective disorder. J Clinical Psychiatry 66: , Ritvo EC, Glick ID: Family problems and sports performance. Physician & Sportsmedicine 33:37-41, Glick ID, Duggal V, Hodulik C: Aripiprazole as a dopamine partial agonist: positive and negative effects. J Clinical Psychopharmacology 26: , Glick ID: the ACNP and Me. Academic Psychiatry 31: , Glick ID, Shkedy Z, Schreiner A: Differential early onset of therapeutic response with risperidone versus conventional antipsychotics in patients with chronic schizophrenia. International Clinical Psychopharm, 21: , Glick ID, Borus JF: Through the Golden Chalkboard. Academic Psychiatry 30: , Strakowski SM Johnson JL, DelBello MP, Hamer M, Green AI, Tohen M, Lieberman JA, Glick ID, Patel JK. Quality of life during treatment with haloperidol or olanzapine in the year following a first psychotic episode. Schizophrenia Research 78: , /31/

42 134. McEvoy JP, Johnson J, Perkins D, Lieberman JA, Hamer RM, Keefe RSE, Tohen M, Glick ID: Insight in first episode psychosis. Psychological Medicine 60: , Green AI, Lieberman JA, Hamer RM, Glick ID, et al: Olanzapine and haloperidol in first episode psychosis: Two-year data. Schizophrenia Research 86: , Glick ID: Understanding the results of CATIE in the context of the field. CNS Spectrums 11:40-47, Rait D, Glick ID: Reintegrating family therapy training in psychiatric residency programs: making the case. Academic Psychiatry 32:76-80, Rait D, Glick ID: A Model for reintegrating couples and family therapy training in psychiatric residency programs. Academic Psychiatry 32:81-86, Ritvo EC, Melnick I, Marcus GR, Glick ID: Psychiatric conditions in cosmetic surgery patients. Facial Plastic Surgery 22: , Chakos MH, Glick ID, Miiller AL, et al: Baseline use of concomitant psychotropic medications to treat schizophrenia in the CATIE trial. Psychiatric Services 57:1-8, Glick ID, Salzman C, Cohen BM, Klein DF, Moutier C, Nasrallah AH, Ongur D, Wang P, Zisook S: Improving the Pedagogy Associated With the Teaching of Psychopharmacology. Academic Psychiatry, 31: , Glick ID, Pham D, Davis JM: Concomitant medications may not improve outcome of antipsychotic monotherapy for stabilized patients with nonacute schizophrenia. J Clinical Psychiatry 67: , Glick ID, He X, Davis JM: First-generation antipsychotics: current status. Primary Psychiatry 13:51-58, Kim SH, Ivanova O, Glick ID, Reaven G: Metabolic impact of switching antipsychotic therapy to aripiprazole after weight gain: a pilot study. J Clin Psychopharmacology, 27: , Davis JM, Chen N, Glick ID: Issues that may determine the outcome of antipsychotic trials: industry sponsorship and extrapyramidal side effect. Neuropsychopharmacology, 33: , Zisook S, Glick ID, Jefferson JW et al: Teaching psychopharmacology: what works and what doesn t. J Clin Psychopharmacology, 28:96-100, /31/

43 147. Glick ID, Poyurovsky M, Ivanova O, Koran L: Aripiprazole in Schizophrenia Patients with Comorbid Obsessive-Compulsive Symptoms. J Clinical Psychiatry, 69: , Janicak PG, Glick ID, Marder SR et al: The efficacy of aripiprazole across the symptom spectrum of schizophrenia: a pooled analysis from five short-term studies. J Clinical Psychiatry, 70:25-35, Poyurovsky M, Glick ID, Koran LM: Lamotrigine augmentation in schizophrenia and schizoaffective patients with obsessive-compulsive symptoms. J Psychopharm, 29: , Glick ID, Peselow ED: New antipsychotic agents. Primary Psychiatry, 15:57-64, Peselow ED, Malavade K, Lowe RS, Glick ID: Historical and other treatments in psychiatry. Primary Psychiatry, 15:42-49, Klein DF, Glick ID: Conflict of interest, journal review and publication policy. Neuropsychopharmacology, 33: , Glick ID, et al: The efficacy, safety, and tolerability of aripiprazole for the treatment of schizoaffective disorder: results from a pooled analysis of a sub-population of subjects from two randomized, double-blind, placebo-controlled, pivotal trials. J Affect Disorder, (2009) doi: /j.jad Glick ID, Bosch J, Casey DE: A double-blind randomized trial of mood stabilizer augmentation using lamotrigine an valproate for patients with schizophrenia who are stabilized and partially responsive. J Clin Psychopharmacology, 29: , Kraemer C, Glick ID, Klein DF: Clinical trials design lessons from the CATIE study. American J Psychiatry, 166: , Glick ID, Bossie CA, Alphs L, Canuso CM: The onset and persistence of antipsychotic response in patients with schizophrenia. J Clinical Psychopharm, 29:542-7, Glick ID, Balon R, Ballon J Rovine D: Teaching pearls from the lost art of psychopharmacology. J Psych Practice,15: , Glick ID, Kamm R, Morse E: The evolution of sport psychiatry, Circa Sports Medicine, 39: , /31/

44 Book Chapters, CME Publications & Columns: 1. Glick ID, Bennett SE. Psychiatric effects of progesterone and oral contraceptives. In: Shader R (ed) Psychiatric Complications of Medical Drugs. New York, Raven Press, 1972, pp Glick ID. Psychotropic action of oral contraceptives. In: Itil TM (ed), Psychotropic Action of Hormones. White Lake, NY, Spectrum Publications, Inc., 1976, pp Glick ID. The quality of delivery of mental health services to the community. In: Serban G (ed) New Trends of Psychiatry in the Community. Cambridge, Ballinger Publishing Co., 1977, pp Kessler DR, Glick ID. Family therapy. In: Ostwald P, Ruesch J (eds) Communication and Human Interaction. New York, Grune and Stratton, Inc., Glick ID. Practical considerations (Discussions of "The effects of social class on parental values and practices" by Kohn ML and of "The development of children in motherheaded families" by Hetherington EM, Cox M, Cox R), In: Reiss D, Hoffman H (eds) The American Family: Dying or Developing. New York, Plenum Press, 1979, pp 73-78, Glick ID, Kessler DR, Clarkin JF. Approaches to family therapy. In: Arieti S, Brodie HKH (eds), American Handbook of Psychiatry, Volume VII, New York, Basic Books, 1981, pp Glick ID, Clarkin JF. The effects of family presence and brief family intervention for hospitalized schizophrenic patients: A review, In: Harbin HT (ed) The Psychiatric Hospital and the Family. Spectrum, Inc., 1982, pp Clarkin JF, Frances AJ, Glick ID. The decision to treat the family: Selection criteria and enabling factors. In: Aronson ML, Wolberg LW (eds) Group and Family Therapy. New York, Brunner/Mazel, 1981, pp Glick ID, Clarkin JF. Family therapy when an affective disorder is diagnosed. In: Gurman AS (ed) Questions & Answers in the Practice of Family Therapy, New York, Brunner/Mazel, 1981, pp Glick ID, Bennett SE. Oral contraceptives and the menstrual cycle. In: Friedman RD (ed) Behavior and the Menstrual Cycle. New York, Marcel Dekker, Inc, 1982, pp Glick ID, Borus J. Family therapy for the impaired physician. In: Scheiber SC, Doyle BD (eds) The Impaired Physician. New York, Plenum Press, 1983, pp /31/

45 12. Clarkin JF, Glick ID. Supervision of family therapy. In: Blumenfield M (ed) Applied Supervision in Psychotherapy. Grune and Stratton, 1982, pp Grunebaum H, Glick ID. The basics of family treatment. In: Grinspoon L (Ed): Psychiatry Update, Vol II. Washington APA Press, 1983, pp l4. Magaro PA, Talbott JA, Glick ID. The inpatient care of chronic schizophrenia. In: Bellack AS (ed), Schizophrenia - Treatment, Management, and Rehabilitation. Orlando, Fl, Grune and Stratton, 1984, pp Haas GL, Clarkin JF, Glick ID. Marital and family treatment of depression. In: Beckham EE, Leber WR (eds), Handbook of Depression: Treatment, Assessment, and Research. Homewood Illinois, The Dorsey Press, 1985, pp Glick ID. Treatment of premenstrual syndrome in psychiatric practice. In: Osofsky HJ, Blumenthal SJ (eds) Premenstrual Syndrome: Current Findings & Future Directions, Progress in Psychiatry. Washington, D.C., American Psychiatric Press, 1985, pp Glick ID, Clarkin JF. The family model of intervention. In: Sederer L (ed) Inpatient Psychiatry: Diagnosis and Treatment, Second edition. Baltimore, Williams and Wilkins, 1986, pp (third edition, 1991, pp ). 18. Stewart TJ, Bjorksten OJ, Glick ID. Sociodemographic aspects of contemporary American marriage. In: Bjorksten OJ (ed) New Clinical Concepts in Marital Therapy. Washington, D.C., American Psychiatric Press, Inc Glick ID, Haas GL, Clarkin JF: The family and posthospital treatment compliance among affective disorders. In: Halbreich U, Feinberg SS (eds) Psychosocial Aspects of Nonresponse to Antidepressant Drugs, Washington, D.C., American Psychiatric Press, Glick ID, Quitkin FM, Bennett SE: The influence of estrogens, progestins and oral contraceptives on depression, In: Halbreich U, Rose R, (eds) Hormones and Depression. New York, Raven Press, 1987, pp Talbott JA, Glick ID: The inpatient care of the chronic mentally ill. In: Lion JR, Adler WN, Webb WL (eds) Modern Hospital Psychiatry. New York, Norton & Company, 1988, pp Craig JC, Gruenke LD, Klein FD, Glick ID, et al. Development of a method for the determination of chlorpromazine and its major metabolites by gas chromatography/mass spectrometry, and application to biological fluids, Perspectives in Psychopharmacology: A Collection of Papers in Honor of Earl Usdin, Edited by W. Bunney and R. Barchas, New York, Alan R. Liss, Inc., 1988, pp /31/

46 23. Glick ID, Clarkin JF, Haas GL. Family and Couple Therapies, in Treatments of Psychiatric Disorders (Karasu, T. Byram, (ed) A Task Force Report of the American Psychiatric Association, Washington, D.C. APPI, Clarkin JF, Glick ID, Haas GL, Spencer, JH Jr. Inpatient Family Intervention for Affective Disorders. In: Keitner, GI (ed) Depression and Families: Impact and Treatment, Progress in Psychiatry Series, American Psychiatric Press, Wash. DC, Clarkin JF, Haas GL, and Glick ID: Inpatient Family Intervention. In: Clarkin JF, Haas GL and Glick ID (eds) Affective Disorders and the Family: Assessment and Treatment, New York, Guilford Press, 1988, pp Clarkin JF and Glick ID: Instruments for the Assessment of Family Malfunction. In: Wetzler S, (ed), Measuring Mental Illness: Psychometric Assessment for Clinicians, American Psychiatric Press, Washington, D.C. 1989, pp Glick I D, Dulit RA, Wachter E, Clarkin JF: A Survival Guide for Patients with Borderline Personality Disorder and Their Families. In: Minakawa K (ed) New Approaches to the Borderline Syndrome, Toyko, Iwasaki Gakujutsu Shuppan, 1991, pp Glick ID, Freund NY and Olfson M: What a Psychiatric Hospitalization Can and Cannot Do: A Review of Efficacy Studies. In: Persad E, Kazarian SS and Joseph LW (eds) The Mental Hospital in the 21st Century. Toronto, Canada, Wall & Emerson, Inc., 1992, pp Clarkin JF, Haas GL and Glick ID: Family and Marital Therapy. In: Paykel, ES. (ed) Handbook of Affective Disorders, 2nd edition. New York, Churchill Livingstone, 1992, pp Glick ID, Clarkin JF and Goldsmith SJ: Combining Medication with Family Psychotherapy. In: Beitman B (ed), Combined Treatments, the American Psychiatric Press Review of Psychiatry, Vol. 12. Washington, D.C. American Psychiatric Press, Inc., 1993, pp Klerman GL, Weissman MW, Markowitz J, Glick ID, Wilner PJ, Mason B, Shear MK: Medication and Psychotherapy. In: Bergen, AE and Garfield, SL (eds), Handbook of Psychotherapy and Behavioral Change, 1994, John Wiley, New York. fourth edition, pp Glick ID, Braff D, Janowsky D: Short and Long-Term Psychopharmacological Treatment Strategies. In: Psychopharmacology: The Fourth Generation of Progress, Bloom FE, Kupfer DJ (eds). Raven Press, New York, 1995, pp Revised: Glick ID, Marder S, Janowsky D, Suppes T, DeBattista C: New short- and long-term psychopharmacologic treatment strategies for schizophrenia, bipolar 12/31/

47 disorder and depressive disorder. In: Watson SJ, Deutch A (eds), Psychopharmacology: The Fourth Generation of Progress CD-ROM, Philadelphia, PA, Lippincott-Raven, DeBattista C, Glick ID: The applicability of pharmacotherapy for neurosis and personality disorder: In: Current Opinion in Psychiatry, 1995, pp Glick ID: Unbundling the Function of an Inpatient Unit: In: JP Docherty (ed), Inpatient Psychiatry in the 1990's: New Directions in Mental Health Services. San Francisco: Josey Bass, 1994, pp Glick ID: Neuroleptic-psychosocial interactions and prediction of outcome. In: Gaebel W, Awad AG (eds): Prediction of Neuroleptic Treatment Outcome in Schizophrenia - Concepts and Methods. New York, Springer-Verlag, 1994: pp Thase ME, Glick ID: Combined Treatment. In: Glick ID (ed), Treating Depression. San Francisco, Jossey-Bass, 1995, pp Sholevar GP, Glick ID, Sholevar EH: Family Intervention and Psychiatric Hospitalization. In: Textbook of Family and Couples Therapy. Edited by GP Sholevar and LD Schwoeri. Washington, DC, American Psychiatric Publishing, Inc., 2003, pp Glick ID, Lecrubier Y, Montgomery SA, Vinar O, Klein D. Promising Psychopharmacological Agents *Available in Europe. In: Schatzberg AF, Nemeroff CB (eds), Textbook of Psychopharmacology. Washington, DC, American Psychiatric Press,1995: pp Glick ID, Clarkin JF: Family In: Sacks MH, Sledge WH, Waren C (Eds) Core Readings in Psychiatry: An Annotated Guide to the Literature, Washington, APPI, 1995: pp Clarkin JK, Glick ID: Family and Marital Therapy In: Sacks MH, Sledge WH, Waren C (Eds) Core Readings in Psychiatry: An Annotated Guide to the Literature, Washington, APPI, 1995: pp Glick ID, Clarkin JF: Family Support and Intervention. In: Sederer LI and Rothschild AJ, Acute Care Psychiatry: Diagnosis and Treatment, Baltimore, Williams & Wilkins, 1997: pp Glick ID: Familiy Associations and Family Therapy: from Conflict to Collaboration. In: Clerici M., Bertrando P (Eds) Psychoeducation and Self-Help in Major Psychiatric Disorders, Torino, Italy, Boringhieri Editore, (in press) 12/31/

48 43. Belanoff JK, Glick ID: New Psychotropic Drugs for Axis I Disorders: Recently Arrived, in Development and Never Arrived. In: Schatzberg AF, Nemeroff CB (eds), Textbook of Psychopharmacology, Second Edition. Washington, DC, American Psychiatric Press, 1998, pp Glick ID: Family therapies: efficacy, indications and treatment outcomes. In: Janowsky DF (ed), Psychotherapy: Indications and Outcomes, American Psychiatric Press, 1999, pp Jeste DV, Glick ID: Editors introduction: intervention research in psychosis: past, present, and future. In: NIMH Schizophrenia Bulletin, 26: , Belanoff JK, Glick ID: New Psychotropic Drugs for Axis I Disorders. In: The Essentials of Clinical Psychopharmacology. Edited by AF Schatzberg and CB Nemeroff. Washington, DC, American Psychiatric Press, 2001, pp Tandon R, Glick ID: Introduction. In: Managing Schizophrenia: A Comprehensive Primer. New York, McMahon Publishing, 2002, pp Glick ID, Loraas EL: Family Treatment of Borderline Personality Disorder. In: Family Therapy and Mental Health. Edited by MacFarlane MM. New York, NY, The Haworth Press, 2001, pp Ritvo EC, Glick ID: Couples Therapy, for the text, Textbook of Psychiatry, Second Edition, Edited by Tasman A, Lieberman J, Kay J, First MB, Maj M. England, John Wiley & Sons, Ltd, 2003, pp Third Edition, Ritvo EC, Glick ID, Berman E: Couples Therapy. 2008,Vol 2, pp Glick ID, Mullen B: Family Intevention in the Treatment of Personality Disorder and Issues of Compliance. In: Personality Disorder: Current Research and Treatments. Edited by Reich J, Routledge, Taylor & Francis Group, New York, 2005, pp Liberman RP, Glick ID: Drug and psychosocial curriculum for psychiatric residents in the treatment of schizophrenia. Psychiatric Services 55: , Glick ID, Horsfall JL: Diagnosis and Psychiatric Treatment of Athletes. In: Clinics in Sports Medicine. Edited by Tofler IR and Morse ED, Elsevier, NY, 2005, pp Glick ID: Safety and Tolerability of Antipsychotic Therapy for Schizophrenia: Analyzing the Evidence to Ensure Effective Outcomes. First Report. March Ritvo ER, Melnick I, Glick ID: Couples and Family Therapy. In: Hales RE, Yudofsky SC, Gabbard GO. American Psychiatric Publishing Textbook of Psychiatry. Fifth Edition, 2008, /31/

49 55. Glick ID: Combining Pharmacotherapy With Psychotherapeutic Management: Guidelines for Integration. ASCP Corner, J Clin Psychiatry 67: , Balon R, Glick ID, Zisook S: A Model Psychopharmacology Curriculum. Psychiatric Times, April, Glick ID, Tandon R: The Acute Crisis Stabilization Unit for Adults. In: Textbook of Hospital Psychiatry, Edited by Sharfstein S, Dickerson FB and Oldham JM. Arlington, VA, American Psychiatric Publishing Inc., 2008, pp Glick ID: Reflections on the origins and evolution of AFTA. In: AFTA Monograph Series, Reflections of AFTA s early days: moving forward by remembering our past, edited by Sullivan MA & Domokos-Cheng Ham M. American Family Therapy Academy, Inc., Winter 2009, pp Rait DS, Glick ID: Schizophrenia: A Family Psychoeducational Approach. In: How to Practice Evidence Based Psychiatry: Basic Principles and Case Studies, Edited by B Taylor, Am Psych Press, Inc. Washington, DC 2009, pp Letters: 1. Glick ID: Outcome of Deinstitutionalized Patients. Am J Psych 139:843, Glick ID, Klar HM: Schizophrenia. NEJM 306:1366, Frosch WA, Glick ID, Talbott JA: The Teacher as Impediment to Learning: The Problem of Focal Conviction. Arch Gen Psych 40:1257, Glick ID: Who To Blame. New York Times, Feb 12, Glick ID: When a Patient May Be Dangerous. New York Times, Aug 20, Glick ID, Clarkin JC: The Premises of Family Therapy. J Marital & Family Therapy 15: , Glick ID, Olfson M: Benefits of Inpatient Care. Hosp & Community Psychiatry 42:639, Glick ID: Cross-Cultural Panel. Northern Calif Psych Physician, Oct:15, Glick ID, Sacks M: Amateur Hour at Mental Health. New York Times, Feb 1, Glick ID: Newer Antipsychotics. Psychiatric News, Nov 19:21, /31/

50 11. Glick ID, Janowsky D, Zisook S: On Using the ASCP Model Curriculum of Psychopharmacology: Comments and an Update. Academic Psych 25: , Glick ID: We Are Family. New York Times, Nov 6:7, Glick ID, Siris SG, Davis JM. Treating Schizophrenia with Comorbid Depressive or Demoralization Symptoms (letter). J Clin Psychiatry 69:501, Glick ID, Marder SR: Drs. Glick and Marder Reply. J Clin Psychiatry 6: , Davis JM, Chen N, Glick ID: Subjecting Meta-analyses to Closer Scrutiny: Little Support for Differential Efficacy Among Second-Generation Antipsychotics at Equivalent Doses. Arch Gen Psychiatry 63: , Davis J, Leucht S, Glick ID: Catie Findings Revisited. Psychiatry Services, 60: 125, Glick ID: The long and the short of it: are shorter periods of hospitalization beneficial? E- Letter in the British J Psychiatry, Feb, Editorials: 1. Glick ID, Showstack JA, Klar HM: Toward the definition and delivery of appropriate care. Am J Psychiatry 139: , GAP Committee on the Family: The challenge of relational diagnoses: Applying the biopsychosocial mood in DSM-IV. Am J Psychiat, 146: , Judd LL, Glick ID: The National Institute of Mental Health: prospects and promises. Biol Psychiatry, 26: , Glick ID, Zisook S, Shader RI: The challenge of teaching psychopharmacology and Improving Clinical practice. J Clin Psychopharmacology, 25: , 2005 Book Reviews: 1. Glick ID: Treating the Treatment Failures by Arnold M. Ludwig, Grune & Stratton, Inc. 1971, 235 pp. California Medicine 177: 104, July Glick ID: Mom s House, Dad s House by Isola Ricci, Macmillan Publishing Co. 1980, 270 pp. J Psychiatry Law, Federal Legal Publications, Inc., Glick ID, Clarkin KC: Handbook of Family Therapy edited by Gurman AS and Kniskern DP, Brunner-Mazel 1981, 796 pp. Hospital and Community Psychiatry 33: , June /31/

51 4. Glick ID: Inpatient Psychiatry: Diagnosis and Treatment edited by Sederer LI, Williams and Wilkins, 1983, 337 pp. New England J Medicine 309:619, Glick ID, Clarkin KC: The Strength of Family Therapy: Selected papers of Nathan W. Ackerman, Brunner/Mazel, 1982, 460 pp. J Marital and Family Therapy , July Perry S, Glick ID: Massachusetts General Hospital Handbook of General Hospital Psychiatry edited by Thomas Hackett and Ned Cassem, PSC 1987, 658 pp. NEJM 317:1609, Glick ID: The Creative Process of Psychotherapy by Arnold Rothenberg, WW Norton & Co, 1987, 210 pp. Am J Psychiatry 146:675, Glick ID: Bringing Up Baby Without Destroying Mommy and Daddy by Jerry Lewis, Brunner/Mazel, 1989, xii pp. Contemporary Psychiatry 9:96, Glick ID: Evaluating Family Mental Health by John Schwab, J Stephenson, John Ice, Plenum, 1993, 452 pp. Psychiatric Times, p. 41, November Glick ID: The Sorrow of War: A Novel of North Vietnam (1994) by Bao Ninh, New York Riverhead Books, 1996, 235 pp. Am J Psychiatry 157:12, December 2000 Films and Videotapes: 1. Glick ID, Marshall G: Videotape Playback in Family Therapy. 16mm, B & W, Sound 45 min., Glick ID, Marshall G: Family Therapy: An Introduction. 16 mm, B & W, Sound 45 min., 1970 Commentaries: 1. Practice Guidelines for the Treatment of Bipolar Disorders. In Abstracts of Clinical Care Guidelines, 7:5, 1995, pp Glick ID: Introduction to the Classic Article Section. J Psychotherapy Practice Research 6: , Thompson JW, Glick ID. Teaching and Learning Psychopharmacology: A Strategy for the Practicing Physician. Focus IV: , /31/

52 TEACHING SERVICES: University of California, San Francisco : Director of Medical Student Education, Dept. of Psychiatry: First Year Medical Students (a) Behavioral Science and Psychopathology, Seminar Leader, Winter, 2 hrs/wk. Lecture, "Psychophysiologic Disorders," given to entire class 1970 (b) Basic Clerkship 1-A. Supervisor, 2 hrs/wk, Spring Second Year Medical Students a) Psychiatry 121, Basic Psychiatry. Seminar Leader, 3 hrs/wk, Spring, Fall, Winter b) Psychiatry 18, Behavioral Science and Psychopathology. Seminar Leader, 3 hrs/wk, Fall Quarter; 2 hrs/wk, Spring Quarter, Course Coordinator, Spring, c) Psychiatry 100, Psychopathology Course Committee, Course Coordinator and Lecturer, 6 hrs/wk, Winter, d) Psychiatry 101, Psychopathology Course Committee, Course Coordinator and Lecturer, 6 hrs/wk, Winter, e) Psychiatry , Introduction to Clinical Psychiatry: Course Committee and Lecturer, 6 hrs/wk, Fall-Winter Course Coordinator and Lecturer, 6 hrs/wk, Fall-Winter Course Supervisor and Lecturer, 6 hrs/wk, Winter-Spring; Lecturer Third Year Medical Students a) Psychiatry 110, Clinical Clerkship in Psychiatry. l hour/week, 1968-present; Acting Director, Fall, Fourth Year Medical Students a) Psychiatry 110, Clinical Clerkship in Psychiatry. 1 hour/week b) Behavioral Specialist Pathway, Clinical Subpathway, Individual and Family Therapy. Coordinator, 1 hour/week, Summer, Fall, Winter, Spring, /31/

53 TEACHING SERVICES (continued): Residents, Department of Psychiatry a) Basic Psychiatry 1. Seminar Series Participant b) Supervisor, 1st, 2nd, 3rd, and 4th Year Psychiatry Residents c) Seminar on Hospital Psychiatry to Psychiatric Residents. 1 hour/week d) Seminar, Family Dynamics and Therapy. 3 hrs/wk, Fall, 70; Spring, 71; Spring, e) Clinical Psychiatry for Non-Psychiatrists. 2 hrs/wk, Fall-Winter f) Paramedical Staff. 5 hrs/wk 1970 g) Committee to conduct qualifying examinations for admission to candidacy for PhD degree, B. Tesher, Nursing, in the field of family therapy h) The Teaching-Learning Process in Psychiatry. To Psychiatric Residents, Fall- Winter, 2 hrs/wk i) Coordinator, Basic Psychiatry II, to all Second Year Psychiatric Residents j) Core seminar, Theory & Practice of Family Therapy, as part of Basic Psychiatry II, to all second year psychiatric residents, , , with David Kessler, MD k) Seminar on Clinical Research Design, Elective, Third Year Psychiatric Residents Cornell University Medical College : First Year Medical Students 1979 a) Understanding Human Behavior, Preceptor, 10 weeks, Fall 1980 b) Understanding Human Behavior, Lecturer and Panelist, Fall 1982 c) Investigative Approaches of Human Behavior, Preceptor, Spring 12/31/

54 Third Year Medical Students 1978 a) Psychological Assessment of Medicine, Preceptor, Spring 1978 b) Core Clerkship, Preceptor, Summer Other a) Faculty Advisor b) Internship Advisor Faculty and Staff -- Department of Psychiatry 1978 a) Family Therapy Supervisory Seminar for Payne Whitney Faculty, 9 weeks, Spring 1978 b) Family Therapy Supervisory Seminar for Westchester Division Faculty, 9 weeks, Fall 1978 c) Seminar on Intro to Psychiatric Research for Payne Whitney Staff, 2 weeks, Fall Residents: Department. of Psychiatry Research Courses: a) Introduction to Research, PGY II's, April-June b) Intermediate Research Course, PGY lll s, 10 weeks, January-April c) Advanced Research Seminar, PGY IV's, 10 weeks, April-June Psychopharmacology Courses a) Psychopharmacology Rounds, PGY II, III & IV's, 1982-present; Coordinator b) Psychopharmacology Consultant, to Inpatient Services, , c) Outpatient Psychopharmacology, PGY III's, 1990-present, weekly, all year d) Psychopharmacology Supervision, PGY III's & IV's 12/31/

55 Family Therapy Courses a) Seminar on The Family Interview, PGY II Summer Course b) Family Therapy-Inpatient Introductory Course, as part of PGY II Core Curriculum, 8 wks c) Family Therapy-Outpatient, for PGY III's as part of the Core Curriculum, Intermediate Course, 8 weeks, Winter d) Family Therapy, for PGY IV's, as part of Continuous Case Conference, Payne Whitney Clinic, 12 weeks, Fall 1978 e) Seminar on Evaluation of the Family, as part of the Summer Orientation for PGY I's and II's and Psychology Interns, Westchester Division, Summer f) Introduction to Family Therapy, as part of Core Curriculum PGY II's, Westchester Division, 8 weeks (90 min.), Winter g) Continuous Case Conference on Family Therapy, for the Child Psychiatry Service. Bimonthly, September to June Hospital Psychiatry Courses a) Criteria for Selection of Inpatient Treatment Modalities, as part of PGY II Core Curriculum. 6/hours/yearly b) Inpatient Psychiatry, for PGY II's, 3 weeks, Summer, (yearly) c) Assistant Unit Chief Clinical Rounds, PGY IV's, Payne Whitney Clinic, biweekly d) Psychopathology Course, Schizophrenia to PG II's General Psychiatry Courses a) Psychiatric Resident Tutorial, Payne Whitney Clinic, 6/hours/yearly b) Supervisor, Long Term Psychotherapy, PGY II's Stanford University School of Medicine present: General Psychiatry Courses a) Psychopathology course, PGY II, Treatment Modules on Schizophrenia & Bipolar Disorder b) PGY IV Board Review Course, Schizophrenia Module c) Chairman's Rounds 12/31/

56 Hospital Psychiatry Courses a) Inpatient Medical Student and Resident Supervision b) Inpatient Psychiatry, Course Coordinator and Lecturer, PGY II 1. Overview 2. Workup and Treatment Planning 3. Treatment of Psychosis Psychopharmacology Courses Introduction to Psychopharmacology, PG II, Personality Disorder Bipolar Disorder, Medication and Compliance Issues Strategies of Outpatient Psychopharmacology, PG III, Course Coordinator and lecturer 1. Schizophrenia 2. Combining & Integrating Psychotherapeutic Intervention with Medication 3. Art of Psychopharmacology 2004 Neuroscience, PG III Lecture, Metabolic Side Effects of Antipsychotics Introduction to Psychopathology and Psychopharmacology, PG II, 4 quarters/year, Course Director (with Sara Mueller, MD and Sallie DeGolia, MD) and Lectures History of Psychiatric Treatments Personality Disorders Medical School Courses Winter, , Medical School Clerkship, Psychotic Disorder and Neuroleptic Treatment. Outside UCSF, Cornell University Medical College & Stanford University Columbia University, College of Physicians and Surgeons. Basic Clinical Psychiatry, to Third Year Medical Students, Fall-Winter, 3 hrs/wk Hillside Hospital. Supervision and Teaching, First and Second Year Psychiatric Residents, 15 hrs/wk, all year U.S. Army Hospital Specialized Treatment Center. Ft. Gordon, Georgia. Basic Psychiatry I, to Medical and Paramedical Staff, l hr/wk, all year Medical College of Georgia. Family Therapy, to Psychiatry Dept. Staff, Residents, and Medical Students, 2 hrs/wk, 20 wks/yr 12/31/

57 Mt. Zion Hospital and Medical Center. Seminar in Psychopharmacology, Psychosomatic Conference, to Second and Third Year Psychiatry Residents, two 90-minute sessions yearly 1986 School of Medicine, University of Verona. Seminar on Recent Developments in American Psychiatry, to Psychiatric Residents and Faculty, January-June, six 90 minute sessions COMMUNITY AND PUBLIC SERVICE: Presentation of paper "Psychophysiologic Factors in the Etiology of Preeclampsia," American Psychosomatic Society, April Grand Rounds, "Psychophysiologic Factors in the Etiology of Schizophrenia," to the Dept. of Psychiatry, Mt. Zion Hospital, San Francisco Grand Rounds, "Psychophysiologic Factors in the Etiology of Schizophrenia," to the Dept. of Obstetrics and Gynecology, Mt. Zion Hospital, Presentation of paper, "Mood and Behavioral Changes Associated with the Use of the Oral Contraceptive Agents: A Review of the Literature," Eighth Annual Psychiatric Research Society Meeting, Presentation of paper, "The 'Sick' Family and Schizophrenia - Cause and Effect?" to the Tenth Annual Psychiatric Research Society Meeting, Cincinnati, Institute Leader, "Family Dynamics and Treatment," Annual Meeting, Georgia Branch, National Association of Social Workers, February Invited Lecture, "The Place of Occupational Therapy in Clinical Psychiatric Treatment," Georgia Occupational Therapy Association, Institute Leader on "Family Therapy and Hospital Psychiatry," at Columbia, S.C., VA Hospital September 1967 Invited Lecture, on "The School and the Family," to the Annual Meeting of the Georgia Association of Visiting Teachers, Augusta, Georgia, November Seminar Leader on "Family Therapy," at Macon, Ga., Mental Health Clinic, Macon, Ga., November Invited Address, "The Changing Role of the Family," Unitarian Fellowship, Augusta, Ga., December /31/

58 Invited Lecture, "Basic Clinical Psychiatry" to Psychology Students, Paine College, Augusta, Ga., (Jan)1968. Lecture and Panel Discussion, "The Role of the Clergy in Family Counseling, at a seminar on Family Counseling, Augusta, Ga., February Address, "The Family and Southern Society," to First Mt. Moriah Baptist Church, Augusta, Ga., April Film Presentation: Videotape Playback in Family Therapy (with G. Marshall) 16mm. B & W 10 min. Presented at the 1968 annual meeting, American Psychiatric Association, Boston, Mass. May 16, 1968 Grand Rounds, "Mood and Behaviorial Changes Associated with Use of Oral Contraceptives," OBGYN, University of California, San Francisco, September Participant, panel on Training of Family Therapists, Don D. Jackson Memorial Family Conference, Asilomar, California, February Lecture on "Current Status of Family Therapy," given to Association of Family Therapists, San Francisco, 3/69. Film and Seminar Discussion on "An Introduction to Family Therapy," given at the Clinical Seminar Series, Langley Porter Neuropsychiatric Institute, Psychology Dept., March Two-Day Seminar on Current Developments in Psychiatry given at Dept. of Psychiatry, Medical College of Georgia, May Film "Family Therapy: An Introduction," presented at the Annual Meeting, American Psychiatric Association, Miami Beach, Fla., May Discussion of paper entitled "Psychosexual Responses to Ileostomy and Colostomy" at American Psychiatric Association Meeting, Miami Beach, Fla., Film "Family Therapy: An Introduction," shown at Staff Meeting, Mental Research at Ninth Western Divisional Meeting 1969, of Westen Psychiatric Association, Seattle, August Moderator of Panel on Family Therapy: Rationale, Methods, Teaching and Research at Ninth Western Divisional Meeting 1969, of Western Psychiatric Association, Seattle, August Discussion of Paper, "The Psychiatrist as Counselor and Friend to the Family," by Herbert C. Wimberger, MD, at Ninth Western Divisional Meeting, Western Psychiatric Association, Seattle, August Abstracts Editor, Family Process, July /31/

59 Participant in CBS News Reports Program titled "The Pill," KPIX, February Participant on Panel: "Therapists and Families," American Orthopsychiatric Association 47th Annual Meeting in San Francisco, March Lecture on "Issues in Family Therapy Training," presented to Interdisciplinary Training Program Seminar, Napa State Hospital, May Moderator of Panel, "Issues in Training of Family Therapists," American Psychiatric Association Annual Meeting, May Discussion Leader, NIMH Career Teachers in Psychiatry Meeting, Boston, October, 1971 Participant In Panel, "Emotional Problems of Psychiatric Residents," American Psychiatric Association Annual Meeting, May, Presentation of paper entitled "Management of Psychoses Associated with Dialysis," American Psychiatric Association Annual Meeting, May Regional Coordinator, "The Psychiatrist as Teacher," for the National Conference on Teaching Psychiatry, one-day regional meeting held at San Francisco, May Presentation of Paper and Participant on Panel, "Stress Events & Psychiatric Illness," at the Symposium"Stress: Its Impact on Thought and Emotion," University of California at San Francisco, June 1972 Group Leader, Regional Coordinator, and Presentation at "Free University" of film on Family Therapy at the national conference, "The Psychiatrist as a Teacher." Airlie House, October 3-6, Lecture, "Transference and Countertransference," to Graduate Psychiatric Nursing Students, University of California, San Francisco, November Resource Teacher in Section on "University Dept. of Psychiatry" at the First National Conference on Training in Family Therapy, Philadelphia, November 30 - December 2, Lecture, "Depression," presented as part of a section entitled "Dilemmas in Therapy" as part of the 23rd Annual Course for Physicians in General Practice, Mt. Zion Hospital and Medical Center, February Presentation of paper, "Short vs. Long Hospitalization: A Prospective Controlled Study -- Preliminary Results of a One-Year Follow-up of Schizophrenics," Research Seminar, Dept. of Psychiatry, Mt. Zion Hospital, April /31/

60 Presentation of paper, "Short vs. Long Hospitalization: A Prospective Controlled Study -- Preliminary Results of a One-Year Follow-up of Schizophrenics," at the Annual Meeting, American Psychiatric Association, Honolulu, Hawaii, May, Presentation of paper, "Indications and Relative Contraindications for Family Treatment, Circa 1973," at the San Francisco Family Forum, San Francisco General Hospital, January 10, Presentation of paper, "Treatment and Outcome in Schizophrenia," at the Merger Celebration in Honor of the Merger of Langley Porter Neuropsychiatric Institute with University of California, San Francisco, February, Presentation of paper, "Indications and Contraindications for Family Therapy," at the Nathan W. Ackerman Memorial Conference, Venezuela, February, Film presentation, "Family Therapy: An Introduction:" 1971: 12 showings 1972: 8 showings 1973: 8 showings 1974: 6 showings Discussant, Conference, "Lithium: Its Role in Manic-Depressive Illness," Chief's Conference, Dept. of Psychiatry, Mt. Zion Hospital, San Francisco, March 12, Presentation of paper, "Short Versus Long Psychiatric Hospitalization for Schizophrenia - Preliminary Results, One Year Followup," Noon Conference, Langley Porter Neuropsychiatric Institute, San Francisco, 3/74. Presentation of paper, "Mood and Behavioral Changes Associated with the Use of Oral Contraceptives," 1st World Congress of Biological Psychiatry, Buenos Aires, Argentina, September, Presentation of paper, "Short Versus Long Psychiatric Hospitalization: A Controlled Study," Dept. of Psychiatry Grand Rounds, Cornell University Medical College, New York, NY, November Presentation of paper, "Short Versus Long Psychiatric Hospitalization: A Controlled Study," SUNY, Downstate Medical Center, New York, NY, November Coordinator, "The Role of the Family in Medical Practice," Third National Workshop on Psychiatric Education, Association for Academic Psychiatry, Chicago, Illinios, November Presentation of paper, "Short Versus Long Hospitalization - A Prospective Controlled Study: One Year Followup Results," Section on Interaction of Drugs and Nonsomatic Therapies, American College of Neuropsychopharmacology, Puerto Rico, December Presentation of paper, "Short Versus Long Hospitalization: A Prospective Controlled Study. IV- A. One Year Followup Results for Schizophrenics," Research Conference, Dept. of Psychiatry, Mt. Zion Medical Center, San Francisco, February 18, /31/

61 Panel Discussant, "The Treatment of Schizophrenia at Langley Porter Institute," Noon Conference, Langley Porter Institute, San Francisco, April 30, Panel Moderator, "Controlled Studies of Alternative Lengths of Hospitalization for Psychiatric Illness," presented at the 1975 Annual Meeting, American Psychiatric Association, Anaheim, California, May Presentation of paper, "Short Versus Long Hospitalization: A Prospective Controlled Study. IV. One Year Followup Results for Schizophrenics," American Psychiatric Association Annual Meeting, Anaheim, CA, 5/75. Radio presentation, "Loxitane in Schizophrenia," CBS Radio Network, July 12 and 13, Discussant, "Conceptual Approaches to Schizophrenic Disorder," Grand Rounds, Dept. of Psychiatry, University of California, San Francisco, September 22, Discussant, "Depression in Medical Practice," Grand Rounds, Dept. of Medicine, University of California, San Francisco, September 23, Presentation of paper, "Short Versus Long Hospitalization: A Prospective Controlled Study. II. Results for Schizophrenic Inpatients," Langley Porter Institute weekly research staff conference, October 10, Panelist, "Can a Psychiatric Hospital Survive Mental Health and Marijuana?" Grand Rounds, Dept. of Psychiatry, UCSF, November 18 and 25, Seminar Leader, "Issues in Family Therapy," California Branch District Meeting American Psychiatric Association Conference, Palm Springs, November Presentation of paper, "Short VersusLong Psychiatric Hospitalization: A Controlled Study. Medication and Outcome for Schizophrenics," American College of Neuropsychopharmacology, Puerto Rico, December Exhibit, entitled "A Teaching Package for a Preclinical Psychiatry Course," 30th All-University Faculty Conference, University of California, Santa Barbara, March 25-27, Discussant and Presentation of paper, "Short Versus Long Psychiatric Hospitalization," as part of a symposium: "A Critical Appraisal of Community Psychiatry," Kittay Scientific Foundation, NY, 3/76. Presentation of paper, "Controversial Premises of Marital and Family Therapy," (with David R. Kessler, MD) for the San Francisco Family Forum, Family Health Center, San Francisco General Hospital, April 15, /31/

62 Presentation and Discussion, "Short Versus Long Psychiatric Hospitalization: A Controlled Study, Two Year Results," Grand Rounds, Dept. of Psychiatry, UCSF, April 20, Panelist, "Schizophrenia -- Which Treatment and For Whom," 1976 Annual Meeting, American Psychiatric Association, Miami, May Panelist, "What Makes Medical Students So Difficult To Teach?" 1976 Annual Meeting, American Psychiatric Association, Miami, May Panelist, "Controversies in Psychiatric Education," 1976 Annual Meeting, American Psychiatric Association, Miami, May Presentation of paper, "Increasing Learning During the Psychiatric Residency," (with Leon Epstein, MD) 1976 Annual Meeting, American Psychiatric Association, Miami, May Presentation of paper, "Indications and Contraindications for Family Therapy; Changing Concepts," Psychiatry Grand Rounds, Dept. of Psychiatry, School of Medicine, U.C. Davis, September Presentation of paper, "Short Versus Long Psychiatric Hospitalization: A Controlled Study: Two Year Results," Dept. of Psychiatry, Mt. Sinai School of Medicine, New York, September Presentation of paper, "Short Versus Long Psychiatric Hospitalization: Final Results and Treatment Implications," Dept. of Psychiatry, Mt. Zion Hospital and Medical Center, San Francisco, October Keynote Speaker, "Short-Term Intensive Psychiatric Hospital Treatment: Which Treatment and for Whom?" National Conference on Short-Term Intensive Psychiatric Hospital Treatment, Scottsdale, AZ, 11/76 Panel Moderator, "Treating the Impaired Physician: Confidentiality vs. Responsibility," presented at the 1976 Annual Meeting, Association of American Medical Colleges, San Francisco, November Examiner, American Board of Psychiatry and Neurology, Seattle, February Special Lecture, "A Teaching Package for a Preclinical Psychiatry Course," Dept. of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, February Presentation of paper, "Short Versus Long Psychiatric Hospitalization: A Controlled Study," Grand Rounds, Dept. of Psychiatry, University of New Mexico, Albuquerque, New Mexico, March Presentation of paper, "Indications and Contraindications for Family Therapy," Grand Rounds, Veterans Administration Hospital, Albuquerque, New Mexico, March /31/

63 Referee, Journal of Nervous and Mental Diseases, Archives of General Psychiatry, American Journal of Psychiatry, and Family Process. Hospital and Community Psychiatry. Presentation of paper, "The Architectural Design of a Psychotherapeutic Milieu," 1977 Annual Meeting of the American Psychiatric Association, Toronto, Canada, May Panelist, "New Directions in Family Research: Ritual, Real Time and Images," 1977 Annual Meeting of the American Psychiatric Association, Toronto, Canada, May Panel Moderator, "Schizophrenia - Which Treatment and For Whom?", 1977 Annual Meeting of the American Psychiatric Association, Toronto, Canada, May Panelist and Discussion Group Leader, at conference entitled "Families In Contemporary America: Varieties of Form, Function and Experience," jointly sponsored by the Dept. of Psychiatry and Behavioral Sciences of the George Washington University School of Medicine and the Center for Continuing Education in Mental Health of the Psychiatric Institute Foundation, Washington, D.C., June Television Presentation, Role of Clinical Psychiatry - on "The Hidden Universe" - ABC National Television Documentary, June Presentation of paper, "Short Versus Long Psychiatric Hospitalization," World Psychiatric Association, Honolulu, August Presentation of paper, "Indications and Contraindictions for Family Therapy," as part of an invited seminar on Family Therapy, World Psychiatric Association, Honolulu, August Advisory Editorial Board Member, International Journal of Family Therapy, as of September Psychiatric Quarterly, Discussant, "The Premenstrum: A Psychological Investigation," Grand Rounds, Dept. of Psychiatry, University of California, San Francisco, November 22, Presentation of paper, "Development of a Curriculum and of a Faculty for Medical Student Education in Psychiatry," The Annual Meeting of the Association of Academic Psychiatry, New Orleans, January Presentation of paper, "A New Drug Treatment for Premenstrual Psychosis," Poster Session, The Annual Meeting of the American Psychiatric Association, Atlanta, Georgia, May Organizer, Special Session, "Treating the Impaired Physician: Confidentiality and Responsibility," The Annual Meeting of the American Psychiatric Association, Atlanta, Georgia, May /31/

64 Presentation of paper, "Hospitals in the 1980s: Service, Training and Research," Presented as part of the Special Session, "Hospital Treatment of Emotional Disorders: Circa, 1978, at the Annual Meeting of the American Psychiatric Association, Atlanta, Georgia, May Lecture and Discussion, "Indications and Contraindications for Family Therapy: Circa, 1978," at Grand Rounds, Dept. of Psychiatry, The New York Hospital-Cornell University Medical College, May 17, Presentation of paper, "Research in Occupational Therapy," at a Conference entitled, "A Revitalization Movement within Occupational Therapy" sponsored by Metropolitan New York District, New York State Occupational Therapy Association. May Presentation and Discussion, "Family Therapy & Crisis/Loss,"Memorial Hospital, New York, November 2, l978. Presentation and Discussion, "The Hospital Management of the Suicidal Patient," at a Symposium: "The Suicidal Patient: Identification and Treatment," sponsored by Dept. of Psychiatry, Albany Medical College, March 28, 1979, Albany, New York. Presentation and Discussion, "Psychiatric Problems in General Practice," as part of a Symposium: "Common Medical Problems in Office Practice," sponsored by the Continuing Education Committee of St. Vincent's Hospital, Santa Fe, N.M., March 30, Presentation and Discussion, "Effects of Divorce on the Family," as part of a Symposium, "Divorce and the Patient," Sponsored by Continuing Education Committee of St. Vincent's Hospital, Santa Fe, N.M., 3/79. Presentation of paper, "Short Versus Long Psychiatric Hospitalization: A Controlled Study -- Final Results," Grand Rounds, McLean Hospital, Boston, Massachusetts, April Presentation of paper, "A New Drug Treatment for Premenstrual Exacerbation of Schizophrenia" at Harvard Medical School, Dept. of Psychiatry, Boston, Massachusetts, April Presentation of paper, "The Physician's Family: Approach to Impairment," as part of a Symposium, "The Impaired Physician: Prevention and Treatment," at the Annual Meeting, American Psychiatric Association, Chicago, May Discussant, "Psychotherapy Supervision," at the American Psychiatric Association's Annual Meeting, Chicago, May Presentation, "Short Hospital Stay is Better than Long Hospital Stay?" "Pro Position" at the 31st Institute on Hospital and Community Psychiatry, September 3-6, 1979, New Orleans. Presentation, "Future Directions in Hospital Psychiatry," keynote speech, Dept. of Psychiatry, at Alumni Teaching Day, Long Island Jewish-Hillside Medical Center, Glen Oaks, New York, September /31/

65 Grand Rounds, "The Family Model in an Inpatient Setting," Dept. of Psychiatry, North Shore Hospital, Manhasset, New York, October Grand Rounds, "The Family Model in an Inpatient Setting," Dept. of Psychiatry, Albert Einstein College of Medicine, New York, NY, October Grand Rounds, "Family Therapy -- Indications and Contraindications," Dept. of Psychiatry, City Hospital Center at Elmhurst, October Grand Rounds, "Psychiatric Hospitalization for the 1980s: A Controlled Study of Short Versus Long Hospitalization, Final Results," Dept. of Psychiatry, Cornell University Medical College, April Invited Paper, "Psychiatric Aspects of Basketball," Psychiatric Annals Volume 10, Number 3: , Organizer of Continuing Medical Education Seminar, titled, "Hospital Treatment: Which Treatment and How Long for Which Patients?" Cornell University Medical College, Dept. of Psychiatry, April Presentation on "The Role of Psychoanalysis in Family Therapy," as part of a Continuing Medical Education Course entitled, "The Role of Psychoanalysis in Contemporary Psychiatry," at Cornell University Medical College, Spring, Discussant for Symposium, "Enhancing Treatment Compliance," at the Annual Meeting of the American Psychiatric Association, San Francisco, Presentation on "Leadership in the Hospital," as part of a Course on "Leadership," at the Annual Meeting of the American Psychiatric Association, San Francisco, Presentation on "Family Therapy and the Treatment of the Child" at the weekly Child- Adolescence Staff Meeting, Dept. of Child Psychiatry, Mt. Sinai Hospital, November Participant, on Radio Program, "Conference Call: Parents & Children, WABC, November 30, 1980, New York. Grand Rounds, "Psychiatric Hospitalization for the 80s," St. Joseph's Hospital and Medical Center, Paterson, New Jersey, February Keynote Speaker, "Illness and the Impact on Family Systems," at a Symposium entitled "Illness and the Family," sponsored by La Tortuga & Sherman Clinic, Santa Fe, March 198l. Presentation of paper, "Thinking Disorder in Depression: Longitudinal Results" (with Braff D, Griffin P), and "Outcome of Irregularly Discharged Mental Patients" (with Braff D, Johnson G), for the American Psychiatric Association Annual Meeting, New Orleans, May /31/

66 Consultant for Departmental Planning, Dept. of Psychiatry, Mt. Zion Hospital, San Francisco, CA, June Chapter Consultant, Family Therapy, American Psychiatric Assn. Commission on Psychiatric Therapies, Grand Rounds, "Short Vs Long Hospitalization: Final Results," State University of New York, Syracuse, NY, 9 /81. Grand Rounds, "Treating the Hospitalized Schizophrenic Patient and Family," Rockland Psychiatric Center, Orangeberg, New York, October Presentation, "Short Versus Long Hospitalization for Schizophrenia," World Psychiatric Association/APA Regional Meeting, New York City, November Chairman, Education Committee and session on the "Teaching of Psychopharmacology," Annual Meeting, American College of Neuropsychopharmacology, San Diego, December Presentation, "The Family Model in an Inpatient Setting," Family Study Group, SUNY, Downstate Medical Center, January Presentation of paper, "Duration of Hospitalization as a Variable in Outcome," (John F. Clarkin, PhD and Ira D. Glick, MD), The National Association of Private Psychiatric Hospitals, Scottsdale, Arizona, January Panelist, "Family Therapy of Suicidal Behavior," Annual Meeting of Assn. of Suicidology, New York City, 4/82. Presentation of paper, "Thought Disorder and Depression in Psychiatric Patients," (David L. Braff, MD and Ira D. Glick, MD) for the Western Psychological Association Annual Meeting, Sacramento, CA, April Panelist, "The Widening Scope of Family Therapy," Annual Meeting of the American Psychiatric Association, Toronto, Canada, May Presentation of paper, "Which Chronic Patients Mostly Need Readmission," (with Braff D, MD, Klar H, MD), for the Annual Meeting of the American Psychiatric Association, Toronto, Canada, May Discussant, Conference on "The Changing American Family," The 67th Annual Seymour Silverberg Lecture, Long Island Jewish-Hillside Medical Center, June Keynote Address, "Couples in the 1980s: Emerging Trends," Workshop on "Step-Parenting," and Panel Discussion - all at the Symposium, "Marital and Sexual Therapy," The Family and 12/31/

67 Couples Institute, The Dept. of Psychiatry, Tufts University School of Medicine, Boston, June Presentation of Research Project, "Inpatient Family Intervention: A Controlled Study" and Presentation of "The Family Therapy Training Program at PWC" at the 1982 Annual Meeting, American Family Therapy Association, Boston, June Invited Guest, Interviewed on topic of "Vacations & Couples," on Travel Talk, Dena Kaye, WMCA, NYC, 10/82. Invited Lecturer, "The Changing American Family: Emerging Trends and Comparison with the Japanese Family," Dept. of Psychiatry, Juntendo University, Tokyo, October Grand Rounds, "Toward the Definition and Delivery of Mental Health Care," Massachusetts Mental Health Center, Boston, October Grand Rounds, "Guidelines for Family Therapy," Dept. of Psychiatry, Medical College of Georgia, 1/83. Grand Rounds, "Guidelines for Family Therapy," Dept. of Psychiatry, Tulane University and Louisiana State University, February Presentation of paper, "Teaching Investigative Psychiatry to Psychiatric Residents, a Sequential Curriculum: Everything You Wanted to Know About Research, But Were Afraid To Ask." Free University Presentation, at the Annual Meeting of the Association for Academic Psychiatry, Tampa, March Presentation of paper, "A New Drug Treatment for Premenstrual Schizophrenia," at the Eleventh Annual Conference on Psychosomatic Obstetrics and Gynecology, Sugar Loaf, Temple University Conference Center, Philadelphia, March Visiting Scholar, Dept. of Psychiatry, School of Medicine, University of Vermont, Burlington, March Grand Rounds, "Psychiatric Hospitalization for the 1980s," Dept. of Psychiatry, School of Medicine, UCLA and Harbor Hospital, Los Angeles, April Grand Rounds, "Toward the Definition and Delivery of Mental Health Services: Who Should Pay and for What?" Dept. of Psychiatry, UCSF, San Francisco, April Invited Paper, "Treatment of Severe Premenstrual Syndrome (PMS) and Premenstrual Exacerbation of Psychiatric Disorder," Premenstrual Syndrome Workshop, co-sponsored by Center for Studies of Affective Disorder, Psychobiological Processes & Behavioral Medicine Section, Clinical Research Branch, and the Intramural Research Program, NIMH, April /31/

68 Presentation, "Treatment of Dual Doctor Couples," as part of an APA Issue Workshop, "Dual Doctor Couples" at the Annual Meeting of the American Psychiatric Association, New York, May Co-Chair and Presentation, "Overview" for Component Presentation, "Obstacles to Quality Clinical Systems," presented by APA Committee on Administrative Psychiatry, at the Annual Meeting of the American Psychiatric Association, New York, May Presentation and Co-Moderator, APA Issue Workshop, "Family Therapy Training in Residency Programs," at the Annual Meeting of the American Psychiatric Association, New York, May Presentation, "The Basics of Family Treatment" (with Henry Grunebaum, MD), as part of "Psychiatry Update," at the Annual Meeting of the American Psychiatric Association, New York, May Presentation, "Review of Length of Stay Research," as part of a course, "Inpatient Treatment Programs: Programs: Acute and Long-Term," at the Annual Meeting of the American Psychiatric Association, NY, 5/83. Presentation of paper, "The Importance of Thought Disorder in Depressives" (with David Braff, MD), at the Annual Meeting of the American Psychiatric Association, New York, May Presentation of paper, "Inpatient Family Intervention: A Controlled Study," at the Annual Meeting of the American Psychiatric Association, New York, May Presentation of Research Project, "Inpatient Family Interventions: A Controlled Study" and Presentation of "The Family Therapy Training Program at PWC" at the 1983 Annual Meeting, American Family Therapy Association, San Francisco, California, June Grand Rounds, "Psychiatric Hospitalization for the 1980s," Bergen Pines County Hospital, Paramus, NJ. 6/83. Presentation, "Inpatient Family Intervention: A Controlled Study," at the Annual Meeting of the American Psychological Association, Anaheim, California, August Grand Rounds, "When Should the Chronic Patient be Hospitalized," Dept. of Psychiatry, St. Luke's/Roosevelt Hospital Center, New York, September Distinguished Lecturer, "Doing Research Without Pain," University of Medicine and Dentistry of NJ, 101/83. Lecture, "Diagnosis and Treatment of Depression," as part of a course, "Recent Advances in Medicine," Temple University School of Medicine, Philadelphia, November /31/

69 Co-Chairman, ACNP Training Session, "Issues in Clinical Psychobiologic-Psychopharmacologic Research Training," Annual Meeting of the American College of Neuropsychopharmacology, San Juan, Grand Rounds, "Toward the Definition of and Delivery of Mental Health Services - Who Should Pay and for What?" The New York Hospital-Cornell University Medical College, January Grand Rounds, "The Changing Role of the Hospital in Treatment of the Chronic Patient," Roosevelt Hospital, New York, February Invited Lecturer, "Focus on Family Psychotherapy Advances" and "Practical Office Psychotherapy," Winter Update, Dept. of Psychiatry, University of South Dakota, February Free University Presentation, "Teaching Integration of Psychiatric Models to Residents," at the Annual Meeting of the Association of Academic Psychiatrists, Tampa, March Grand Rounds, "Diagnosis and Treatment of Depression" at Grand Rounds, in Dept. of Psychiatry in 5 settings, Grand Rounds, "Toward the Definition of and Delivery of Mental Health Services: Why Don't Patients Receive Appropriate Care?" Dept. of Psychiatry, Mt. Sinai, April Invited Lecture, "Towards the Definition of and Delivery of Mental Health Services: Why Don't Patients Receive Appropriate Care?" Dept. of Psychiatry," The University of New Mexico, April Grand Rounds, "Toward the Definition of and Delivery of Mental Health Services," Dept. of Psychiatry, College of Physicians and Surgeons of Columbia University, April Grand Rounds, "Psychiatric Hospitalization for the 1980s," Dept. of Psychiatry, New York Medical College, Valhalla, New York and Metropolitan Hospital, New York City, May At the Annual Meeting of the American Psychiatric Association, Los Angeles, May 1984: Presentation, "Treatment of the Premenstrual Syndromes," as part of a Symposium, "Premenstrual Syndrome: Current Findings and Future Directions." Faculty, "Short-Term Psychosocial Inpatient Treatment," as part of a Course, "Short- Term Psychiatric Treatment." Leader of Discussion Group, "Delivering State-of-the-Art Multimodality Treatment." Co-Chair and Presentation, "New Demographic Trends in American Marriage," (with Oliver Bjorksten, MD and Thomas Stewart, PhD), as part of a Symposium, "New Clinical Concepts in Marital Therapy." 12/31/

70 Chairman and Presentation, "Inpatient Family Intervention: A Controlled Study, Preliminary Results," (with J. Clarkin, PhD, G. Haas, PhD, J. Spencer, MD, et al), as part of a Symposium, "Results of Family Treatment: Second Generation Studies." Grand Rounds, "Is There Any Future for Long-Term Hospitalization?" Silver Hill Foundation, New Canaan, CT, June Grand Rounds, "Which Chronic Patients Most Need Readmission?" Norristown State Hospital, 9/94. Visiting Lecturer, "Why Don't Patients Receive Appropriate Psychiatric Treatment?" Dept. of Psychiatry, University of Chicago School of Medicine, September Invited Lecturer, "Creativity and Madness," Annual Meeting, Louisiana Psychiatric Society, New Orleans, 9/84. Invited Lecturer, "Guidelines for Family Therapy," Departments of Psychiatry, Tulane University and Louisiana State University, October Presentation, "The Family Model and the Treatment of Affective Disorders," at Albert Einstein Medical Center, Northern Division, Philadelphia, October 24, Grand Rounds, "Indications and Contraindications," Dept. of Psychiatry, Bronx Lebanon Hospital Center, 11/94. Departmental Colloquia, "Why Don't Patients Receive Appropriate Psychiatric Treatment?" Dept. of Psychiatry, University of Pennsylvania, December Guest Speaker, "Trends in Marriage & Marital Therapy," South Jersey Psychiatric Society, Cherry Hill, N J, 12/84. Co-Chair, ACNP Study Group, "Psychotropic Drug and Psychotherapy Interaction Research," Annual Meeting of the American College of Neuropsychopharmacology, San Juan, Co-Chairman, ACNP Training Session, "Proposed Curriculum for Teaching Psychopharmacology," Annual Meeting of the American College of Neuropsychopharmacology, San Juan Grand Rounds, "Guidelines for Marital and Family Therapy," Detroit Psychiatric Institute and Lafayette Clinic, Detroit, January Continuing Education Workshop, "Family Therapy - Working with Couples," Dept. of Continuing Education, Harvard Medical School at New York City, January /31/

71 Grand Rounds, "Why Don't Patient Receive Appropriate Psychiatric Treatment?" Dept. of Psychiatry, University of Utah, Salt Lake City, February Grand Rounds, "Diagnosis and Treatment of Depression," Coney Island Hospital, New York, February Grand Rounds, "Inpatient Family Intervention: A Controlled Study - Preliminary Results," University of California, San Francisco, February Grand Rounds, "New Concepts About Inpatient Family Intervention for Psychiatric Disorders," Peninsula Hospital, Hillsdale, California and San Mateo Hospital, San Mateo, California, March Grand Rounds, "New Concepts in Family Intervention in Chronic Mental Illness," Harlem Valley Psychiatric Center, Wingdale, New York, March Grand Rounds, "Psychiatric Hospitalization for the 1980s: A Controlled Study of Short-Term Versus Long-Term Hospitalization," Duke University Medical Center, Durham, North Carolina, March Invited Faculty, "The `Shrinking' of Inpatient Psychiatry: What To Do About Limited Hospital Stays" and Workshop, "Family Work on an Inpatient Unit," both as part of course at Harvard Medical School, Dept. of Continuing Education, Boston, March Grand Rounds, "Recent Trends in Marriage and the Family: Effects on Therapy," Tufts-New England Medical Center, Boston, April Grand Rounds, "The `Shrinking' of Hospital Psychiatry," Dept. of Psychiatry and the Behavioral Sciences, USC School of Medicine, Los Angeles, April Grand Rounds, "Inpatient Family Intervention: A Controlled Study," The Medical College of Pennsylvania, Philadelphia, April Grand Rounds, "The Family and Its Role in Diagnosis and Treatment of Depressive Disorder," Georgetown University School of Medicine, Washington, D.C., April Grand Rounds, "Psychoeducation in a Hospital Setting," Silver Hill Hospital, Silver Hill, Connecticut, 5/85. Grand Rounds, "Guidelines for Marital and Family Therapy: Circa 1985," Dept. of Psychiatry, Stanford Medical School, Palo Alto, California, May At the Annual Meeting of the American Psychiatric Association, Dallas, May 1985: Workshop, Presentation of "A Model Psychoharmacology Curriculum," (with David S. Janowsky, MD, Richard I. Shader, MD and Carl Salzman, MD) 12/31/

72 Presentation, "The Family and Antidepressant Noncompliance" (with John Clarkin, PhD and Gretchen Haas, PhD) as part of a Symposium, "Resistance to Antidepressants: Psychosocial Factors" Presentation, "Quality Treatment and Practitioner Competence" as part of a Symposium, " Evaluation of Knowledge and Practice in Psychiatry - Joint Session with the Association for Academic Psychiatry" Study Group, "Residents with Marital Distress: The New Epidemic?" Chairman and Presentation, "Inpatient Family Intervention: A Controlled Study," (with John Clarkin, PhD, Gretchen Haas, PhD, James H. Spencer, MD, Alfred Lewis, MD and Joanne Newman, M.S.W.) as part of a symposium "Results of Family Therapy Outcome Studies" Faculty, "Short Term Psychosocial Inpatient Treatment," as part of a Course, "Short- Term Psychiatric Treatment" Workshop, "Family Therapy, Severe Psychiatric Problems and the Psychiatric Hospital: Critical Issues at the Interface," as part of a series of workshops, "Family Therapy: The Master Therapists," sponsored by Dept. of Psychiatry, University of Connecticut School of Medicine, 6/85. Grand Rounds, "Diagnosis and Treatment of Depression," Dept. of Psychiatry, Bowman Gray School of Medicine, Winston-Salem, North Carolina, August Invited Address, "Survival for the Physician and the Family in the 1980s," Capital Medical Society, Tallahassee, Florida, August Grand Rounds, "Indications and Contraindications for Family Therapy," Dept. of Psychiatry, Emory University, Atlanta, September, Invited Presentation, "The Shrinking Of Hospital Psychiatry And What To Do About It," Annual Meeting, Hospital Corporation of America, Orlando, December ACNP Poster Presentation, "Inpatient Family Intervention: The Patient, the Family and Compliance with Drug Treatment for Affective Disorders," December Presentation of paper, "Inpatient Family Intervention: A Controlled Study" at the Annual Meeting of the American Psychiatric Association, Washington, D.C., May, Invited Lecture, "The Family and Recent Developments in Psychiatry," Family Institute of Milan, Italy, 3/86. 12/31/

73 Visiting Professor, "`Family Therapy: Indications and Contraindications," Dept. of Psychiatry, School of Medicine and Surgery, University of Naples, Italy, May, Grand Rounds, "The Patient, the Family and Psychiatric Hospitalization," Dept. of Psychiatry, Jefferson Medical College, Philadelphia, October, Grand Rounds, "Psychiatric Hospitalization for the 1980's," Dept. of Psychiatry, Hahnemann University, Philadelphia, October, Grand Rounds, "Treating the Family of the Hospitalized Patient, Is it Worth It?" North Shore University Hospital, New York, October, Grand Rounds, "Combination Therapy: A Study of Inpatient Family Intervention," Westwood Lodge Hospital and Pembroke Hospital, Boston, October, Grand Rounds, "Receiving Effective Psychiatric Treatment," Albert Einstein Medical Center, PA, 11/86. Grand Rounds, "Working With The Family - Is It Worth It? A Controlled Clinical Trial of Inpatient Family Intervention", Dept. of Psychiatry, Cornell University Medical College and Payne Whitney Clinic, The New York Hospital, November, Grand Rounds, "New Developments in the Treatment of Schizophrenia: Combining Drug and Family Therapy," Dept. of Psychiatry, Lincoln Hospital, New York, November, Grand Rounds, "Psychosocial Interaction in the Treatment of Schizophrenia," Dept. of Psychiatry, Coney Island Hospital, Brooklyn, November, At the Annual Meeting of the American College of Neuropsychopharmacology, Washington, D.C., 1986: Co-Chair, ACNP Training Session, "Teaching Psychopharmacology in the 1990's" Chair, Presentation of Paper, "The Teaching of Psychopharmacology in the United States" ACNP Poster Presentation, "The Patient, the Family, and Compliance with Drug Treatment for Affective Disorders" At the Annual Meeting of the American Psychiatric Association, Chicago, Illinois, May, 1987: Presentation, "Inpatient Family Intervention for Affective Disorders" as part of a Symposium, "Depression and Families: Recent Advances" Presentation, "Inpatient Family Intervention for Psychotic Disorders" as part of a Symposium, "Advances in Family Psychiatry" 12/31/

74 Presentation, "Study Design Influences Generalizability of Result" as part of a Symposium, "Long- Term Treatment Strategies in Schizophrenia" In Japan, lectures and other activities during sabbatical year, 1987: 1) New Directions in Family Therapy, School of Medicine, Kanazawa University, January. 2) Indications and Contraindications for Family Therapy, Kochi Medical School, Kochi City,Shikoko 3) The Psychoeducational Approach, Psychoanalytic Seminar, Keio University & Hospital 4) Indications and Contraindications for Family Therapy, Tokyo Community Counseling Service 5) The Family on the Move: Family Function and Problems, International School of the Sacred Heart, Tokyo, April. 6) Diagnosis and Therapy of Depression, Dept. of Psychiatry, Tokai University, April. 7) Psychoeducational Treatment in Psychiatry, Okayama Prefectorial Mental Hospital, April. 8) Indications and Contraindications for Family Therapy, Psychiatric Research Institute of Tokyo 9) Hasagawa Hospital - April-June a. New Concepts in Treatment of Schizophrenia b. Psychoeducational Treatment in a Hospital Setting c. Diagnosis and Therapy of Depression 10) The Changing American Family, Continuing Education Course, Japan NIMH 11) Indications and Contraindications for Family Therapy, Dept. of Psychiatry, School of Medicine, Fukuoka University 12) Recent Trends in Treatment of Mental Patients, Dept. of Social Administration, Tokyo Metropolitan Hospital 13) Indications and Contraindications for Family Therapy, Tokyo Family Therapy Association 14) The Changing American Family, Emerging Trends and Comparisons with the Japanese Family, U.S. Information Service Seminar, Sapporo, Hokkaido 15) Combination Therapy in Modern Psychiatry, Keio Medical School 16) A Model Psychopharmacology Curriculum, Nihon University, Tokyo 17) The Changing American Family, Emerging Trends and Comparisons with the Japanese Family, U.S. Information Service Seminar, Tokyo 18) Featured Guest, The Changing American Family, Japanese-American Cultural Program, NHK - Educational TV 19) The Changing American Family, Emerging Trends and Comparisons with the Japanese Family, U.S. Information Service Seminar, Nagoya 20) A Study of the Quality of Psychiatric Care - Preliminary Results, Staff Conference, Japan NIMH 12/31/

75 Research Conference, "A Controlled Study of Transitional Day Care for Non-Chronically Ill Patients," Dept. of Psychiatry, Cornell University Medical College and Payne Whitney Clinic, The New York Hospital, 9/87. Grand Rounds, "Working with the Family of a Hospitalized Patient - Is It Worth It?" Dept. of Psychiatry, Brookdale Hospital, Brooklyn, New York, September, Clinical Conference, Grady Memorial Hospital and Emory Medical School, Atlanta, Georgia, October, Invited Lecture, "Recent Advances in Psychiatry: The Family and Family Therapy," Prasat Neurological Hospital, Bangkok, November, Invited Lecture, "Recent Advances in the Treatment of the Psychoses," Dept. of Neurology & Psychiatry, Pra Mongkutklao Army Hospital, Bangkok, November, The Annual Meeting of the American College of Neuropsychopharmacology, San Juan, Puerto Rico, 12/87: Study Group - Drug & Psychosocial Therapy in Schizophrenia and Affective Disorders, Co- Chair with Nina Schooler, PhD Presentation of Paper - Inpatient Family Intervention: Final Results for Schizophrenia and Affective Disorder Grand Rounds, "New Therapies in Depression: Combining Drugs & Psychotherapy," Pacific Presbyterian Medical Center, San Francisco, January, Guest Consultant, Biological Psychiatry Colloquium, "Clinical Management of a Treatment Resistant Patient with a Bipolar Compulsive Disorder," Pacific Presbyterian Medical Center, San Francisco, January, Grand Rounds, "Inpatient Family Interventions for Psychotic Disorders," South Beach Psychiatric Center, Staten Island, New York, February, Grand Rounds, "Inpatient Family Intervention: A Randomized Clinical Trial," Dept. of Psychiatry, Emory University School of Medicine, Atlanta, Georgia, February, Presentation, "How to Teach Family Therapy and (Even, Sometimes) Succeed," (with Alan Manevitz, MD), Annual Meeting of the Association for Academic Psychiatry, Free University Section, Tampa, Florida,3/88. 12/31/

76 Presentation & Workshop, "The Interface of Psychodynamic Psychotherapy and Psychopharmacology" 10th Annual Menninger Foundation Winter Conference, Park City, Utah, March, 1988: The Annual Meeting of the American Psychiatric Association, Montreal, Canada, May, 1988: Presentation, "The Family and Schizophrenia" as part of a Symposium, "Psychosocial Treatment of Schizophrenia" with James Spencer, MD, Gretchen Haas, PhD, John Clarkin, PhD, et al Presentation, "Inpatient Family Intervention: Follow-up Results" as part of a Symposium, "Psychotherapy: Process and Outcome" with James Spencer, MD, Gretchen Haas, PhD, John Clarkin, PhD, Alfred Lewis, MD Presentation, "Predictors of Early Stabilization in Schizophrenia" as part of a Symposium, "Long-term Treatment Issues in Schizophrenia" with Nina Schooler, PhD, Sam Keith, MD, Alan Balleck, MD, et al The Annual Meeting of the Association for Clinical Psychosocial Research, Montreal, Canada, May, 1988: Presentation, "Family Therapy Manuals: Treatment in Search of a Manual or Manuals in Search of a Treatment" as part of a Symposium on Psychotherapy Manuals, with John Clarkin, PhD and Gretchen Haas, PhD. The Annual Meeting of the American Family Therapy Association, Montreal, Canada, June, 1988: Presentation, "Inpatient Family Intervention: Final Results for Schizophrenia and Affective Disorder" Plenary Session, "NIMH Update" The Regional Symposium of the World Psychiatric Association, Washington, D.C., October 1988: Presentation: "Developing an Effective Treatment Equation" Presentation: "The Family Model and Schizophrenia" Participant on Panel: "Mental Health and the News Media," The Fourth Annual Rosalynn Carter Symposium on Mental health Policy, Atlanta, October Keynote Speaker, "National Priorities in Mental Health Research," First Annual Kansas Scientific Symposium, Kansas City, October /31/

77 Grand Rounds, "Family Therapy: Indications and Contraindications," Carrier Clinic, Princeton, NJ, 11/88. Presentation: "The National Institute of Mental Health Public Academic Liaison Initiative," National Association of Social Workers 1988 Annual Conference, Philadelphia, Pennsylvania, November Presentation: "Fostering Collaborative Research that Impacts the Adminstration of Public Mental Health Programs: The Federal Perspective." American Public Health Association, Boston, MA, November The American College of Neuropharmacology (ACNP) 27th Annual Meeting, San Juan, Puerto Rico, 12/88: Presentation of paper for the TSS Collaborative Study Group, "Depressive Symptomatology, Negative Symptoms and Extrapyramidal Symptoms (EPS) in Acute Treatment Response and Short Term Outcome," as part of a symposium, Acute Treatment Response and Short Term Outcome in Schizophrenia" Poster with the IFI Research Group, "Working with the Family to Improve Medication Compliance" Keynote Remarks, "The NIMH Program for 1989 and its Implications for Training." Annual Meeting of AADRPT, San Diego, California, January Keynote Address, "NIMH Prospects and Promises," California Coalition for Mental Health, Los Angeles, California, January Presentation of paper, "The Programs of the NIMH and Their Implications for Training," 1989 Annual Meeting of the Association for Academic Psychiatry, Atlanta, Georgia, March Ground Rounds, "Among Doctors, Patients, and Family: Achieving Effective Treatment for Serious Mental Illness," Chope Hospital, San Mateo, California, April Poster Presentation, "Depressive Symptomatology, Negative Symptoms and Extrapyramidal Symptoms (EMPS) in Acute Treatment Response and Short Term Outcome," International Congress on Schizophrenia Research, San Diego, California, April At the Annual Meeting of the American Psychiatric Association, San Francisco, California, May 1989: Workshop, Presentation of "The Family and DSM-IV: A Progress Report from the Group for the Advancement of Psychiatry" (with LC Wynne MD, L Combrinck-Graham MD, and AL Price MD) 12/31/

78 Workshop Chairperson, Presentation of "Public/Academic Liaison: Can It Work?" (with SC Shulz MD. JD Burke MD, D Jones MSW, and GM Simpson MD) Presentation, "Inpatient Family Intervention: Process Results" (with JF Clarkin PhD, JH Spencer MD, GL Haas PhD, and AB Lewis MD) as part of a Paper Session, "Family Therapy Strategies" Co-author, "Sex Differences in Schizophrenia Outcome," (with GL Haas PhD, JF Clarkin PhD, and JH Spencer MD) as part of a Paper Session, "Schizophrenia Treatment Outcomes: New Consideration" Co-author, "Social and Family Factors Predict Early Stabilization," (with NR Schooler PhD, JB Severe MS, SJ Keith MD. AS Bellack MD, WA Hargreaves PhD, JM Kane MD, and PT Ninan MD) as part of a Symposium, "Long-term Treatment Issues in Schizophrenia" Presentation, "State/University Collaboration: The Public-Academic Liaison," National Conference on Mental Health Statistics, San Diego, California, June 1989 At the Eleventh Annual Meeting of the American Family Therapy Association, Colorado Springs, CO, 6/89 Chair, Interest Group, "Medications, Hospitalization and Family Systems" Presentation, "The Family and Treatment of Depression" Presentation, "NIMH Update" Grand Rounds, "Family Intervention for Affective Disorders," Dept. of Psychiatry, Louisiana State University Medical Center, New Orleans, October Invited Speaker, "The National Plan for Research to Improve Care of the Severely Mentally Ill," at a conference, "Privatization of Mental Health Care: A National Perspective," Center for Health and Human Resources Policy, JFK School of Government, Harvard University, Boston, Massachusetts, October At the 1989 Institute on Hospital and Community Psychiatry of the American Psychiatric Association, Philadelphia, October 1989: Lecture, "Update from the NIMH" Workshop, "Follow-up Studies of Hospitalized Psychiatric Patients: Triumphs, Tragedies, and Surprises" (with Harding, CM) Symposia, "Family Intervention and Psychiatric Hospitalization" (with Sholevar, GP) 12/31/

79 Poster, "Improving Treatments for the Severely Mentally Ill - Implications of the Italian Psychiatric Reform" Grand Rounds, "The Effectiveness of Treatment for Major Depressive Disorder One year Later," Jefferson Medical College, Philadelphia, November Workshop, "Fundamentals of Mental Illness Research," National Mental Health Association Scientific Symposium, Washington, November At the 1990 Annual Meeting of the ACNP, Maui, December Study Group, "Public/Academic Liaison to Generate Psychpharmacology Research: Can it Work?" (Co-chair with Schulz S) Open Session, "New Initiatives of the NIMH - the PAL Initiative" Grand Rounds, "Working with the Family of the Hospitalized Patient: Is It Worth It Over the Long Run?" Holliswood Hospital, Queens NY, December Presentation of Paper, "A Cross National Followup Study of the Treatment of Major Depressive Disorder," Annual Meeting Psychiatric Research Society, Park City, Utah, March Grand Rounds, "Increasing the Effectiveness of Psychiatric Care: What Happens to Patients and Their Families After Hospitalization", Dept. of Psychiatry, University of North Carolina, Chapel Hill, April At the 1990 Annual Meeting of the American Psychiatric Association, New York, May 1990: Vestermark Award Session, "Overview of the Model Curriculum and a Follow Up Evaluation of its Usefulness," as part of the session, "The Teaching and Learning of Psychopharmacology in the 1990's: How to Jump in a Rapidly Moving Train" A Workshop, "National Plan Research on Severely Mentally Ill" (with Burke, J) Presentation, "Cross-National Study of Major Depressive Disorders." as part of Symposium, "Cultural Aspects of Depression in Asia and America" Research Colloquia, "Drug and Family Treatment for Major Affective Disorder," Dept. of Psychiatry, University of Pennsylvania School of Medicine, May Brief Presentation, "Making Inpatient Family Intervention Work," American Family Therapy Association, Philadelphia, June Invited Presentation, "Implications of the Italian Reform for the Delivery of Mental Health Services in the U.S. and Canada," sponsored by British Columbia Mental Health Society, Vancouver, July, /31/

80 At the 7th Annual Scientific Symposium, National Mental Health Association, "New Findings & Practical Applications Of Mental Health Research" Houston, Texas, 1990: Workshop, "Fundamentals of Mental Illness Research" Workshop, "Increasing the Effectiveness of Psychiatric Treatment." Professional Symposium Series, "Psychoeducation for Patients and Families: What and How," Portsmouth Pavilion, Portsmouth, New Hampshire, September, Grand Rounds, "Effectiveness for the Patient and Their Families of Psychiatric Care: A Cross- National Study of the Process of Treatment and Outcome of Major Depressive Disorder," Brookside Hospital, Nashua, New Hampshire, September, Grand Rounds: "The Family and Affective Disorder: A Followup Study." Butler Hospital, Brown University School of Medicine, Providence, November Grand Rounds: "Effectiveness of Inpatient Psychiatric Care: A Two Year Followup Study of Major Affective Disorder." Manhattan Psychiatric Center, New York, December Grand Rounds, "Does Treatment Help? The Process of Hospital Treatment and Outcomes for Major Depressive Disorder." Dept. of Psychiatry, The New York Hospital-Cornell University Medical College, NY, 1/91. Presentation, "A Model Curriculum in Psychopharmacology." Annual Meeting of the Association for Academic Psychiatry, Free University Section, Tampa, Florida, March, Grand Rounds, "Increasing Effectiveness of Psychiatric Care: What Happens to Patients and Their Families After They Leave the Hospital." Dept. of Psychiatry, The New York Hospital- Cornell Medical College-Westchester Division, NY, March Grand Rounds, "The Changing American Couple and Indications for Marital Therapy." State University of New York Health Science Center at Brooklyn, New York, April, At the Annual Meeting of the American Psychiatric Association, New Orleans May 1991: Presentation: "Family Outcome of Hospitalization for Mood Disorders" with Lorenzo Burti, MD, Kuninao Minakawa, MD, Michael Sacks, MD, Katsua Maehara, MD Invited Lecture: "The Integration of Psychopharmacology with Psychosocial Therapies for Treatment of Psychoses" sponsored by The Bipolar Foundation, Buenos Aires, Argentina, July /31/

81 Invited Lecture: "Psychoeducation as the Tool to Integrate Psychopharmacology with Psychosocial Therapies for Schizophrenia and Bipolar Disorder." sponsored by The Uruguayian Psychiatric Society, Montevideo, Uruguay, July Invited Lecture: "Effectiveness in Psychiatric Care: A Followup Study of Major Affective Disorder." Dept. of Psychiatry, LSU, New Orleans, October Clinical Research Award Address: "Effectiveness in Psychiatric Care: II. Outcome for the Family After Hospital Treatment for Major Affective Disorder." Annual Meeting of the American Academy of Clinical Psychiatrists, New Orleans, October At the Annual Meeting of the American College of Neuropsychopharmacology, Puerto Rico, December 1991: Study Group, "Maximizing the Effectiveness of Medication for Schizophrenia and Affective Disorder," Study Group organizer and Co-chair as well as Presenter (with four others) Presentation, "Effectiveness of Psychiatric Care, A Followup Study of Psychopharmacologic Practices in Treatment of Major Affective Disorder." As part of a Symposium on Transcultural Psychopharmacology organized by T. Ital and N. Sartorius Poster, "Increasing the Effectiveness of Psychiatric Care: Achieving Effective Medication Management" (with three others) Grand Rounds, "The Changing American Couple and Indications for Marital Therapy." Coney Island Hospital, Brooklyn, New York, January, 1992 At the Annual Meeting of the American Psychiatric Association, Washington, D.C., May 1992: Debate: Resolved: For Most Psychiatric Inpatients, a Ten Day Hospitalization is as Effective as a Longer Stay (with M. Herz, MD) Paper: Increasing the Effectiveness of Treatment for Mood Disorder, as part of a symposium, The Family and Mood Disorder. New Research Poster: "Psychoeducation For Mood Disorder" with Lorenzo Burti, MD, Keigo Okonogi, MD and Michael Sacks, MD. Poster: "Achieving Effective Medication Management" with Lorenzo Burti, MD, Koji Suzuki, MD and Michael Sacks, MD, NCDEU Annual Meeting, Boca Raton, Florida, June International Seminar: "Revamping of the Uruguayan Mental Health System: New Patterns of Care, Methods of Diagnosis and Treatment for Severe Mental Disorders" sponsored by the Uruguayan Psychiatric Association, World Association for Psychosocial Rehabilitation and the 12/31/

82 Republican National Bank, Director and Lecturer, Uruguay, June 1992 with John P. Docherty, MD. Grand Rounds: "Alternative Treatments of Bipolar Disorder." Bronx State Psychiatric Center. NY9/92. Grand Rounds: "Effectiveness in Psychiatric Care: A Follow-up Study of Hospitalized Patients with Major Affective Disorder." St. Vincent's Hospital and Medical Center. New York. September, Grand Rounds, "Alternative Treatments of Bipolar Disorder." Bronx State Psychiatric Center, NY,9/92. Invited Plenary Lectures: At the Fall Meeting, Louisiana Psychiatric Association, Destin, Florida, 1992: a) "Theoretical Background and Literature Underlying Psychopharmacotherapy and Marital/Family Therapy Combinations" b) "The New Algorithms for Combining Marital/Family Therapy with Drug and Other Psychotherapies" Invited Lecture, "The Role of Psychotherapy in Combination with Pharmacotherapy," as part of a symposium, "Bipolar Disorder: Current Progress and Future Directions in Diagnosis and Management," sponsored by Stanford University School of Medicine, San Francisco, October, Workshop, "The Millennium Has Arrived: Suggestions for a New Model of (and Research Questions about) Hospital Treatment of Psychiatric Disorders," Institute on H&CP, Toronto, October, Grand Rounds, "Combining Medication and Psychosocial Strategies for the Treatment of the Major Psychoses." Stanford University Medical Center, Stanford, CA, November, Grand Rounds, "Effectiveness in Psychiatric Care: What Happens to the Patient and Family After Hospitalization." Creedmoor Psychiatric Center, New York, December, At the Annual Meeting of the American College of Neuropharmacology (ACNP), Puerto Rico, December 1992: Paper, Treatment Strategies in Schizophrenia, (with 12 co-authors) Invited Lecture: "Combining Treatments to Improve Outcomes: A Follow up Study of Major Affective Disorders in Italy, Japan and the United States." Bronx District Branch of the American Psychiatric Association, New York, March, At the Annual Meeting of the American Psychiatric Association, San Francisco, May, 1993: 12/31/

83 Invited Speaker for the Annual Review of Psychiatry Series, the Combined Treatments Symposium, Combining Medications with Family Psychotherapy (with Scott Goldsmith and John Clarkin) Workshop, Medication and the Italian Reform (with L. Mosher, G. Palermo and A. Bartolomeis) Lecture: "Increasing Effectiveness of Psychiatric Inpatient Care." Medical Staff, Dept. of Psychiatry, Stanford University Hospital, September, Grand Rounds, "Effectiveness in Psychiatric Care." Dept. of Psychiatry, Bronx-Lebanon Hospital Center, Bronx, NY, November At the Annual Meeting of the American College of Neuropharmacology (ACNP), Hawaii, December 1993: Paper, Promising New Medications for Schizophrenia not Available in the U.S.A., (with five co-authors) as part of the European College of Neuropsychopharmacology panel, Are You Missing Anything? Recent Psychotropics Available in Europe, But Not in U.S.A. (Chair, Stuart Montgomery) Poster, Promising Psychopharmacologic Medications not Available in the U.S.A. (with five co-authors) Lecture: "Medication Combined With Couples Treatment" as part of a symposium, "Clinical Pharmacology: An Update", Stanford University School of Medicine, January, Grand Rounds: The Role of the Psychiatric Hospital in the 1990 s, Langley Porter Psychiatric Institute, UCSF, San Francisco, March Grand Rounds: New Strategies for the Treatment of Acute and Chronic Schizophrenic. California Medical Facility, Vacaville, CA. April Grand Rounds: Atypical Antipsychotic Medications, Sacred Heart General Hospital, Eugene OR, April 1994 Invited Presentation: A Cross Cultural Study of Treatment of Mood Disorders in Italy, Japan and the United States, The Northern California Psychiatric Society 1994 Annual Meeting, Olympic Valley, CA, April, Lecture: New Strategies for Treatment of Acute and Chronic Schizophrenia as part of a symposium, New Approaches to Treating Schizophrenia. Stanford University School of Medicine, May /31/

84 Paper: Psychiatric Aspects of Basketball Annual Meeting, International Society of Sports Psychiatry, Philadelphia, May Poster: Efficacious and Safe Psychotropics Not Available in the US., 1994 Annual Meeting, Society of Biological Psychiatry, Philadelphia, May Training Seminar: The Legal - Psychiatric Interface, for San Francisco, Santa Clara & San Mateo judges and other legal mental health professionals, San Jose, CA, August, Keynote Address, "Combining Medication with Psychosocial and Rehabilitation Strategies in the '90s": sponsored by the Department of Psychiatry, University of Saskatchewan and the Department of Psychiatry, University of Alberta Hospitals, presented at Edmonton, Saskatchewan, and at Kingston,Canada, October, Grand Rounds, "Combining Medications and Psychotherapy in the 1990's: Researching Clinical Issues". California Pacific Medical Center, San Francisco, October, Grand Rounds, "Changing Models of Psychiatric Care: Psychiatric Hospitalization for the 90's." Chope Hospital & San Mateo Health Services Agency, San Mateo, CA, November, Poster: "Current European Clinical Trials of Anti-Dementia Drugs," (with Shwartz GE, Montgomery S, Klein F) at the 1994 Annual Meeting of the American College of Neuropsychopharmacology, San Juan, Puerto Rico, December, Grand Rounds, "Combining Psychotherapy and Drugs in the 1990's." Department of Psychiatry, University of Arizona Health Sciences Center, Tucson, January, Lecture: "Combining Psychotherapy & Pharmacotherapy" as part of the 1995 Annual Meeting of the American College of Psychiatrists, Acapulco, Mexico, February, Grand Rounds, "Diagnosis and Treatment of Psychotic Disorders Related to Parturition" Department of Ob/Gyn, Stanford University School of Medicine, March, At the Biannual International Congress on Schizophrenia Research (ICSR), Warm Springs, VA, May, 1995 Poster: Lithium Augmentation Fails to Reduce Symptoms in Poorly Responsive Schizophrenic Outpatients, (withschultz SC, TSS Collaborative Study Group). Poster: Promising Psychopharmacologic Medications Not Available in the USA, Glick, ID, (with Lecrubier Y, Montgomery S, Vinar O, Klein DF). Clinical Update: "The Forces Forming Character," at the 1995 Annual Meeting of the Northern California Psychiatric Society,Pacific Grove, CA, April, /31/

85 Keynote: "Combining Family Therapy with Medication for the Treatment of Axis I Disorders." as part of seminar, Effective Approaches: Working With Children, Adolescents and Their Families. Tender Lion Family Program, Family Service Agency of San Francisco, April Grand Rounds: "New Strategies for Treating Schizophrenia," Eden Hospital, Castro Valley, CA, May, Poster: "New Psychopharmacologic Strategies for Treatment," (with Braff D, Janowsky D) at the 1995 Annual Meeting of the Society for Biological Psychiatry, Miami, FL, May, Grand Rounds: "The Effectiveness of Family Therapy for Inpatient Psychiatric Patients, Department of Psychiatry, School of Medicine, UC Davis, and Sacramento County Mental Health, Sacramento, November, Grand Rounds: "Psychiatric Hospitalization for the 90's," Napa State Hospital, Napa, CA, December,1995. At the Annual Meeting of the American College of Neuropsychopharmacology (ACNP), Puerto Rico, December Mentor: Travel Awardee. Poster: New Treatment Strategies, (with Braff D, Janowsky D). Poster: Treatment Outcomes of First Episode & Chronic Multiepisode Schizophrenia, (with Lieberman J, et al). Study Group: A Psychopharmacologic Jam Session: A Dialogue on Tricks of the Trade, (with Janowsky D, Klein D, Schatzberg A) Lecture: "Family Therapies: Efficacy, Indications and Therapy Outcomes." Annual Meeting of the American Psychopathological Association, New York, March, Lecture: "Pharmacologic Treatment of Schizophrenia, at the 1st Stanford Review of Psychopharmacology Course, San Francisco, March, Grand Rounds: A Model Curriculum in Psychopharmcology for the 21st Century, San Mateo County General Hospital, San Mateo, March, Grand Rounds: Sertindole and New Antipsychotic Therapies for Schizophrenia, Atascadero State Hospital, Atascadero, CA, April, Grand Rounds: New Treatments and New Pharmacologic Strategies for Schizophrenia, Sutter Center for Psychiatry, Sacramento, CA, April, Lecture: Advancing the Treatment of Mania. Departments of Psychiatry, University of California, Irvine and University of Southern California, Los Angeles, CA, June, At the Annual Meeting of the American Family Therapy Academy, San Francisco, June /31/

86 Poster: Inpatient Family Intervention: Final Results from a Controlled, Random- Assignment Study, (with three others). Roundtable: The Family Model and Psychiatric Illness. Grand Rounds: Combing Medication with Family Intervention for Axis I Disorders, Hackensack Hospital Medical Center, Hackensack, NJ, September, International Congress: Schizophrenia: New Frontiers, Association for Research on Schizophrenia, Milan, October, Keynote: Family Associations and Family Therapy: From Conflict to Collaboration. Workshop: Psychoeducational Treatment of Schizophrenia: The Inpatient Family Intervention Study Experience Grand Rounds: Treatment Strategies in Schizophrenia: Final Results, Stanford University School of Medicine, Department of Psychiatry and Behavioral Sciences, Stanford, CA, November, Grand Rounds: New Drugs and New Strategies in Schizophrenia, Menlo Park Veterans Administration Hospital and Palo Alto Veterans Administration Hospital, Menlo Park and Palo Alto, CA, November, Grand Rounds: Combining Medication with Psychotherapeutic Intervention, Dept of Psychiatry, University of Miami School of Medicine, Miami, December, Grand Rounds: Atypical Antipsychotics & New Treatments/New Strategies for Schizophrenia Kaiser Hospital, San Francisco, CA, November, 1996 Central Missouri Psychiatric Society, St. Louis, MO, November, 1996 Boone County Medical Society, MO, November, 1996 Fulton State Hospital, Fulton, MO, November, Coutesville V-A Medical Center, Coutesville, PA, December, 1996 Institute of Pennsylvania, Philadelphia, PA, December, 1996 Arizona Alliance for the Mentally Ill, Phoenix, AZ, January, 1997 Good Samaritan Regional Medical Center, Phoenix, AZ, January, 1997 Porter Hospital, Denver, CO, January, 1997 University of Colorado Health Sciences Center, Denver, CO, January, 1997 First Hospital, Vallejo, CA, February, 1997 Mercy Memorial Hospital, Ardmore, OK, March, 1997 St Mary s Hospital, Colorado West Mental Health Meeting, Grand Junction, CO, April, 1997 Lakeview Veterans Administration Hospital, Chicago, IL, June, 1997 California Psychiatric Society South Coast Chapter, Santa Cruz, CA, July, 1997 County of Santa Cruz Community Mental Health Services, Santa Cruz, CA, July, 1997 Fulton State Hospital, Fulton, MO, August, 1997 Department of Psychiatry, School of Medicine, University of Missouri, Columbia, MO, August, 1997 Flower Hospital, Toledo, OH, September, /31/

87 International Health Care, Salt Lake City, UT, September, Napa State Hospital, Napa, CA, Sacred Heart Medical Center, Spokane, WA, October, John George Psychiatric Pavilion, San Leandro, CA, November, Tampa General Hospital, Tampa, FL, February, Florida Hospital, Orlando, FL, February, Peninsula Hospital, Burlingame, CA, January, At the Annual Meeting of the American College of Neuropsychopharmacology (ACNP), Puerto Rico, December, Study Group: A Psychopharmacologic Jam Session:Tricks of the Trade, moderator and participant. Poster: New Psychotropic Drugs for Axis I Disorders: Recently Arrived, In Development, and Never Arrived (with Belanoff J, Golden W). Grand Rounds: Inpatient Family Intervention: A Controlled Study, National University of Taiwan, Taipai, Taiwan, December, Grand Rounds: Combining Medication with Family Intervention for Axis I Disorders, Texas Tech Health Sciences Center, Amarillo, TX, January, Medical Students Forum: Working With Families of Seriously Ill Patients, Texas Tech Health Sciences Center, Amarillo, TX, January, Grand Rounds: Combined Therapy for Treatment of Axis I Disorders, First Hospital Vallejo, Vallejo, CA, February, Research Seminar: Treatment Strategies in Schizophrenia: Final Results, Department of Psychiatry, College of Medicine, University of Iowa, Iowa City, IA, March, Grand Rounds: Combining Medicine in Psychosocial Intervention, Department of Psychiatry, College of Medicine, University of Iowa, Iowa City, IA, March, Keynote: New Developments in Antipsychotics, Western Colorado Psychiatric Meeting, Colorado Springs, CO, April, International Congress on Schizophrenia Research, Colorado Springs, CO, April Poster: New Psychotropic Drugs for Schizophrenia (with Belanoff J). Grand Rounds: Diagnosis and Treatment of Schizophrenia, St. Vincents Hospital, New York, NY, April Invited Seminar: New Treatments for Agitation and Aggression in Axis I Disorders, University of Medicine and Dentistry of New Jersey, Piscataway, NJ, April, /31/

88 Lecture: Current Concepts in the Treatment of Schizophrenia, Conference: Understanding and Treating Schizophrenia: Progressing into the Next Century, Ann Arbor, MI, April, At the Annual Meeting of the American Psychiatric Association, San Diego, CA, May, 1997: Paper: New Strategies and New Treatments for Schizophrenia, (with Belanoff J and DeBattista C). Paper: The Professional Athlete as Role Model. Poster: The Teaching of Psychopharmacology in the 1990 s, (with Klein D, Doraiswamy M, Lydiard B). NCDEU Annual Meeting, Boca Raton, FL, June, Lecture: Combining New Antipsychotics with Psychosocial Intervention in the 1990 s, St. Lawrence Hospital, E. Lansing, MI, September, Lecture: Combining New Antipsychotics with Psychosocial Intervention in the 1990 s, as part of the program, Contemporary Issues in Psychiatry. Huran Valley Center, Yipsilanti, MI, September, Lecture: New Treatment Approaches for Psychosis in the Elderly, McComb Hospital, Detroit, September, Grand Rounds: New Treatments for Schizophrenia, Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, October, Grand Rounds: New Treatments for Schizophrenia, Department of Psychiatry, School of Medicine, Indiana University, Indianapolis, IN, November, At the 36th Annual Meeting of the American College of Neuropsychopharmacology (ACNP), Waikoloa, HI, December, Poster: The Teaching of Psychopharmacology in the 1990 s, (with ASCP Committee)). Poster: Extrapyramidal Symptom Profile of Sertindole, (with L. Ramirez) Continuing Education Update on Schizophrenia, for Neuroscience Regional Research Managers, Eli Lilly Co., at Stanford University School of Medicine, February, Expert Breakout Session (Schizophrenia). Second Stanford Psychopharmacology Review Course. Stanford, CA, March, Lecture: New Treatments and New Strategies for Schizophrenia: New Data, West Coast College of Biological Psychiatry, Palo Alto, California, Lecture: Progress in Psychoses: Improving Treatment and Evaluation, Enhancing Cognition, Continuing Medical Education Seminar, Los Angeles, April, /31/

89 Grand Rounds: Combining Medication with Psychotherapy, Weber County Mental Health Center, Ogden, Utah, April, Grand Rounds: New Treatments and New Strategies for Schizophrenia, University of California at Irvine, Irvine, California, April Grand Rounds: New Treatments and New Strategies for Schizophrenia, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, May Grand Rounds: Combining Medication and Psychotherapy for Psychiatric Disorder, North Shore University Hospital, Great Neck, New York, May Grand Rounds: Combining Medication with Psychotherapy, Department of Psychiatry, Wright State University School of Medicine, Dayton, Ohio, May, Grand Rounds: The Patient, the Family and Medication, Palo Alto and Menlo Park Veterans Administration, California, June, At the Annual Meeting of the American Psychiatric Association, Toronto, May, 1998: Industry Symposium: New Atypical Antipsychotics: Data versus Clinical Experience, Chair and lecturer: Lecture 1: History of Somatic Therapy for Schizophrenia Lecture 2: Combining Medication with New Antipsychotics Grand Rounds: An Overlooked Serotonin Dopamine Blocker; Loxapine Revisited, Atascadero Forensic Center, Atascadero, California, September, Grand Rounds: New Atypical Antipsychotics, Department of Psychiatry, Louisianna State University, New Orleans, October, Lecture: Schizophrenia: Receptor Profiles & Efficacy, at the Continuing Education Seminar, Psychopharmacology 1998 Clinical and Research Update, sponsored by Department of Psychiatry, Stanford University and West Coast College of Biological Psychiatry, San Francisco, California, October, Invited Lecturer: Clinical Efficacy of Antipsychotics, at the World Psychiatric Association and the Mexican Psychiatric Association, Guadalajara, Jalisco, Mexico, October, Invited Lecturer: Combining Medication Therapy with Family Interventions, Bipolar Dirsorder Minifellowship, Stanford Univrsity School of Medicine, Palo Alto, California, November,1998 Grand Rounds: Combining Medication with New Antipsychotics, Herrick Hospital, Berkeley, California, November, /31/

90 Invited Lecturer: A Model Currriculum in Psychopharmacology, Payne Whitney Clinic and Cornell University Medical College, New York, December, At the Annual Meeting of the American College of Neuropsychopharmacology, Puerto Rico, December, 1998: Study Group: A Psychopharmacological Jam Session: A Dialogue on Psychosis, (Moderator and Participant) Poster: New Psychotropic Drugs for Axis I Disorders; Recently Arrived, in Development and Never Arrived, (with JK Belanoff and JS Ballon). Poster: The Teaching of Psychopharmacology in the 1990 s: The First Year Experience with the Model Curriculum, (with PM Doraiswamy, J Halper, DS Janowsky, DF Klein, RB Lydiard, J Osterheld, DW Preven, P Ross, NG Ward and S Zisook). Grand Rounds: Combining Medication and Psychotherapy for Axis I Disorders, Dept Psychiatry, College of Physicians and Surgeons and New York State Psychiatric Institute, New York, December, Grand Rounds: Combining Medications with Psychosocial Intervention for Axis I Disorders, Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, Texas, January,1999. Grand Rounds: Combining Medications with Psychosocial Intervention for Axis I Disorders, Department of Psychiatry, University of Texas at Houston, March, Symposium: Teaching Biological Psychiatry to Residents, West Coast College of Biological Psychiatry, Tucson, April, At the Biannual International Congress on Schizophrenia Research, Santa Fe, April, 1999: Poster: The Efficacy Spectrum for New Antipsychotics in Clinical Practice with S Marder, P Vasudevan. Poster: Comparisons of the Effects of the Newer Atypical Antipsychotics in the Treatment of Schizophrenia, with J Davis. Grand Rounds: Combining Drugs and Ps;ychotherapy for Axis I Disorders. Department of Psychiatry, University of Mississippi Medical Center, Jackson, May, At the Annual Meeting of the American Psychiatric Association, Washington DC, May, 1999: Paper Presentaton: A Model Psychopharmacology Curriculum (with DF Klein and B Lydiard, et al) Paper Presentation: Keeping the Athlete Functioning, (with J Horsfall). Invited Lectures: The New Atypical Antipsychotics - Efficacy and Outcomes, delivered in May, 1999 at Departments of Psychiatry in Japan at: St Marianna University, Tokyo Hiroshima University, Hiroshima 12/31/

91 Kyorin University, Tokyo Fukushima Medical University (joint sponsorship with the Fukushima Medical Society), Fukushima Invited Lecture: Psychopharmacology in Psychiatry. Department of Psychiatry, University Hospital Utrecht, The Netherlands, August Grand Rounds: New Treatments for Psychoses. The Netherlands, August, Vincent van Gogh Hospital, Venray Delta Hospital, Poortugal Workshop: Annual Meeting of the Association for Academic Psychiatry, New Orleans, October, A Followup Evaluation of a Model Curriculum in Psychopharmacology, 1999 Workshops: Northwest Medical Health Institute and Oregon Psychiatric Association, Gleneden Beach, Oregon, November, New Treatments for Psychosis in the Year 2000 Combining Medication with Psychotherapy for Axis I Disorders Grand Rounds: Combining Medication with Psychotherapy for Axis I Disorders. Santa Barbara County CMHC, Santa Barbara, November, Grand Rounds: New Short and Long-term Strategies for Schizophrenia, Bipolar Disorder and Depressive Disorder. Department of Medicine, Stanford University School of Medicine, December, Grand Rounds: Teaching Psychopharmacology in the New Millennium. Department of Psychiatry, University of Hawaii at Manoa, December, Study Group Presentation: Clozapine Treatment Resistance: What Does it Mean? New Methodological Issues in the Study of Treatment Refractory Schizophrenia, at the Annual Meeting of the ACNP, Acapulco, Mexico, December, Invited Lecture: New Treatments and New Strategies for Psychosis for the Millennium, 2000 Annual Meeting of the Philippine Psychiatric Association, IIilo, Philippines, January, Grand Rounds: Combining Medical and Psychosocial Interventions for Schizophrenia. Grand Rounds Presentation at Nihon University and Keio University, Tokyo, Japan, February, Workshop: Organizer and Moderator, Introduction to Neuropsychopharmacology: Pathophysiology to Clinical Practice. A Workshop for the Neurobiology Unit, Roche Bioscience. Palo Alto, CA, February, Lectures: 12/31/

92 Overview of New Medication Strategies for Axis I Disorders Schizophrenia Clinical Trials Design (with Alan Schatzberg) Invited Lecture: Long Term Maintenance: Risperidol versus Haldol. In the symposium, Psychosis: New Perspectives and Strategies, Monte Carlo, March, Korea: April, 2000 Grand Rounds: Indications for New Antipsychotics, Seoul National University, Seoul. Invited Lecture: New Treatments for Bipolar Disorders, Annual Meeting, Korean Psychopharmacology Association. New Antipsychotics for Bipolar Disorder, Samsung Hospital, Seoul. Regional Symposium, Kyong-Ju, New Antipsychotics for Bipolar Disorder. Regional Symposium, Kwang-Ju, New Antipsychotics for Bipolar Disorder. At the 2000 Annual Meeting of the American Psychiatric Association, Chicago, May, Industry-supported Symposium: New Antipsychotics: From Practice to Theory. - Co-chair and Paper, The Efficacy Spectrum for Atypicals in Clinical Practice. Symposium: Psychopharmacological Approaches to the Athletic and Exercise Population. - Paper, Diagnosis and Psychiatric Treatment of Athletes. Media Session: - Cultural Identity on the Tex Mex Border: Impact on Relationships Past and Present, discussion of movie, Lone Star, Chair and Presenter Co-Chair, Forum, The Future of Psychopharmacology: Generativity and Mentoring at the NCDEU Annual Meeting, Boca Raton, May, Grand Rounds: Combining Medication with Psychotherapeutic Intervention for Axis I Disorders. Department of Psychiatry, University of California at San Diego, June, Grand Rounds: Atypical Antipsychotics. Alameda Center for Behavioral Healthcare, June, Sabbatical, New Zealand and Australia, July-August, 2000 New Zealand Grand Rounds, New Treatments for Psychosis, Dept Psychiatry, School of Medicine, Otago University, Dunedin, July, Australia (August, 2000) All grand rounds presentations or as invited lecturer for community mental health practitioners and students on 1) atypical antipsychotics, 2) combining medication with psychotherapy and/or 3) the teaching and learning of pharmacotherapy. Brisbane 12/31/

93 Royal Brisbane Hospital Princess Alexandra Hospital Prince Charles Hospital Ipswich Hospital and Wolsten Park Hospital Sydney Royal North Shore Hospital Macquarie Hospital Hornsby Hospital and Manley Hospital Cumberland Hospital Nepean Hospital St. Vincents Hospital Melbourne Royal Melbourne Hospital St. Vincents Hospital Alford Hospital Teleconference: Hallarat, Bendigo, Hobart, Warrnambool and Trarigan Hospitals EPPIC Mental Health SKY Unit Round Table with Professors of Psychiatry, Victoria Plenary Lecture: New Trends in Treating Psychosis regional symposium Adelaide Royal Adelaide Hospital, Glenside Campus Lecture, Southern Australian Psychiatrists Perth Graylands Hospital Lectures, Psychiatrists both Southern and Northern regions Queen Elizabeth Hospital Grand Rounds: New Drugs for Brain Disorders. Department of Pharmacology and Toxicology, College of Pharmacy, University of Texas, Austin, September Grand Rounds: Combining Medication and Psychotherapy. Department of Psychiatry, University of Texas, San Antonio, September Invited Speaker: New Drugs for the Treatment of Psychoses. Central California Psychiatric Society, Fresno, September Workshop: The Nuts and Bolts of Psychiatric Course Planning in the New Millennium Annual Meeting of the Association of Academic Psychiatry, Vancouver, October, 2000 (with Rona Hu). Grand Rounds: The New Atypical Antipsychotics. Western State Psychiatric Hospital, Seattle, November, Invited Lecturers: US Psychiatric and Mental Health Congress, San Diego, November /31/

94 Combining Medication and Psychotherapeutic Intervention Diagnosis and Psychiatric Treatment of the Elite Athlete Grand Rounds: Cutting Edge Inpatient Pharmacotherapy. San Mateo Community Mental Health Service. San Mateo, November Postgraduate Education Seminar, for Lilly Pharmaceutical Co. (Japan). Treatment of Psychosis in the New Millennium, Dec At the 2000 Annual Meeting of the ACNP, Puerto Rico, December, 2000 Study Group: Comparing Antipsychotics: What Do We Really Know? Chair and Presenter; (with Rajiv Tandon, Moderator). Poster, A Model Psychopharmacology Curriculum (with the ASCP Committee) Poster, The Efficacy and Extrapyramidal Side Effects of the Atypical Antipsychotics (with J. Davis). Grand Rounds: New Antipsychotics Controversies and Questions. Palo Alto Veterans Administration, Palo Alto, January Invited Lecture: Psychosis and Atypical Antipsychotics, at the conference Psychopharmacology in the Year 2001, sponsored by the American Society of Clinical Psychopharmacology, Maui, February Grand Rounds: New Treatments for Psychosis. Maui Community Mental Health Center, Maui, February Preceptor: Update on Schizophrenia. Pfizer Preceptorship, Stanford, CA, February Invited Lectures: Japan, March 2001 Combining Medication with Psychosocial Intervention for Treatment of Schizophrenia, at 1) Department of Psychiatry for School of Medicine, Hiroshima University, 2) at Kita-Kyusyu University, Kyushu, and 3) at the National Center of Neurology and Psychiatry (NCNP), Tokyo. Atypical Antipsychotics, for the Department of Psychiatry, School of Medicine, Chiba University, Chiba. Grand Rounds: Long-term Treatment of Schizophrenia in the Community. Santa Maria County Mental Health Center, Santa Maria, CA, April Lecture: Treatment of Geriatric Psychosis. St Johns Medical Center, Oxnard, CA, April Grand Rounds: Atypical Antipsychotics. Santa Barbara College Hospital, Santa Barbara, CA, April /31/

95 Invited Lecture: Diagnosis and Management of Treatment-Resistant Schizophrenia, at the symposium, Psychiatric Care in Community Residential Setting, sponsored by the Los Angeles County of Mental Health and the Southern California Psychiatric Society, Los Angeles, CA, April At the 2001 Annual Meeting of the American Psychiatric Association, New Orleans, May, Chair, Industry Symposium, A New Era for Managing Psychosis: Rebuilding Lives for Patients and Families. Paper, Consumer Organizations May Improve Medication Compliance. Poster, The Efficacy and Extrapyramidal Side Effects of the Atypical Antipsychotics, with Davis, J. Poster, Ziprasidone s Benefits Versus Olanzapine on Weight and Insulin Resistance. Presentation, A Model Curriculum in Psychopharmacology, at the workshop, Teaching Psychopharmacology to Residents Using Evidence-based Algorithms. NCDEU 2001 Annual Meeting, Phoenix, May, 2001 Poster, The Efficacy and Extrapyramidal Side Effects of the Atypical Antipsychotics. Co-Chair, Workshop, Mentoring Throughout the Professional Life Cycle: Challenges and Lessons (with A. Gelenberg) 7 th World Congress of Biological Psychiatry, Berlin, Germany, July 2001 Poster, Ziprasidone vs Olanzapine: Weight, Lipids, Insulin. Grand Rounds: New Antipsychotics: Ziprasidone. Kaiser, Santa Teresa, San Jose, August CME Lecture: Schizophrenia: New Treatment Dimensions, at the program, Psychopharmacology Clinical and Research Update, sponsored by the West Coast College of Biological Psychiatry, San Francisco, CA, October Grand Rounds: New Antipsychotics: Current Controversies. Menlo Park Veteran s Administration Hospital, Menlo Park, December, At the 2001 Annual Meeting of the American College of Neuropsychopharmacology, Hawaii, December Chair, Special session, Teaching Neuropsychopharmacology, and presentation, The Teaching of Psychopharmaclogy: Who Does It? With What Materials?) Poster, Improving the Teaching of Psychopharmacology: Circa 2001, (with D Janowsky and S Zisook). Poster, The Efficacy of Atypical Antipsychotics Compared to Typical Antipsychotics: A Meta-Analysis Revisited, (with N Chen and J Davis). 12/31/

96 Lectures: Current Controversies Around the New Atypical Antipsychotics, at the Nevada Adult Mental Health Center, and the Psychiatry Dept, Nevada Dept of Corrections, Reno, Nevada, Dec Grand Rounds: Advancements in the Management of Schizophrenia. Spokane Community Mental Health Center, January, Grand Rounds: Schizophrenia: The New Atypical Antipsychotics. Dept of Psychiatry, Oregon Health Sciences University, Portland, Oregon, January, Grand Rounds: New Data and New Indications for the Atypical Antipsychotics in Both Psychotic and Non-psychotic Disorders. Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, March, Invited Lecture: The Use of New Antipsychotic Agents to Treat Bipolar Disorder, as part of a CME course on treating Bipolar Disorder. Department of Psychiatry, UC Davis, Sacramento, CA, March, Grand Rounds: Clinical Management of Psychosis: The Short- and the Long-term. UCLA Neuropsychiatric Institute, Los Angeles, CA, April, Grand Rounds: Fiscal Pharmacology of the Atypical Antipsychotics. Napa State Hospital, Napa CA, April, CME Lecture: Stabilizing the Dopamine-Serotonin System: A New Era in the Treatment of Psychosis. San Diego, CA June, Grand Rounds: The Efficacy of Atypical Antipsychotics: A Meta-analysis Revisited. Manhattan State Hospital, New York, New York, June Sabbatical, Japan, July 2002 Plenary Lectures: The New Atypicals: New Data and Controversies at the symposium Challenges and Opportunities in the Management of Schizophrenia, Osaka and Tokyo, July, Grand Rounds: The New Atypicals: Challenges and Opportunities, 1) Kyoto University, 2) Sapporo Medical School, 3) Tokushima Medical School and 4) Okayama International Hospital. CME Lecture: Borderline Personality Disorder, Medication and the Family. Conference, on Borderline Personality Disorder, Research and Treatment, Stanford University Medical Center, September, Grand Rounds: The New Atypicals. Northwest Behavioral Healthcare, Department of Mental Health, Northfield, Ohio, September, /31/

97 CME Lecture: Novel Antipsychotics: What We ve Learned; What We Need to Know. Case Western Reserve University School of Medicine, Cleveland, September, CME Lecture: New Steps in the Evolution of Antipsychotics: The Role of Partial Agonists, Sponsored by Bristol-Myers Squibb and Otsuka Pharmaceutical: San Diego, June, 2002; San Francisco, September, 2002; New York City, September, 2002; Seattle, March, 2003; Phoenix, April, 2003; Long Island, May, Grand Rounds: The New Atypicals. Metropolitan State Hospital, Los Angeles, Sept Grand Rounds: The New Atypicals. San Joaquin Community Mental Health Center, Fresno, September Lecture: Mental Illness and the Workplace. Section on Labor Law, Annual Meeting of the State Bar of California, Monterey, October Grand Rounds: The New Atypicals. San Francisco Veterans Administration Hospital, San Francisco, October Grand Rounds: Update on the Atypical Antipsychotics. Department of Psychiatry, University of California at San Diego, San Diego, October Grand Rounds: Aripiprazole and the New Antipsychotics. Mood Disorders Program, UCSF, San Francisco, November CME Lecture: The New Antipsychotics: Are There Differences? First West Coast ASCP Psychopharmacology Symposium, San Francisco, November, Lecture: Aripiprazole Efficacy and Safety. Continuing Education Meeting, BMS, Laguna Nigel, CA November Grand Rounds: Second Generation Antipsychotics: New Data and New Dilemmas. Napa State Hospital, Napa, CA, December At the 2002 Annual Meeting of the American College of Neuropsychopharmacology, Puerto Rico, December 2002: Chair, Second Annual Session on Teaching Neuropsychopharmacology, and presentation of paper The ASCP Model Psychopharmacology Currticulum: New Scope and New Audiences. Poster: Cocomitant Psychotropic Medication Use in a Two-Year Study Comparing Clozapine and Olanzapine for the Prevention of Suicidal Behavior. 12/31/

98 Poster: A Meta-analysis of the Efficacy of Second-Generation Antipsychotics, (with John Davis) National Teleconference: Improving Outcome in Schizophrenia. Psychlink, Dallas, TX, January Grand Rounds: Update on Mood Disorders. Carlisle Hospital, Carlisle, PA, January Public Lecture: The Changing American Family: New Roles, Opportunities and Challenges for Men, Women and Children. Dickinson College, Carlisle, PA, January Lecture: The New Atypicals and Treatment of Psychoses at the 2003 Biannual CME Conference. University of Wisconsin School of Medicine and Madison Institute of Medicine, Madison, WI, March Plenary Lectures: Annual Meeting Central California Psychiatric Society, Monterey, CA, March Combined Treatment of Axis I Disorders The New Atypicals Invited Lecture: Recent Advances in Treatment of Schizophrenia. Stanford University School of Medicine Seventh Psychopharmacology Course, Update in Psychopharmacology Clinical Case Conference, Stanford, March, Poster: The Efficacy of Atypical Antipscychotics Compared to Typical Antipscychotics: A Meta-Analysis. (with N Chen and J Davis). International Congress of Schizophrenia Research, Colorado Springs, CO April, Presentation: Effectiveness of Aripiprazole. Regional Advisory Council Bristol Myers- Squibb, Phoenix, AZ, April, Grand Rounds: New Atypicals: New Medications and New Controversies. LSUHSC, Shreveport, LA Baton Rouge CMHC, Baton Rouge, LA, April 2003 Grand Rounds: Atypicals: New Drugs New Controversies. St. Peter Regional Treatment Center, St. Peter, MN, May Invited Lecture: Combining Medication with Psychotherapy. St. Luke s Hospital, Dept of Psychiatry, Racine, WI Rogers Memorial Hospital, Dept of Psychiatry, Milwaukee, MN, May At the 2003 Annual Meeting of the American Psychiatric Association, San Francisco, May, /31/

99 Lecture, Clinical Considerations in the Management of First-Episode and Acute Exacerbation of Schizophrenia, as part of the industry-supported symposium, Managing the Spectrum of Psychotic Disorders. Discussion, as part of an Issue Workshop: Psychiatric Perspectives on the Execution Process: A Continuing Conundrum, with HJ Osofsky, RK Bailey, AM Freedman, AL Halpern, DM Mancuso.Lecture: Overview of the Efficacy of 2 nd and 1 st Generation Antipsychotics, as part of an APA symposium, Meta-Analyses of the Efficacy of 2 nd vs 1st-Generation Antipsychotics, chaired by ID Glick and JM Davis. Discussion, Efficacy of Atypicals in Acute Care Settings, as part of an industrysupported symposium, Best Practices in Antipsychotic Use. Plenary Speaker: Update on Care and Treatment of Schizophrenia. Southeast Regional Committee, National Alliance for the Mentally Ill, Pennsylvania Chapter. Norristown State Hospital, Norristown, PA, June Grand Rounds: Atypicals: New Drugs and New Controversies, June Milwaukee Veterans Administration Milwaukee County Mental Health Clinic Winnebago Mental Health Clinic Colloquium: Recent Trends in the Development of Novel Antipsychotics. Atascadero State Hospital, CA, July Grand Rounds: Combining Medication with Psychotherapy to Improve Compliance. Santa Clara Valley Mental Health Center, August Invited Lecture: A Meta-analysis of Antipsychotic Medications Are the Secondgeneration Agents Better than the First-generation Agents? 1) Westchester Medical Center and 2) Rockland State Hospital, August, Lecture Tour: First vs Second Generation Antipsychotics: Efficacy and Use of Polypharmacy Strategies. Asahiyama, Tottari, Osaka, Fukuoka and Saga, Japan, September, Grand Rounds: The New Atypical Antipsychotics, Phoenix, October 2003, Good Samaritan Hospital Phoenix V.A. Hospital CME: Management of Treatment Refractory Schizophrenia, UC Davis and Sacramento County, September Grand Rounds: Use of Atypicals in Special Populations, at the Medical College of Georgia and at Augusta VA Psychiatric Hospital, Augusta, GA, October, /31/

100 Grand Rounds: New Treatments for Psychosis, at the Mayo Clinic, at the University of Minnesota Medical School and at Minneapolis VA Medical Center, October, Grand Rounds: New Treatment for Treatment Resistant Schizophrenia, Kirby Forensic Psychiatric Center, New York City, November, At the Annual Meeting of the American College of Neuropsychopharmacology, Puerto Rico, December 2003: Study Group Co-Chair, New Comparative Studies of Antipsychotics: Evidence from Controlled Trials versus Clinical Practice and presentation on Efficacy of Antipsychotics. Chair, Third Annual Session on Teaching of Neuropsychopharmacology. Poster: Maintenance Therapy with Haloperidol Decanoate or Quetiapine. Poster: Issues Which May Determine Outcome of Antipsychotic Trials: Populations, Sponsorship, Design, etc. Poster: Update on Psychopharmacology Curriculums: Is There Any Relationship of Teaching to Clinical Practice? Grand Rounds: A Meta-analyses of the Efficacy of Antipsychotics, Harvard-Longwood Grand Rounds Services and Caritas St. Elizabeth s Hospital Series, Boston, January Invited Lectures, New Data, Treatments and Controversies about Schizophrenia and Psychosis, India, February, Goa Psychiatric Society Bombay Calcutta Gowati Dehli Kochin-Kerola Grand Rounds: Combining Psychotherapy with Medication: Is It Helpful? Kern Medical Center, Bakersfield, CA, April, Invited Lecture: Antipsychotics for Bipolar Disorder: Monotherapy an Adjunct? Central California Psychiatric Society, Bakersfield, April, At the Annual Meeting of the American Psychiatric Association, New York, May, 2004: Issue Workshop participant: Evidence-based treatment for schizophrenia in a correctional setting. Symposium discussant: Personality disorders in the workplace. Master Educator Clinical Consultation: Combining and integrating medication and psychotherapy for schizophrenia and other Axis I disorders. 12/31/

101 Grand Rounds: Practical Management of Psychoses at South Nevada Adult Mental Health Center, Las Vegas, May, At the Annual Meeting of NCDEU, Phoenix, June 2004 Poster: Maintenance Therapy with Haloperidol Decanoate and Quetiapine: A Controlled Random Assignment Study. Lecture: Families in the Treatment of Personality Disorders and Issues of Compliance. As part of the symposium Personality Disorders: Research & Treatment An Update. Stanford University Medical Center, June, Lecture: Terrorism, Changing Family Roles and Functions and Women s Wellness: Part II. Women s Wellness Rounds, Stanford University School of Medicine, June, Grand Rounds: What Does Psychotherapy Add to Medication Alone for Axis I Disorders. Dept Psychiatry & Behavioral Sciences, Stanford Univ School of Medicine, Sept, 2004 Grand Rounds: Combining Medications and Psychotherapy. Dept of Psychiatry, University of Iowa School of Medicine, September, Grand Rounds: Antipsychotic Use in Special Populations. Dept of Psychiatry, UCSF University Medical Center, Fresno, CA, October, Lecture: New Treatments for Schizophrenia. Univ of Oklahoma Health Sciences Center, Oklahoma City, October, 2004 Grand Rounds: New Treatments for Psychosis. Fulton State Hospital, Fulton, MO, Oct, Grand Rounds: New Treatments for Psychosis. Dept of Psychiatry, University of Missouri, Columbia, MO, Oct, Grand Rounds: New Treatments for Schizophrenia. Dept of Psychiatry, Univ of Kansas School of Medicine, Wichita, KA, October, Lecture: New Treatments of Schizophrenia. North West Missouri State Hospital, Kansas City, KA, October, CME Program: A Workshop: Interpreting Mental Health Scales and Their Practical Application to Your Practice US Psychiatric and Mental Health Congress, October, Chair Lecture: Assessment Scales: How Are They Useful? 12/31/

102 At the Annual Meeting of the American College of Neuropsychopharmacology, Puerto Rico, December, 2004: Poster: New Developments in Teaching of Psychopharmacology, with Sid Zisook. Poster: Second Generation Atypicals vs. First Generation Decanoate, with Stephen Marder. Poster: Analysis of Industry vs Investigator Initiated Trials, with John Davis. Chair: Fourth Annual ACNP Teaching of Psychopharmacology session. Lecture: Combination Drug Strategies in Schizophrenia. As part of the symposium Stanford Psychopharmacology: Course and Clinical Update. Stanford University Medical Center, March, Lecture: Metabolic Issues of Atypical Antipsychotics. Dominican Santa Cruz Hospital, March, Consultant: Antipsychotic Drugs. Smith Barney Citigroup 2005 Healthcare Conference, Washington, D.C., March, 2005 (with John Kane, M.D. and Les Citrone, M.D.). At the 2005 Annual Meeting of the American Psychiatric Association, Atlanta, GA, May, Debate, Resolved: Seccond Generation Antipsychotics are Uniformly Superior in Safety and Efficacy to First Generation Antipsychotics. Moderator: Richard E. D Alli, MD Affirmative: Ira D Glick, MD, John M Davis, MD Negative: Rajiv Tandon, MD, William T Carpenter, Jr., MD Chair, Symposium, Use of Concomitant or Adjunctive Medications in Schizophrenia, Paper presentation, Efficacy of Concomitant Medications for Stabilized Patients with Schizophrenia, (with J Davis). Paper presentation, The Challenge of Teaching Psychopharmacology in the New Millennium: The Role of Curriculum (with S Zisook) as part of Symposium Teaching Psychopharmacology in the 21 st Century. Chair, Symposium, Inpatient Psychiatry: Crisis and Response. Paper presentation, Inpatient Psychiatry at the Turn of the Century (with G Carter & R Tandon). ASCP Corner: Challenges and Opportunities in Teaching Psychopharmacology During Residency Training. Zisook S, GlickI, Goldberg DA. J Clin Psychiatry 66:7, July 2005 Lecture: Careers in Geriatric Psychopharmacology: Collaboration with Big Pharma, at the Eleventh Annual Summer Research Institute in Geriatric Psychiatry, Stanford University, July /31/

103 Grand Rounds: Update on Schizophrenia and Bipolar Disorder. Sacred Heart Hospital, Spokane, WA, October, Grand Rounds: Update on Schizophrenia and Bipolar Disorder. American Lake VA, Tacoma, WA, October, CME Lecture: Overcoming the Issues of Noncompliance in Schizophrenia, at the 2005 U.S. Psychiatric & Mental Health Congress, Las Vegas, October, Grand Rounds: New Atypicals. Shasta Community Mental Health, Redding, October At the Annual Meeting of the American College of Neuropsychopharmacology, Hawaii, December, 2005: Chair: Fifth Annual Teaching Neuropsycopharmacology session: The Neglected Constituencies: Can Teaching About Psychopharmacology Change Attitudes and Practices? Paper: The Challenge of Teaching at the Academic-Industry Interface (with Terence Ketter). Invited CME Lecture: New Treatments for Schizophrenia, Psychopharmacology Update for Visiting Clinical Research Psychiatrists from Spain, Stanford University School of Medicine, January, Invited Lecture: Results From the CATIE Study as a part of the Stanford Psychopharmacology Course and Clinical Update. Stanford University Medical Center, March Grand Rounds: New Treatments for Schizophrenia. Bismarck Community Mental Health Center, Bismarck, North Dakota, April Invited Lectures: The CATIE Study: What Does It Mean In the Context of the Field, Japan, May, Tokyo Akita Fukuoa Nagoya Toshugi Hiroshima Saitama At the Annual Meeting of the American Psychiatric Association, Toronto, May, Poster: Clinical and Metabolic Impact of Switching Antipsychotic Therapy (with J Kim and G Reaven) Grand Rounds: The CATIE Study: New Results. Department of Psychiatry and Behavioral Sciences, Stanford, CA, June, 2006, 12/31/

104 At the Annual NCDEU Meeting, Boca Raton, Florida, June, 2006: Poster: A New Psychopharmacology Curriculum for the Teaching of Psychopharmacology. At the Biannual Meeting of the CINP (Collegium Internationale NeuroPsychopharmacologium, Chicago, July 2006 Presenter: The CATIE Study in Context, Debate, (Chair, H. Meltzer) CME Update: Meeting the Challenges of Obtaining Optional Outcomes in Schizophrenia; Improving Function Over the Long Run, (with Meltzer H, Altamura C and Lindenmeyer JP) CME Update: The CATIE Study. Fresno Community Mental Health Center, August Neuropsychiatry Collaborative Grand Rounds: New Advances in the Neuroscience and Treatment of Schizophrenia: The CATIE Study. Stanford University School of Medicine, September, 2006 At the APA 58 th institute on Psychiatric Services, New York, October, 2006: Workshop: Concomitant Medication in Schizophrenia: What We Know, Don t Know, and Ignore (with Miranda Chakos and Jay Patel) Poster: Metabolic Impact and Psychiatric Outcome of Switching Antipsychotic Therapy to Aripiprazole After Weight Gain (with J Kim and G Reaven). Grand Rounds: Combining Medication with Psychotherapeutic Intervention, Downstate Medical Center, SUNY, Brooklyn, October Grand Rounds: The CATIE Study: Clinical Implications, at the Porterville Developmental Center, and at the Tulare County Mental Health Clinic, Fresno, CA Invited Lectures: 1) The New Model of Acute Inpatient Treatment of Schizophrenia, and 2) Improving the Efficacy of Outpatient Treatment with Intramuscular Antipsychotic Treatment, China, November, Beijing Shanghei Sunya At the Annual Meeting of the ACNP, Hollywood, FL, December 2006 Posters: Onset of response with oral paliperidone extended-release tablets in patients with acute schizophrenia Metabolic impact and psychiatric outcome of switching antipsychotic therapy to aripiprazole after weight gain 12/31/

105 The challenge of teaching psychopharmacology in the new millennium: the role of curricula Chair, ACNP Teaching Neuropsychopharmacology Plenary (with S Zisook) Co-chair, Issues in Ethics Plenary session (with D Braff) Presentation: Working w/industry Collaboratively and Ethically Lecture: Schizophrenia: Current Treatment. Rockland Psychiatric Center, White Plains, NY, December Lecture: New Models for Inpatient Psychiatry and Partial Hospitalization Programs. Outpatient Psychiatric Services, Fairmont Hospital Campus, San Leandro, CA January, Lecture: CATIE Investigator Education Series. Los Angeles, Seattle and San Francisco, Winter, 2007 Grand Rounds: The CATIE Trial in Context. University of Utah Neuropsychiatric Institute (UNI), Salt Lake City, UT, February Lecture: Update on Treatment of Schizophrenia: Data from CATIE & Cutlass Trial. 11 th Annual Psychopharmacology Course & Clinical Update Stanford University School of Medicine, Department of Psychiatry & Behavioral Sciences, Stanford, CA, March, Lecturer: CATIE Investigators Educational Series, Los Angeles, San Francisco, Seattle, March, Invited Plenary Lecture: New Treatment Options for Schizophrenia, at the Global Meeting Training-the-Trainees (Paleperidone ER). Johnson & Johnson Pharmaceutical, Barcelona, Spain, May At the Annual Meeting of the Society of Biological Psychiatry, San Diego, May 2007 Presenter and Moderator: Workshop on Concomitant Medication in Schizophrenia (with Miranda Chakos) Poster: Determination of onset of response to treatment with paliperidone extended-release in patients with acute schizophrenia. At the Annual Meeting of the American Psychiatric Association, San Diego, May 2007 Paper: An Overview of the Field of Sports Psychiatry, as part of a symposium, How to Practice Sports Psychiatry: A Demonstration. Grand Rounds: Understanding and Treating Schizophrenia: Final Results from the CATIE Study. Stanford University School of Medicine, Stanford, May, Grand Rounds: The CATIE Study and New Treatments for Schizophrenia, at the MetroHealth Hospital and at the Department of Psychiatry, Case Western State University, Cleveland, June /31/

106 Invited Lecture. The New Model of Inpatient Psychiatry: Intensive Care and Beyond, Contra Costa Medical Center, Martinez, CA, November, At the Annual Meeting of the ACNP, Boca Raton, Florida, December, 2007 Co-chair, ACNP Teaching Neuropsychopharmacology An Epiphany for Psychopharmacology Education for Residents and Practitioners: A Demonstration (with Constantine Lyketsos); Presentation: Using a Model Curriculum for the Standard Lecture Format: Having the Content and Lighting the Fire, (with Sid Zisook). Posters: Industry sponsorship and outcome at antipsychotic trials (with John Davis) Do concomitant medications improve outcome of antipsychotic monotherapy for stabilized patients with non-acute schizophrenia? (with John Davis) Patterns of response with paliperidone ER and placebo in patients with schizophrenia (with C Bossie, C Canuso, Y Zhu and L Alphhs) Grand Rounds: Proven Efficacy in Schizophrenia: Highlights. Kaweah Delta Mental Health Hospital, Visalia, CA, January, 2008 Resident Forum: Schizophrenia Update, UCSF Fresno Center, Fresno, CA, January, 2008 Grand Rounds: Current Treatment of Schizophrenia after CATIE and CUtLASS. Department of Psychiatry, New York University School of Medicine, NY, March At the Annual Meeting of the American Psychiatric Association, Washington, DC, May Posters: Aripiprzole in the Treatment of Schizoaffective Disorder Patients: A Pooled Analysis from Two Randomized, Double-blind, Placebo-controlled Trials, first author. Patterns of Response with Paliperidone ER and Placebo in Patients with Schizophrenia, first author. At the NCDEU Annual Meeting, Phoenix, AZ, May, 2008 Poster: The efficacy of aripiprazole on the five dimensions of schizophrenia derived by factor analysis: Pooled data from five short-term studies (with Philip Janicak et al) Workshop: Psychopharmacology Education for Residents, Clinicians, and Industry Personnel: A Demonstration. Chair Presentation: Teaching Psychopharmacology: A Complete Curriculum At the XXVI CINP Congress 50 th Anniversary of the CINP, Munich, Germany, July, /31/

107 Paper: What have we learned from the present generation of multi-target agents for schizophrenia? How does pharmacology link to clinical actions? (with Davis J and Leucht S) Grand Rounds: Combining Medication and Psychopharmacology for Axis I Disorders. Northshore University Hospital, Glen Cove, New York, Sept 2008 At the Annual Meeting of the Association of Academic Psychiatry, Santa Fe, Sept, 2008 Poster: Going globally with a psychopharmacology curriculum for residents, medical students and clinicians. (with Zisook, S) Special Session: Problems & strategies of teaching cutting-edge clinical psychopharmacology for residents and medical students. Workshop: A group networking exercise to increase collaborative scholarship in writing. (with Hilty, D) At the Annual Meeting of the American College of Neuropsychopharmacology, Scottsdale, AZ, Dec Co-Chair, Teaching Neuropsychopharmacology Session. Teaching Psychopharmacology: Successes and Failures in Determining Whether Anyone Learned Anything (or Did the Message Get Across? ) 8 th Annual ACNP Educational Plenary Session: Presentation: Evaluating Med Student and Residency Competency in Psychopharmacology. Study Group: Long-Term, Large-Scale Clinical Trials of Psychiatric Medications and Treatment Strategies Chair: Ira Glick with D Klein, H Kraemer, T Insel, M Trivedi, J Coyne, J Csernansky Poster: Aripiprazole in Schizophrenia Patients wih Comorbid Obsessive-Compulsive Symptoms. Poster: Exploration of Placebo Response Found in Recently Conducted vs. Earlier Trials of Patients with Schizophrenia, with Larry Alphs, Ibrahim Turkoz, Carla Canuso, Cynthia Bossie. Grand Rounds: Barriers to Academic-Industry Education and Research Collaboration. Department of Psychiatry, Stanford University School of Medicine, Stanford, CA, Feb 2009 Panel Participant: Psychiatry and Pharma: Where Do We Draw The Line? Northern California Psychiatric Society, 50 th Annual Meeting, Monterey, CA, March, 2009, with Stotland S and Reus V. At the Annual Meeting of the American Psychiatric Association, San Francisco, May, /31/

108 A New Model for Acute Psychiatric Hospitalization, in the symposia, Advances in Hospital Psychiatry, with R Tandon. Family Intervention to Improve Efficacy and Effectiveness of Medication for Schizophrenia, as part of symposia on Optimizing Treatment Outcome in Axis I Disorders: Augmentation with Family Interventions. Grand Rounds: Berkshire Medical Center, Pittsfield, MA, July, 2009 Staying Current in Psychopharmacology Current Treatments of Schizophrenia Medical Expert Witness: at the Trial Academy, International Association of Defense Counsels, Stanford, July Invited Lecture. At the Department of Psychiatry, Polyclinic Hospital School of Medicine, University of Milan, October, Long-term Treatment of Schizophrenia The Art of Psychopharmacology Invited Participant The High Prevalence of Poor Medication Adherence in Schizophrenia, as part of a Forum, Value of Long-acting Therapies (LATS), supported in part by Janssen, Las Vegas, October, 2009 At the 3 rd International Forum on Innovation in Psychiatry, Milan, Italy, November, 2009 Long-term Antipsychotic Treatment: Modality, Problems and Comparisons At the 3 rd Annual International Brain Conference, Lake Buena Vista, FL, December, 2009 An Analysis of Recent Research on Schizophrenia: Long-term Safety and Efficacy of Antipsychotics At the 48 th ACNP Annual Meeting, Hollywood, FL, December, 2009 Poster: A Model Curriculum for Teaching Medical Students Psychopharmacology Poster: Family Presence and Support is Correlated with Outcome for Patients with Chronic Schizophrenia Chair, Teaching Neuropsychopharmacology, 9 th Annual ACNP Educational Plenary Sessison, The Impossible Dream: Keeping Up with Clinical Neuroscience & Psychopharmacology, Circa 2010 Lecture: A Radical Proposal for Staying Current Invited Lecture as part of the Parent-Education Series at Marin Academy, San Rafael, CA, Feb, 2010 Family Function and the Teen Years: Surviving, Let-alone Thriving. 12/31/

109 Invited Lecture at the 14 th Congress of the Italian Society of Psychopathology (SOPSI), Rome, Feb, 2010 Evaluation of the Efficacy of Atypical Antipsychotics on Major Psychosis with Longterm Treatment. Invited Lecture at the Northern California Psychiatric Society, 2010, Annual Meeting, Monterey, March, 2010 Cutting Edge Treatment for Schizophrenia: New Data and New Treatments for the Clinician At the 2010 APA Annual Meeting, New Orleans, May, 2010 Course organizer and lecturer for Psychopharmacology Master s Course, Staying on the Cutting Edge of Advances in Clinical Psychopharmacology Pharmacotherapy of Schizophrenia: Clinical Implications of New Research ASCP Psychopharmacology Course Combining Medication and Psychotherapeutic Intervention for Axis I disorders Panel: At the New Research Approach to Mental Health Intervention Meeting (NCDEU) Boca Raton, FL, June 2010, Combining Medication with Psychosocial Intervention to Improve Outcome of Axis I Disorders Combining Medication with Psychosocial Intervention to Improve Outcome of Schizophrenia (with Marder S) PHOTOGRAPHY: Training Tutorial - Mitch Heickin Published Photos 1995 Museo de San Isledefonso, Mexico City, in the New England J Medicine, Sept 7, 1995, p Golden Gate Morning, in the New England J Medicine, Aug. 30, 2001, pg Midnight, Fort Mason, in the New England J Medicine, Aug. 1, 2002, pg Nocturne, in the New England J Medicine, July 24, 2003, pg South American Psychiatric Hospital Series, cover Neuropsychopharm, Sept, Oct, Nov, Laundry, Gawati, India, in the New England Journal of Medicine, April 5, 2007, page Sunset, Botswana, NEJM, in press. 12/31/

110 Golden Gate Morning, Cover, J Neuropsychopharmacology, Dec, 2008, Jan & Feb, Golden Gate Bridge at Night, Cover photo for the American Journal of Psychiatry, Oct, Private Collections Jules Bernstein and Lisa Lipsett Garry K. Marshall Prizes Shows 1997 Third Place, Color, at the annual meeting of the Art Association of the APA (American Psychiatric Association), for Toroko Gorge, Taiwan Second Place, Black and White, at the annual meeting of the Art Association of the APA (American Psychiatric Association), for Castel del Monte, Italy 2000 First Place, Color, at the annual meeting of the Art Association of the APA (American Psychiatric Association), for Argentinian Tango, (Argentina) Honorable Mention, Color, at the annual meeting of the Art Association of The American Psychiatric Association, for Golden Gate Morning. Group Show, Presidio Nocturnes, at the Presidio Alliance, San Francisco, Dec-Jan, Group Show, Ft Mason and Environs (an exhibition that explores the night landscape and features over a dozen established and emerging Bay Area photographers), at the San Francisco Fort Mason Center, Nov Group Show, Art & Psychiatry, Dept Psychiatry, Stanford University School of Medicine, December One-Person Show, San Francisco Moods, Angelina s Café, San Francisco 12/31/